data_2ks1_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ks1 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.7 m . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.875 0.369 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.81 -48.45 81.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.12 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 62.1 t -53.1 -38.13 29.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.131 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 64.8 t -70.25 -37.42 71.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.11 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.12 -46.09 94.02 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.525 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.2 mp -70.9 -42.38 77.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.874 0.369 . . . . 0.0 111.117 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.1 mt -65.43 -34.94 79.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.888 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.0 mt -68.41 -46.76 69.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.936 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 97.0 t -60.3 -38.3 77.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.118 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 89.9 t -63.65 -51.82 65.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.125 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 62.0 t -62.52 -53.58 45.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.114 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.9 mt -60.33 -32.83 71.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.929 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.89 -47.92 81.29 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.458 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.6 t -75.07 -33.02 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.816 0.341 . . . . 0.0 111.08 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 73.9 t -70.71 -53.05 23.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.118 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -61.95 -44.29 97.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.5 -49.5 76.18 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.505 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 58.9 mt . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 120.879 0.371 . . . . 0.0 111.135 -179.972 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.841 0.353 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.51 -53.79 31.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.954 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.1 -55.43 20.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 10.8 mt -52.2 -45.22 65.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.922 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 1.4 tt -55.05 -46.99 75.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.942 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.78 -39.51 84.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.922 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 69.6 t -63.8 -47.98 88.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.068 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 36.5 t -64.76 -47.54 88.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.132 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.91 -35.69 66.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.046 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 1.7 tp -73.32 -38.82 65.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.887 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.4 -40.91 53.77 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.529 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 54.8 mt -73.59 -38.31 51.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.857 0.36 . . . . 0.0 111.104 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -69.06 -39.03 84.6 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.467 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 10.9 mt -71.66 -39.6 70.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.907 0.384 . . . . 0.0 110.907 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -69.41 -37.62 77.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.864 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.42 -28.58 59.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.88 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 14.2 ttt180 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.92 -179.946 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.8 m . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.907 0.384 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.58 -50.55 64.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.072 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 66.1 t -53.2 -44.75 53.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.128 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 65.6 t -65.9 -35.53 75.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.127 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.83 -46.23 94.06 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.47 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mp -70.6 -42.85 78.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.893 0.378 . . . . 0.0 111.088 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.5 mp -65.23 -35.25 80.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.92 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.5 mt -67.84 -46.33 72.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.931 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 84.9 t -60.89 -37.88 77.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.1 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 89.7 t -63.38 -53.02 50.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.127 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.9 t -61.12 -53.39 49.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.161 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 mt -60.3 -33.33 72.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.937 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.25 -47.96 83.43 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.486 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.8 t -74.91 -33.22 29.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.873 0.368 . . . . 0.0 111.079 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.7 t -70.37 -46.93 69.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.074 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -64.56 -48.84 73.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.911 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -56.62 -47.27 85.9 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.472 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 67.4 mt . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 120.896 0.379 . . . . 0.0 111.13 -179.964 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.792 0.33 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 11.9 tp -68.18 -50.02 57.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.915 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 7.8 tp -57.36 -53.4 58.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.927 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 16.5 mt -53.28 -45.73 68.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 12.4 tp -54.96 -46.4 75.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.92 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 1.3 tt -68.05 -39.94 82.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.871 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 74.6 t -63.59 -48.02 88.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.129 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 36.0 t -64.59 -47.5 88.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.101 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.87 -35.82 66.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.073 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 1.3 tp -73.33 -38.8 65.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.916 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.19 -40.89 55.05 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.505 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 54.8 mt -73.63 -38.75 52.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.907 0.384 . . . . 0.0 111.107 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -67.27 -40.95 92.13 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.471 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 11.5 mt -70.32 -41.08 73.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.853 0.359 . . . . 0.0 110.894 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -67.54 -37.43 82.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.878 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.65 -25.69 57.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.902 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 3.2 mmt85 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.897 -179.954 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.6 m . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.839 0.352 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.11 -51.15 62.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.133 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.5 t -53.35 -46.75 58.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.106 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 87.5 t -63.32 -35.88 73.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.137 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.95 -46.3 93.85 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.444 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.8 mp -71.12 -42.85 75.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.814 0.34 . . . . 0.0 111.118 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.32 -32.92 74.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.5 mt -69.55 -49.26 55.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.934 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 95.3 t -58.36 -39.05 72.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.122 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 93.5 t -63.7 -51.04 75.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.121 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.2 t -63.31 -53.56 44.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.185 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.0 mt -60.37 -32.84 71.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.926 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.02 -47.92 80.81 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.487 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.5 t -75.01 -32.94 27.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.825 0.345 . . . . 0.0 111.123 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.6 t -70.76 -51.44 36.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.118 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -62.42 -45.68 91.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.87 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -57.86 -49.2 76.69 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.542 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 59.8 mt . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.87 0.367 . . . . 0.0 111.114 -179.98 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.783 0.325 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 7.6 tp -61.87 -41.58 98.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.886 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.36 -55.03 36.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.926 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 15.9 mt -52.4 -46.36 66.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 3.6 tp -54.69 -46.55 74.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.869 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.09 -40.15 82.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.946 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 54.8 t -63.18 -47.74 90.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.105 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 36.2 t -64.87 -47.86 86.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.147 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.59 -35.13 65.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.154 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 1.1 tp -72.18 -39.76 68.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.956 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.23 -44.1 44.86 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.545 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 51.9 mt -69.4 -36.97 74.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.879 0.371 . . . . 0.0 111.161 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -71.37 -39.61 61.49 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.501 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 12.6 mt -72.13 -29.75 64.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.878 0.371 . . . . 0.0 110.899 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -81.27 -36.02 30.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.842 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.5 -29.54 61.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.913 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.862 0.363 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.0 -50.12 73.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.051 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 62.5 t -52.99 -37.5 26.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.124 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 89.8 t -70.72 -38.01 71.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.148 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.77 -46.03 94.51 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.443 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.2 mp -70.69 -42.38 77.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.901 0.381 . . . . 0.0 111.159 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.9 mt -65.41 -36.11 82.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.889 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.3 mt -67.79 -45.19 75.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.912 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 99.9 t -61.53 -37.71 78.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.101 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 89.4 t -63.95 -51.84 64.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.12 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.2 t -62.64 -53.45 46.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.17 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.1 mt -60.37 -33.62 72.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.897 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.08 -48.25 81.7 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.474 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.3 t -75.07 -32.93 27.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.913 0.387 . . . . 0.0 111.115 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 56.5 t -70.1 -52.13 33.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.164 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -63.08 -43.37 98.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.9 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.57 -48.67 83.21 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.472 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 58.1 mt . . . . . 0 C--N 1.328 -0.335 0 CA-C-O 120.91 0.386 . . . . 0.0 111.15 -179.989 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.851 0.358 . . . . 0.0 111.116 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 11.0 tp -65.55 -53.84 36.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.944 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 18.3 tp -52.74 -54.87 27.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 4.1 mt -53.4 -44.12 68.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.927 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 8.0 tp -54.98 -48.07 73.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.905 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.91 -39.51 87.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.933 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 50.0 t -63.52 -48.43 86.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.132 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 37.1 t -64.37 -47.45 89.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.177 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.77 -35.73 66.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.084 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.36 -38.85 65.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.37 -40.85 54.1 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.453 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 54.6 mt -73.6 -38.53 52.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.88 0.371 . . . . 0.0 111.112 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.71 -39.14 86.33 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.495 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 10.6 mt -71.66 -40.14 69.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.836 0.351 . . . . 0.0 110.926 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -68.79 -37.46 79.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.32 -28.61 61.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.872 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.888 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.3 m . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 120.892 0.377 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.05 -50.38 68.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.089 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 62.1 t -53.04 -37.32 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.119 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 92.0 t -71.09 -37.83 68.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.129 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.78 -46.07 94.41 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.438 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.2 mp -70.7 -42.36 77.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.822 0.344 . . . . 0.0 111.105 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.1 mt -65.41 -36.01 82.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.4 mt -67.69 -45.65 74.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.969 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 99.8 t -61.14 -38.05 78.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.075 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 89.5 t -63.56 -52.36 58.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.137 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.2 t -61.99 -53.47 47.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.072 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.34 -32.9 71.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.78 -48.39 77.32 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.49 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.2 t -74.45 -33.38 32.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.86 0.362 . . . . 0.0 111.085 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.6 t -70.32 -51.33 39.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.073 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -62.49 -46.25 89.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.905 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -57.35 -48.85 77.48 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.507 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 61.0 mt . . . . . 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 0.0 111.118 -179.962 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.826 0.346 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 2.2 tt -63.87 -54.91 27.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.96 -56.53 13.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.917 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 14.3 mt -52.18 -45.7 65.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.899 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 4.3 tt -54.87 -47.21 74.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.86 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 5.2 tp -67.78 -39.3 84.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 54.7 t -63.77 -47.92 88.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.131 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 36.6 t -64.46 -47.7 88.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.148 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.61 -36.37 66.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.121 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.37 -38.37 65.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.929 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.05 -41.0 55.66 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.468 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 58.2 mt -74.04 -39.28 50.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.901 0.381 . . . . 0.0 111.126 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -67.54 -38.46 90.57 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.484 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 12.5 mt -72.43 -42.13 65.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.886 0.374 . . . . 0.0 110.937 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -65.95 -38.03 87.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.867 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.15 -26.39 53.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.884 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.927 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.3 m . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.855 0.36 . . . . 0.0 110.798 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.93 -50.8 67.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.065 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 62.7 t -53.04 -37.71 27.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.155 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 92.3 t -70.46 -37.87 71.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.148 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.83 -46.09 94.35 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.474 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.2 mp -70.78 -42.29 77.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.865 0.364 . . . . 0.0 111.132 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.2 mt -65.41 -36.02 82.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.1 mt -67.71 -45.64 74.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.932 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 99.6 t -61.02 -38.15 78.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.121 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.1 t -63.52 -52.29 59.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.156 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.2 t -62.12 -53.51 46.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.116 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.39 -32.43 71.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.29 -48.2 76.85 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.495 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 92.7 t -74.92 -33.22 29.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.854 0.359 . . . . 0.0 111.106 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 74.6 t -70.72 -52.77 25.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.171 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -61.68 -46.23 90.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.939 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -57.62 -48.9 78.18 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.456 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.328 -0.347 0 CA-C-O 120.87 0.367 . . . . 0.0 111.137 -179.966 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.791 0.329 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.98 -52.59 48.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.891 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.06 -54.7 31.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.896 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 23.0 mt -52.49 -45.8 66.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 3.2 tt -54.81 -47.37 74.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.946 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.67 -39.25 84.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.909 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 67.2 t -63.76 -48.0 88.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.167 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 37.1 t -64.44 -47.66 88.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.109 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.59 -36.41 66.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.121 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 2.9 tp -73.32 -38.39 65.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.936 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -71.98 -41.02 55.97 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.454 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 58.2 mt -74.07 -39.41 50.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.855 0.359 . . . . 0.0 111.121 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -67.37 -38.52 91.31 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.513 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 6.7 mt -72.41 -46.02 57.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.806 0.336 . . . . 0.0 110.898 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -61.44 -37.79 84.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.903 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.81 -26.08 54.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.876 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 21.0 mtt180 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.846 -179.905 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.2 m . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.857 0.361 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.1 -49.71 74.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.114 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.5 t -53.05 -37.55 27.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.138 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 90.5 t -70.81 -37.64 69.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.118 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.99 -46.08 94.29 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.441 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.2 mp -70.79 -42.23 77.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.879 0.371 . . . . 0.0 111.14 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.7 mt -65.39 -36.11 82.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.914 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.4 mt -67.67 -45.66 74.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.936 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 97.6 t -61.02 -38.04 78.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.149 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 90.3 t -63.58 -52.18 60.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.122 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.9 t -62.38 -53.49 46.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.091 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.2 mt -60.38 -32.55 71.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.923 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.23 -48.22 76.92 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.488 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.5 t -74.85 -33.16 29.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.845 0.355 . . . . 0.0 111.12 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.7 t -70.71 -52.88 24.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.163 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -61.64 -46.01 91.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -57.48 -49.08 76.21 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.534 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 63.7 mt . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 120.891 0.377 . . . . 0.0 111.105 -179.98 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.84 0.352 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.58 -52.55 64.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.946 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 3.2 tp -54.93 -54.94 36.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.917 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 19.7 mt -54.16 -45.27 72.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.903 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 4.9 tt -55.12 -46.96 75.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.94 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.77 -39.64 84.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.888 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 58.0 t -63.64 -48.06 88.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.139 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 37.2 t -64.7 -47.47 88.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.123 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.88 -35.73 66.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.088 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.28 -38.74 65.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.963 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.49 -40.83 53.43 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.469 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 54.7 mt -73.66 -38.31 51.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.905 0.383 . . . . 0.0 111.104 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.95 -39.1 85.37 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.491 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 11.6 mt -71.59 -40.42 69.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.885 0.374 . . . . 0.0 110.962 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -68.33 -37.68 80.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.936 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.48 -27.23 58.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.872 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.856 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.9 m . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.871 0.367 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.5 -49.21 78.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.099 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 62.5 t -53.11 -37.55 27.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.138 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 89.8 t -70.62 -37.93 71.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.135 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.79 -46.1 94.34 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.503 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.2 mp -70.7 -42.3 77.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.87 0.367 . . . . 0.0 111.169 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.7 mt -65.37 -36.15 83.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.918 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.4 mt -67.69 -45.32 75.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.896 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 96.7 t -61.42 -37.82 78.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.133 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 90.1 t -63.85 -51.9 63.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.108 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.2 t -62.6 -53.53 45.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.094 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.47 -32.7 71.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.877 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.99 -47.93 80.88 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.49 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.2 t -75.11 -32.87 27.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.846 0.355 . . . . 0.0 111.11 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 73.7 t -70.9 -53.05 23.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.102 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -62.11 -44.16 97.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.868 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.56 -49.47 76.66 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.457 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 59.6 mt . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 120.87 0.366 . . . . 0.0 111.145 -179.996 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.85 0.357 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 2.6 tp -64.84 -48.62 73.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.957 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.91 -55.6 22.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.888 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 27.4 mt -53.7 -44.34 69.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.879 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.11 -47.19 75.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.93 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.37 -39.95 85.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.954 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 45.1 t -63.51 -48.18 88.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.12 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 38.5 t -64.69 -47.48 88.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.157 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.92 -35.31 66.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.152 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.32 -39.06 65.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.941 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.47 -41.03 53.08 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.531 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 54.3 mt -73.2 -38.08 53.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.875 0.369 . . . . 0.0 111.136 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -69.54 -39.12 79.38 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.497 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 5.9 mt -71.4 -38.74 71.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.807 0.337 . . . . 0.0 110.879 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -69.69 -37.02 76.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.902 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -72.55 -35.33 67.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.884 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.878 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.2 m . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.875 0.369 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.13 -51.0 59.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.1 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 66.0 t -53.14 -46.2 55.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.129 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 84.8 t -64.96 -36.19 77.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.139 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.69 -46.08 94.96 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.506 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.8 mp -70.68 -42.92 77.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.799 0.333 . . . . 0.0 111.091 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.5 mp -65.07 -35.84 82.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.5 mt -67.8 -45.12 75.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 95.4 t -62.06 -36.81 76.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.107 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 89.7 t -64.56 -51.74 63.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.139 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.4 t -62.65 -53.34 48.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.122 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.3 mt -60.24 -37.42 80.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.09 -50.52 66.98 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.499 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.0 t -70.95 -39.53 75.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.859 0.362 . . . . 0.0 111.126 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.8 t -62.53 -53.15 50.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.144 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -61.93 -39.94 93.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.888 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -55.65 -49.56 64.91 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.46 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 64.4 mt . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 120.862 0.363 . . . . 0.0 111.153 -179.957 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.799 0.333 . . . . 0.0 111.121 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.96 -46.75 87.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.861 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 4.3 tp -54.59 -53.61 52.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.898 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 3.3 mt -56.75 -44.79 82.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.939 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 1.1 tt -54.99 -46.98 75.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.906 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 1.1 tt -67.64 -39.82 84.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.953 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 93.2 t -63.58 -48.04 88.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.108 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 38.2 t -64.69 -47.45 88.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.128 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.85 -35.74 66.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.103 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 1.4 tp -73.37 -38.77 65.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.934 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.37 -40.82 54.17 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.47 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 54.5 mt -73.59 -38.53 52.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.872 0.367 . . . . 0.0 111.134 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -67.88 -40.64 89.25 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.476 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 7.5 mt -70.36 -42.44 71.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.887 0.375 . . . . 0.0 110.924 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -65.88 -37.49 86.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.835 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.0 -26.32 59.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.911 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.847 -179.94 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.8 m . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.848 0.356 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.77 -51.27 60.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.115 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.5 t -53.04 -37.74 27.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.097 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 81.7 t -71.32 -37.12 64.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.124 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.87 -46.01 94.49 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.494 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.2 mp -70.76 -42.43 77.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.84 0.352 . . . . 0.0 111.103 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.1 mt -65.33 -35.91 82.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.953 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.4 mt -67.86 -45.5 74.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.941 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 98.4 t -61.33 -37.68 78.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.139 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 87.9 t -64.05 -51.42 69.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.121 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.9 t -63.3 -53.59 43.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.155 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mt -60.44 -32.57 71.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.936 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.2 -47.97 79.62 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.475 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.7 t -75.08 -33.01 27.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.883 0.373 . . . . 0.0 111.125 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 73.4 t -70.89 -53.04 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.145 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -62.03 -45.1 95.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.835 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.13 -49.02 79.35 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.451 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 63.9 mt . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 120.868 0.366 . . . . 0.0 111.157 -179.988 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.806 0.336 . . . . 0.0 111.098 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 1.1 tp -60.94 -55.32 34.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.953 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.31 -55.08 31.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.929 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 13.5 mt -51.94 -45.5 64.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.955 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.06 -46.56 75.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.914 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 3.5 tt -68.03 -39.65 83.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.903 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 47.1 t -63.85 -47.81 89.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.151 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 37.9 t -64.8 -47.41 88.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.121 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.9 -36.17 67.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.11 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.4 -38.48 65.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.919 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.09 -41.24 54.72 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.509 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 58.1 mt -73.64 -39.16 53.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.894 0.378 . . . . 0.0 111.122 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -67.74 -38.59 89.85 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.483 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 12.5 mt -72.64 -38.83 67.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.898 0.38 . . . . 0.0 110.947 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -67.88 -39.88 83.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.856 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.05 -55.12 6.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.88 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.862 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.6 m . . . . . 0 N--CA 1.458 -0.062 0 CA-C-O 120.923 0.392 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.76 -48.97 78.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.087 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 62.5 t -53.2 -40.46 38.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.15 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 66.8 t -69.55 -35.19 65.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.101 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.97 -46.11 92.28 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.47 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.1 mp -70.87 -43.15 77.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.912 0.387 . . . . 0.0 111.143 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -65.27 -32.96 74.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.929 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.6 mt -69.37 -48.65 60.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.91 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 91.7 t -59.22 -38.39 74.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.136 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 91.1 t -63.88 -51.35 70.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.155 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.3 t -63.02 -53.53 45.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.139 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mt -60.5 -32.97 71.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.912 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.74 -47.69 84.07 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.534 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.5 t -75.08 -32.91 27.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.839 0.352 . . . . 0.0 111.152 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 73.8 t -70.81 -53.05 23.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.107 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -62.6 -42.57 99.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -59.34 -49.59 76.91 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.498 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 55.7 mt . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 120.813 0.339 . . . . 0.0 111.056 -179.918 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.816 0.341 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 2.5 tp -64.12 -51.95 61.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.923 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 5.7 tp -52.31 -49.93 63.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.897 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 69.5 mt -57.37 -44.23 84.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.92 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 5.1 tt -55.04 -47.52 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.899 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 2.7 tt -67.1 -39.98 86.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.909 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 91.0 t -63.42 -48.22 88.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.173 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 38.5 t -64.63 -47.37 89.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.113 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.85 -35.63 66.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.071 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 6.3 tp -73.4 -38.85 65.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.885 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.39 -40.78 54.12 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.456 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 54.6 mt -73.66 -38.49 51.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.894 0.378 . . . . 0.0 111.124 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.16 -40.1 88.15 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.54 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 11.8 mt -70.84 -41.72 71.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.837 0.351 . . . . 0.0 110.928 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -67.12 -37.36 83.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.87 -26.02 60.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.852 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.88 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 51.1 m . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.885 0.374 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.48 -51.09 64.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.11 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 78.1 t -53.18 -38.38 30.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.193 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 93.2 t -69.94 -38.03 74.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.151 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.48 -46.14 94.42 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.536 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.2 mp -70.62 -42.68 77.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.868 0.366 . . . . 0.0 111.133 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.2 mt -65.14 -35.97 82.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.922 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.1 mt -67.72 -45.8 73.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.903 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 92.2 t -60.93 -37.96 78.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.172 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.4 t -63.65 -51.89 64.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.121 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 62.0 t -62.39 -53.48 46.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.137 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mt -60.32 -33.83 72.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.89 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.84 -49.08 75.76 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.483 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.0 t -73.12 -32.84 40.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.887 0.375 . . . . 0.0 111.17 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.0 t -70.37 -45.76 73.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.124 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -63.92 -48.61 75.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.838 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -57.16 -49.54 71.4 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.493 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 62.3 mt . . . . . 0 C--N 1.329 -0.321 0 CA-C-O 120.82 0.343 . . . . 0.0 111.11 -179.992 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.869 0.366 . . . . 0.0 111.121 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 1.4 tt -68.45 -45.58 72.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.94 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 19.6 tp -60.55 -55.35 34.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.928 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 32.7 mt -51.95 -47.16 64.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.897 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.33 -46.36 72.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.902 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.36 -39.79 81.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 92.2 t -63.44 -47.63 90.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.109 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 34.8 t -64.01 -47.97 88.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.112 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.17 -36.98 66.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.101 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 4.6 tp -73.25 -38.13 66.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -71.8 -40.98 57.16 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.467 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 58.1 mt -74.2 -39.77 50.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.84 0.353 . . . . 0.0 111.087 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -66.78 -38.39 93.02 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.528 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 12.4 mt -72.26 -45.47 60.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.843 0.354 . . . . 0.0 110.93 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -60.52 -37.7 82.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.94 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.91 -25.67 59.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.86 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.92 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.529 -0.229 . . . . 0.0 112.529 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.2 m -85.94 160.5 52.34 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.578 0.704 . . . . 0.0 110.939 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 144.42 54.05 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.717 2.278 . . . . 0.0 112.327 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.38 170.17 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.14 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -71.42 177.87 3.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.888 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -159.2 177.86 10.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.892 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -174.03 38.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.851 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -156.03 -174.4 4.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.131 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.2 t 62.33 72.58 0.61 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.647 0.737 . . . . 0.0 110.86 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -15.51 37.05 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.655 2.236 . . . . 0.0 112.32 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.86 -16.11 61.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.893 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.9 m -76.32 -35.74 58.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.143 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.7 t -67.41 -36.68 81.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.849 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 85.6 mt -66.52 -51.58 55.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.127 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 60.5 mt -55.75 -42.16 68.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.112 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.7 m -59.91 -50.8 72.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.892 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.81 -48.45 81.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.12 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 62.1 t -53.1 -38.13 29.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.131 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 64.8 t -70.25 -37.42 71.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.11 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.12 -46.09 94.02 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.525 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.2 mp -70.9 -42.38 77.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.874 0.369 . . . . 0.0 111.117 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.1 mt -65.43 -34.94 79.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.888 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.0 mt -68.41 -46.76 69.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.936 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 97.0 t -60.3 -38.3 77.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.118 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 89.9 t -63.65 -51.82 65.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.125 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 62.0 t -62.52 -53.58 45.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.114 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.9 mt -60.33 -32.83 71.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.929 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.89 -47.92 81.29 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.458 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.6 t -75.07 -33.02 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.816 0.341 . . . . 0.0 111.08 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 73.9 t -70.71 -53.05 23.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.118 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -61.95 -44.29 97.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.5 -49.5 76.18 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.505 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 58.9 mt -70.13 -25.98 28.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.879 0.371 . . . . 0.0 111.135 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.6 mt -70.21 -36.8 74.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.95 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 78.0 mt -84.51 -37.44 12.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.1 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.35 -47.37 75.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.889 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.19 -33.47 41.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.892 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.3 ttm180 -71.27 -34.46 70.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -67.75 -68.22 0.4 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -155.64 171.99 19.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.1 118.92 24.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.91 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 7.7 tp -104.32 -29.25 2.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.133 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -82.23 60.07 4.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.882 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 21.0 mttt . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.908 -179.982 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.932 0.396 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 160.7 -166.28 35.41 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.512 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 136' ' ' CYS . . . . . . . . . . . . . 60.1 m 55.65 72.02 1.12 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.646 0.736 . . . . 0.0 110.875 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -18.95 36.74 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.71 2.274 . . . . 0.0 112.329 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 138' ' ' THR . . . . . . . . . . . . . 1.1 m 63.15 29.67 16.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.131 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 61.8 -177.91 0.12 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.899 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -167.02 -83.66 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.499 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 141' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 82.04 0.77 Allowed 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.723 2.282 . . . . 0.0 112.328 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 142' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -151.69 119.91 6.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.895 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . 0.523 ' HA ' ' C ' ' B' ' 144' ' ' PRO . 51.0 mm -51.84 137.16 35.38 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.652 0.739 . . . . 0.0 111.14 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 144' ' ' PRO . . . . . 0.523 ' C ' ' HA ' ' B' ' 143' ' ' ILE . 53.5 Cg_endo -69.8 157.54 92.06 Favored 'Cis proline' 0 C--N 1.342 0.201 0 C-N-CA 122.719 -1.784 . . . . 0.0 112.316 -0.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 11.5 t -177.33 -75.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.857 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 32.5 mm -82.71 -25.5 8.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.148 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -52.5 -30.99 33.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.114 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 72.6 m -53.05 -29.99 33.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.21 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . -55.32 -54.77 32.12 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.486 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 150' ' ' MET . . . . . . . . . . . . . 29.6 mmt -58.16 -51.02 71.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.795 0.331 . . . . 0.0 110.902 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 59.3 t -56.61 -40.35 68.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.129 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -62.06 -42.18 99.72 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.453 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -65.36 -43.67 90.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.841 0.353 . . . . 0.0 111.117 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.51 -53.79 31.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.954 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.1 -55.43 20.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 10.8 mt -52.2 -45.22 65.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.922 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 1.4 tt -55.05 -46.99 75.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.942 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.78 -39.51 84.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.922 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 69.6 t -63.8 -47.98 88.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.068 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 36.5 t -64.76 -47.54 88.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.132 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.91 -35.69 66.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.046 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 1.7 tp -73.32 -38.82 65.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.887 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.4 -40.91 53.77 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.529 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 54.8 mt -73.59 -38.31 51.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.857 0.36 . . . . 0.0 111.104 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -69.06 -39.03 84.6 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.467 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 10.9 mt -71.66 -39.6 70.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.907 0.384 . . . . 0.0 110.907 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -69.41 -37.62 77.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.864 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.42 -28.58 59.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.88 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 14.2 ttt180 -85.05 -24.74 28.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.92 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -25.02 58.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.855 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 74.1 mtm180 -94.79 21.22 7.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.857 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 172' ' ' HIS . . . . . . . . . . . . . 48.6 t60 53.43 31.79 12.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.86 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 81.9 mt -95.02 88.27 2.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.102 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 7.6 p -104.86 141.71 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.163 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 175' ' ' ARG . . . . . . . . . . . . . 8.5 ptt180 -76.24 -36.94 58.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.877 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 2.0 tppm? -156.35 147.54 22.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.883 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.846 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -70.37 160.54 80.82 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.61 0.719 . . . . 0.0 110.851 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 108.68 2.13 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.713 2.276 . . . . 0.0 112.366 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.89 -169.74 0.19 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.13 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -174.11 139.35 0.63 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -164.95 -178.99 5.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.887 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -164.91 82.91 0.38 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.89 -4.16 39.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.093 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.4 t -155.01 70.55 5.73 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.679 0.752 . . . . 0.0 110.856 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -15.57 37.32 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.703 2.269 . . . . 0.0 112.361 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.76 -16.18 61.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.846 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.0 m -76.28 -34.85 59.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.119 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 t -68.96 -38.72 79.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.876 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 43.6 mt -60.59 -45.94 96.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.117 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 65.7 mt -56.82 -46.21 83.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.135 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.8 m -58.56 -45.16 89.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.872 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.58 -50.55 64.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.072 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 66.1 t -53.2 -44.75 53.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.128 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 65.6 t -65.9 -35.53 75.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.127 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.83 -46.23 94.06 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.47 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mp -70.6 -42.85 78.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.893 0.378 . . . . 0.0 111.088 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.5 mp -65.23 -35.25 80.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.92 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.5 mt -67.84 -46.33 72.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.931 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 84.9 t -60.89 -37.88 77.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.1 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 89.7 t -63.38 -53.02 50.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.127 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.9 t -61.12 -53.39 49.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.161 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 mt -60.3 -33.33 72.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.937 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.25 -47.96 83.43 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.486 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.8 t -74.91 -33.22 29.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.873 0.368 . . . . 0.0 111.079 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.7 t -70.37 -46.93 69.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.074 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -64.56 -48.84 73.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.911 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -56.62 -47.27 85.9 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.472 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 67.4 mt -72.02 -26.25 24.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.896 0.379 . . . . 0.0 111.13 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.8 mt -69.77 -37.59 76.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.924 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 51.4 mt -70.82 -35.17 59.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.152 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.1 -50.94 67.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.932 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.9 mtt85 -74.88 -23.56 58.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -64.92 -69.84 0.27 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -67.88 -74.92 0.11 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.924 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -160.42 -74.84 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.891 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -165.02 65.49 0.13 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 24.5 mt 64.57 68.25 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.099 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -165.01 151.82 10.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.879 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.9 tttm . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.891 179.973 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.866 0.365 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -110.54 -137.64 7.6 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.463 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 136' ' ' CYS . . . . . . . . . . . . . 1.8 m 58.28 69.88 1.37 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.61 0.719 . . . . 0.0 110.907 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.85 107.94 1.99 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.645 2.23 . . . . 0.0 112.318 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 138' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.54 101.39 3.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.161 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -155.19 176.16 12.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.884 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -131.53 176.31 19.22 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.506 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 141' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 100.68 0.83 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.719 2.28 . . . . 0.0 112.354 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 142' ' ' LYS . . . . . . . . . . . . . 3.9 tttm -148.77 38.52 0.84 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.877 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . 0.514 ' HA ' ' C ' ' B' ' 144' ' ' PRO . 2.8 mt 65.02 135.4 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.629 0.728 . . . . 0.0 111.12 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 144' ' ' PRO . . . . . 0.514 ' C ' ' HA ' ' B' ' 143' ' ' ILE . 53.6 Cg_endo -69.8 159.09 90.38 Favored 'Cis proline' 0 C--N 1.342 0.196 0 C-N-CA 122.617 -1.826 . . . . 0.0 112.374 -0.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 2.1 t 177.46 -33.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.874 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 34.3 mt -123.33 -32.94 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.135 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.16 -24.01 60.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.105 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 93.3 m -53.35 -27.95 26.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.17 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . -55.52 -54.49 34.26 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.49 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 150' ' ' MET . . . . . . . . . . . . . 18.0 mmt -61.81 -46.6 88.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.784 0.326 . . . . 0.0 110.839 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 59.9 t -55.96 -40.54 63.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.089 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -66.45 -42.17 93.91 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.478 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -60.25 -45.65 92.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.792 0.33 . . . . 0.0 111.125 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 11.9 tp -68.18 -50.02 57.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.915 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 7.8 tp -57.36 -53.4 58.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.927 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 16.5 mt -53.28 -45.73 68.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 12.4 tp -54.96 -46.4 75.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.92 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 1.3 tt -68.05 -39.94 82.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.871 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 74.6 t -63.59 -48.02 88.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.129 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 36.0 t -64.59 -47.5 88.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.101 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.87 -35.82 66.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.073 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 1.3 tp -73.33 -38.8 65.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.916 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.19 -40.89 55.05 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.505 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 54.8 mt -73.63 -38.75 52.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.907 0.384 . . . . 0.0 111.107 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -67.27 -40.95 92.13 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.471 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 11.5 mt -70.32 -41.08 73.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.853 0.359 . . . . 0.0 110.894 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -67.54 -37.43 82.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.878 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.65 -25.69 57.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.902 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 3.2 mmt85 -82.23 -14.24 55.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.897 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.13 -24.82 43.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.861 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -144.86 25.74 1.42 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.833 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 172' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 51.91 32.87 10.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.869 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 3.9 mp 63.15 98.29 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.141 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 12.6 m -104.99 24.67 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.118 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 175' ' ' ARG . . . . . . . . . . . . . 8.3 mtp85 -84.96 -59.46 2.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.922 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -169.6 -64.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.88 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.872 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 63.09 160.53 0.12 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.636 0.731 . . . . 0.0 110.869 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 82.57 0.74 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.702 2.268 . . . . 0.0 112.357 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -174.93 50.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.089 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -156.57 -44.43 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.866 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 61.97 102.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.896 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.7 ttp180 -64.98 -169.86 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.881 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -155.1 90.02 1.25 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.062 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.1 t 66.85 142.57 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.691 0.757 . . . . 0.0 110.857 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -12.45 32.87 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.661 2.241 . . . . 0.0 112.333 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.21 -17.04 64.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.898 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.7 m -75.98 -38.2 57.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.15 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.6 t -66.35 -40.57 89.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.891 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 70.3 mt -56.32 -42.7 74.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.161 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 67.6 mt -57.35 -45.71 85.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.129 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.6 m -60.99 -44.65 97.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.11 -51.15 62.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.133 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.5 t -53.35 -46.75 58.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.106 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 87.5 t -63.32 -35.88 73.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.137 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.95 -46.3 93.85 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.444 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.8 mp -71.12 -42.85 75.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.814 0.34 . . . . 0.0 111.118 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.32 -32.92 74.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.5 mt -69.55 -49.26 55.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.934 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 95.3 t -58.36 -39.05 72.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.122 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 93.5 t -63.7 -51.04 75.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.121 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.2 t -63.31 -53.56 44.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.185 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.0 mt -60.37 -32.84 71.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.926 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.02 -47.92 80.81 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.487 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.5 t -75.01 -32.94 27.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.825 0.345 . . . . 0.0 111.123 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.6 t -70.76 -51.44 36.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.118 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -62.42 -45.68 91.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.87 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -57.86 -49.2 76.69 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.542 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 59.8 mt -70.06 -31.17 46.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.87 0.367 . . . . 0.0 111.114 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.7 mt -64.54 -35.23 80.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.924 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 73.2 mt -86.21 -33.48 7.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.157 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.67 -47.61 83.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.857 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -55.07 -28.08 49.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.881 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.5 -26.57 67.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.892 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 68.0 mm-40 -154.7 107.33 2.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -65.96 95.59 0.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.903 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.7 ttmm -94.1 123.83 37.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.931 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 24.1 mt -136.9 -48.21 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.11 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 58.4 -174.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.828 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.856 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.897 0.38 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -129.05 65.24 0.59 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.494 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 136' ' ' CYS . . . . . . . . . . . . . 1.3 m -77.79 160.54 74.11 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.633 0.73 . . . . 0.0 110.857 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -173.03 0.64 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.662 2.241 . . . . 0.0 112.375 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 138' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.09 121.78 11.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.124 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -76.01 -61.29 1.99 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.862 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -155.42 84.9 0.14 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.465 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 141' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -170.76 0.41 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.681 2.254 . . . . 0.0 112.352 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 142' ' ' LYS . . . . . . . . . . . . . 1.3 tttt 64.06 108.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 2.5 mp 49.07 87.93 0.12 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.654 0.74 . . . . 0.0 111.111 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 144' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 159.37 89.78 Favored 'Cis proline' 0 C--N 1.342 0.185 0 C-N-CA 122.686 -1.798 . . . . 0.0 112.316 -0.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 33.2 t 179.28 -77.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.825 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 29.3 mm -105.23 -17.55 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.151 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -82.57 -21.61 35.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.133 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 86.8 m -52.75 -30.32 32.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.137 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . -52.25 -49.37 50.87 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.47 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 150' ' ' MET . . . . . . . . . . . . . 20.8 mmt -61.92 -51.14 69.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.837 0.351 . . . . 0.0 110.87 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 60.8 t -55.57 -40.78 60.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.176 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -62.56 -43.31 99.19 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.467 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -62.1 -46.93 86.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.783 0.325 . . . . 0.0 111.059 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 7.6 tp -61.87 -41.58 98.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.886 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.36 -55.03 36.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.926 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 15.9 mt -52.4 -46.36 66.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 3.6 tp -54.69 -46.55 74.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.869 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.09 -40.15 82.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.946 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 54.8 t -63.18 -47.74 90.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.105 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 36.2 t -64.87 -47.86 86.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.147 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.59 -35.13 65.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.154 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 1.1 tp -72.18 -39.76 68.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.956 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.23 -44.1 44.86 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.545 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 51.9 mt -69.4 -36.97 74.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.879 0.371 . . . . 0.0 111.161 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -71.37 -39.61 61.49 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.501 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 12.6 mt -72.13 -29.75 64.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.878 0.371 . . . . 0.0 110.899 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -81.27 -36.02 30.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.842 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.5 -29.54 61.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.913 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -15.37 58.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 3.8 ppt_? -54.94 -24.89 25.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.877 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.3 -19.56 47.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.902 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 172' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.85 71.95 0.82 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.868 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 27.2 mt -74.7 138.26 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.187 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 63.4 t -135.56 93.59 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.14 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 175' ' ' ARG . . . . . . . . . . . . . 14.7 ptt85 -160.11 -172.21 3.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.879 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.34 125.49 0.75 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.878 179.975 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.456 -0.258 . . . . 0.0 112.456 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 20.4 m 64.37 153.65 0.12 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.605 0.716 . . . . 0.0 110.876 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 86.58 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.681 2.254 . . . . 0.0 112.336 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -175.09 -36.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.095 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 63.96 158.11 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.885 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 62.11 164.96 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.915 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -165.04 -76.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -175.27 -169.06 0.36 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.122 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.0 t 63.95 68.3 0.87 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.607 0.718 . . . . 0.0 110.827 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 -15.61 37.28 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.723 2.282 . . . . 0.0 112.326 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.56 -16.2 61.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.911 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.0 m -76.16 -34.05 59.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.145 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.6 t -69.04 -36.86 78.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.85 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 48.5 mt -66.55 -50.33 67.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.134 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 65.4 mt -57.79 -44.52 86.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.156 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.5 m -57.75 -48.47 79.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.847 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.0 -50.12 73.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.051 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 62.5 t -52.99 -37.5 26.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.124 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 89.8 t -70.72 -38.01 71.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.148 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.77 -46.03 94.51 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.443 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.2 mp -70.69 -42.38 77.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.901 0.381 . . . . 0.0 111.159 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.9 mt -65.41 -36.11 82.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.889 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.3 mt -67.79 -45.19 75.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.912 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 99.9 t -61.53 -37.71 78.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.101 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 89.4 t -63.95 -51.84 64.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.12 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.2 t -62.64 -53.45 46.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.17 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.1 mt -60.37 -33.62 72.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.897 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.08 -48.25 81.7 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.474 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.3 t -75.07 -32.93 27.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.913 0.387 . . . . 0.0 111.115 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 56.5 t -70.1 -52.13 33.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.164 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -63.08 -43.37 98.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.9 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.57 -48.67 83.21 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.472 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 58.1 mt -70.87 -25.51 26.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.91 0.386 . . . . 0.0 111.15 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.1 mt -70.65 -39.75 73.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.891 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 57.0 mt -73.27 -44.87 54.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.1 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.1 mmmm -61.12 -27.64 68.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.875 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.37 -35.15 73.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.889 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -52.35 56.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.896 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -72.68 170.37 14.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.939 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -155.77 70.41 0.71 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.954 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.39 117.08 3.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.934 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.3 mp -93.02 -66.45 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.156 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 57.39 -177.32 0.06 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.891 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 7.5 tttp . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.914 179.943 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 . . . . . 0 CA--C 1.527 0.071 0 CA-C-O 120.873 0.368 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 156.27 -25.72 0.54 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.475 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 136' ' ' CYS . . . . . . . . . . . . . 1.6 m -78.12 160.48 73.42 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.633 0.73 . . . . 0.0 110.871 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -174.7 0.95 Allowed 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.694 2.263 . . . . 0.0 112.353 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 138' ' ' THR . . . . . . . . . . . . . 4.3 p -76.62 -58.84 3.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.161 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -76.12 -73.29 0.28 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.889 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 86.91 170.49 46.87 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.509 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 141' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -177.67 1.99 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.717 2.278 . . . . 0.0 112.35 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 142' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -146.81 66.27 1.17 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.929 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . 0.517 ' HA ' ' C ' ' B' ' 144' ' ' PRO . 47.5 mm 64.76 135.46 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.661 0.743 . . . . 0.0 111.142 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 144' ' ' PRO . . . . . 0.517 ' C ' ' HA ' ' B' ' 143' ' ' ILE . 53.7 Cg_endo -69.77 160.75 87.52 Favored 'Cis proline' 0 C--N 1.341 0.164 0 C-N-CA 122.62 -1.825 . . . . 0.0 112.369 -0.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.4 -76.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.827 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 2.6 mp -84.18 -25.09 7.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.137 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -54.62 -27.57 40.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.118 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 70.0 m -52.9 -28.97 25.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.123 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . -56.69 -58.41 14.6 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.524 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 150' ' ' MET . . . . . . . . . . . . . 30.6 mmt -58.25 -45.95 86.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.801 0.334 . . . . 0.0 110.927 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 59.4 t -57.27 -40.26 72.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.12 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -65.8 -41.77 95.48 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.485 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -63.04 -38.3 90.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.851 0.358 . . . . 0.0 111.116 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 11.0 tp -65.55 -53.84 36.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.944 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 18.3 tp -52.74 -54.87 27.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 4.1 mt -53.4 -44.12 68.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.927 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 8.0 tp -54.98 -48.07 73.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.905 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.91 -39.51 87.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.933 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 50.0 t -63.52 -48.43 86.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.132 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 37.1 t -64.37 -47.45 89.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.177 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.77 -35.73 66.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.084 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.36 -38.85 65.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.37 -40.85 54.1 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.453 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 54.6 mt -73.6 -38.53 52.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.88 0.371 . . . . 0.0 111.112 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.71 -39.14 86.33 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.495 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 10.6 mt -71.66 -40.14 69.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.836 0.351 . . . . 0.0 110.926 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -68.79 -37.46 79.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.32 -28.61 61.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.872 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.25 -21.65 59.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.888 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -69.39 -19.94 63.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.867 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 35.7 mtm-85 -144.96 30.86 1.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.882 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 172' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.97 -22.49 58.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.812 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 34.1 pt -74.93 -25.09 18.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.128 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 28.3 m -98.99 160.11 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.118 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 175' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.25 71.73 2.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.873 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 9.2 mttm 52.66 89.08 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.896 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.852 -179.997 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.7 m -83.99 160.57 57.63 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.595 0.712 . . . . 0.0 110.88 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 149.15 66.48 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.678 2.252 . . . . 0.0 112.363 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.57 -75.18 0.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.073 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -169.89 -45.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.919 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 60.35 -176.67 0.11 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.934 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.0 mpp_? -73.86 177.91 5.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.902 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -169.97 140.65 2.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.101 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.5 t -57.23 147.43 57.31 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.663 0.744 . . . . 0.0 110.869 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 -15.47 37.35 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.7 2.267 . . . . 0.0 112.365 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.88 -16.23 61.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.892 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.9 m -76.28 -35.54 58.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.133 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 t -67.87 -38.98 83.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.85 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.1 mt -62.53 -48.32 88.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.139 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 72.4 mt -59.99 -43.99 93.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.128 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.3 m -56.2 -47.11 78.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.867 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.05 -50.38 68.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.089 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 62.1 t -53.04 -37.32 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.119 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 92.0 t -71.09 -37.83 68.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.129 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.78 -46.07 94.41 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.438 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.2 mp -70.7 -42.36 77.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.822 0.344 . . . . 0.0 111.105 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.1 mt -65.41 -36.01 82.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.4 mt -67.69 -45.65 74.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.969 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 99.8 t -61.14 -38.05 78.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.075 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 89.5 t -63.56 -52.36 58.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.137 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.2 t -61.99 -53.47 47.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.072 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.34 -32.9 71.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.78 -48.39 77.32 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.49 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.2 t -74.45 -33.38 32.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.86 0.362 . . . . 0.0 111.085 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.6 t -70.32 -51.33 39.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.073 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -62.49 -46.25 89.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.905 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -57.35 -48.85 77.48 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.507 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 61.0 mt -70.83 -25.14 25.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 0.0 111.118 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.4 mt -70.43 -34.42 72.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.94 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 77.9 mt -80.1 -33.16 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.127 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.7 mtmm -78.37 -38.21 42.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.897 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.06 -25.63 62.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.873 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 -64.99 -70.02 0.26 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.851 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -70.85 -74.54 0.14 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.932 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -160.27 -74.62 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.931 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -165.03 -170.11 1.85 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.856 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 6.5 tp -104.94 -30.19 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.153 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 60.16 174.78 0.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.908 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 3.4 tttt . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.946 179.906 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.885 0.374 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 175.07 40.18 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.505 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 136' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -158.76 160.57 29.23 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.597 0.713 . . . . 0.0 110.831 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 175.09 8.6 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.675 2.25 . . . . 0.0 112.32 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 138' ' ' THR . . . . . . . . . . . . . 35.0 p -87.81 134.6 33.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.172 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.72 112.63 3.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.863 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -160.5 171.48 36.69 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.496 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 141' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 172.36 12.8 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.63 2.22 . . . . 0.0 112.363 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 142' ' ' LYS . . . . . . . . . . . . . 27.6 mttt -66.97 96.96 0.46 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.875 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . 0.529 ' HA ' ' C ' ' B' ' 144' ' ' PRO . 2.1 mt 64.47 139.52 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.636 0.731 . . . . 0.0 111.097 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 144' ' ' PRO . . . . . 0.529 ' C ' ' HA ' ' B' ' 143' ' ' ILE . 53.9 Cg_endo -69.75 159.25 89.96 Favored 'Cis proline' 0 C--O 1.231 0.174 0 C-N-CA 122.677 -1.801 . . . . 0.0 112.38 -0.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 178.73 -76.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.87 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 3.5 mp -94.81 -20.81 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.129 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.07 -25.78 66.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.109 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 85.9 m -53.81 -27.51 29.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.137 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . -55.74 -53.02 44.58 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.442 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 150' ' ' MET . . . . . . . . . . . . . 28.9 mmt -57.13 -51.8 67.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.805 0.336 . . . . 0.0 110.887 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 59.5 t -57.47 -40.42 74.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.148 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -60.04 -43.79 97.88 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.502 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -64.69 -46.65 81.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.826 0.346 . . . . 0.0 111.126 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 2.2 tt -63.87 -54.91 27.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.96 -56.53 13.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.917 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 14.3 mt -52.18 -45.7 65.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.899 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 4.3 tt -54.87 -47.21 74.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.86 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 5.2 tp -67.78 -39.3 84.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 54.7 t -63.77 -47.92 88.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.131 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 36.6 t -64.46 -47.7 88.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.148 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.61 -36.37 66.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.121 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.37 -38.37 65.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.929 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.05 -41.0 55.66 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.468 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 58.2 mt -74.04 -39.28 50.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.901 0.381 . . . . 0.0 111.126 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -67.54 -38.46 90.57 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.484 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 12.5 mt -72.43 -42.13 65.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.886 0.374 . . . . 0.0 110.937 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -65.95 -38.03 87.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.867 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.15 -26.39 53.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.884 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.26 -26.25 66.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.927 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 5.2 mtt-85 -67.41 -26.08 66.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.875 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 52.04 29.81 6.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 172' ' ' HIS . . . . . . . . . . . . . 13.5 m80 51.32 86.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.865 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 50.1 mm -77.45 -72.35 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.095 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 12.0 p -96.73 -29.49 3.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.134 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 175' ' ' ARG . . . . . . . . . . . . . 3.9 ttp180 -174.29 -65.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.871 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.33 147.91 3.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.933 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.856 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.2 m -151.72 160.51 31.56 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.632 0.73 . . . . 0.0 110.842 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 -23.88 30.5 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.64 2.227 . . . . 0.0 112.374 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.06 -170.84 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.131 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -160.74 -65.56 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.896 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 54.95 -170.15 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.46 28.09 0.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.856 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.78 -171.27 1.03 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.092 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.1 t 62.72 72.08 0.63 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.65 0.738 . . . . 0.0 110.867 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 -15.46 37.2 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.691 2.261 . . . . 0.0 112.359 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.82 -16.15 61.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.966 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.0 m -76.35 -35.5 58.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.146 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.9 t -67.98 -39.34 83.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.851 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 54.7 mt -62.12 -48.05 90.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.114 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 72.1 mt -61.24 -45.11 99.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.156 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.3 m -54.23 -47.92 71.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.798 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.93 -50.8 67.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.065 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 62.7 t -53.04 -37.71 27.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.155 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 92.3 t -70.46 -37.87 71.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.148 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.83 -46.09 94.35 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.474 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.2 mp -70.78 -42.29 77.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.865 0.364 . . . . 0.0 111.132 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.2 mt -65.41 -36.02 82.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.1 mt -67.71 -45.64 74.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.932 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 99.6 t -61.02 -38.15 78.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.121 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.1 t -63.52 -52.29 59.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.156 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.2 t -62.12 -53.51 46.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.116 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.39 -32.43 71.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.29 -48.2 76.85 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.495 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 92.7 t -74.92 -33.22 29.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.854 0.359 . . . . 0.0 111.106 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 74.6 t -70.72 -52.77 25.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.171 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -61.68 -46.23 90.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.939 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -57.62 -48.9 78.18 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.456 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 67.9 mt -72.49 -26.1 23.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.87 0.367 . . . . 0.0 111.137 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.5 mt -70.47 -42.07 71.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.933 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 49.9 mt -69.91 -35.02 62.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.112 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.5 mmtt -64.87 -43.43 92.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.924 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 67.6 mtt180 -66.87 -30.89 71.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.818 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.62 -53.0 25.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -174.66 125.96 0.3 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.897 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.09 134.68 54.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.925 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.42 160.62 22.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.93 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 5.6 tp -134.95 -40.02 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.137 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 60.18 50.94 5.94 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.887 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 7.3 tptp . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.927 179.982 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.891 0.377 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 83.0 133.89 2.12 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.485 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 136' ' ' CYS . . . . . . . . . . . . . 6.6 p -161.92 72.56 2.38 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.594 0.712 . . . . 0.0 110.924 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 105.81 1.54 Allowed 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.696 2.264 . . . . 0.0 112.348 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 138' ' ' THR . . . . . . . . . . . . . 8.3 t -84.81 143.8 28.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.155 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -164.75 129.25 2.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 135.32 -166.12 24.54 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.477 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 141' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 -172.8 0.61 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.681 2.254 . . . . 0.0 112.325 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 142' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -152.98 119.0 5.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.898 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . 0.525 ' HA ' ' C ' ' B' ' 144' ' ' PRO . 61.5 mt 65.23 135.33 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.616 0.722 . . . . 0.0 111.14 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 144' ' ' PRO . . . . . 0.525 ' C ' ' HA ' ' B' ' 143' ' ' ILE . 53.1 Cg_endo -69.82 -167.21 3.64 Favored 'Cis proline' 0 C--N 1.341 0.18 0 C-N-CA 122.656 -1.81 . . . . 0.0 112.308 -0.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 75.09 4.9 4.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.814 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 10.8 mm -133.49 -39.61 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.14 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -51.67 -29.87 19.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.127 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 89.1 m -53.62 -27.78 28.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.193 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . -55.91 -53.46 42.0 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.505 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 150' ' ' MET . . . . . . . . . . . . . 30.3 mmt -57.86 -52.01 67.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.757 0.313 . . . . 0.0 110.877 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 58.9 t -55.96 -40.37 62.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.139 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -61.33 -43.53 99.24 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.513 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -63.61 -47.15 82.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.791 0.329 . . . . 0.0 111.068 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.98 -52.59 48.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.891 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.06 -54.7 31.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.896 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 23.0 mt -52.49 -45.8 66.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 3.2 tt -54.81 -47.37 74.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.946 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.67 -39.25 84.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.909 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 67.2 t -63.76 -48.0 88.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.167 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 37.1 t -64.44 -47.66 88.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.109 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.59 -36.41 66.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.121 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 2.9 tp -73.32 -38.39 65.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.936 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -71.98 -41.02 55.97 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.454 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 58.2 mt -74.07 -39.41 50.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.855 0.359 . . . . 0.0 111.121 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -67.37 -38.52 91.31 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.513 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 6.7 mt -72.41 -46.02 57.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.806 0.336 . . . . 0.0 110.898 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -61.44 -37.79 84.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.903 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.81 -26.08 54.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.876 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 21.0 mtt180 -79.41 -30.69 42.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.846 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.84 -30.72 70.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 52.6 mtp85 -77.48 -15.32 59.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.903 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 172' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 54.61 31.1 14.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.84 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 36.2 mm 62.05 74.9 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.18 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 12.1 p -99.05 -27.99 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.138 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 175' ' ' ARG . . . . . . . . . . . . . 13.3 ttm-85 -156.75 160.72 39.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.828 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 14.1 tttm -161.08 123.4 3.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.892 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.876 -179.998 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 4.6 p -137.42 156.57 75.0 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.677 0.751 . . . . 0.0 110.887 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 160.93 47.88 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.7 2.267 . . . . 0.0 112.375 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.28 -58.62 7.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.087 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -69.72 156.94 38.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.903 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -146.27 77.68 1.49 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.922 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.5 ptp85 -72.66 147.74 45.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.842 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -173.85 166.71 4.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.102 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.3 t -61.31 147.53 87.09 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.684 0.754 . . . . 0.0 110.879 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -15.54 37.07 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.679 2.252 . . . . 0.0 112.372 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.79 -16.15 61.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.9 m -76.32 -35.6 58.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.164 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 t -67.79 -38.47 83.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 78.8 mt -63.06 -49.02 85.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.132 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 63.5 mt -58.51 -43.77 87.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.16 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.2 m -56.79 -49.25 75.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.863 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.1 -49.71 74.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.114 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.5 t -53.05 -37.55 27.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.138 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 90.5 t -70.81 -37.64 69.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.118 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.99 -46.08 94.29 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.441 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.2 mp -70.79 -42.23 77.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.879 0.371 . . . . 0.0 111.14 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.7 mt -65.39 -36.11 82.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.914 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.4 mt -67.67 -45.66 74.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.936 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 97.6 t -61.02 -38.04 78.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.149 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 90.3 t -63.58 -52.18 60.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.122 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.9 t -62.38 -53.49 46.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.091 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.2 mt -60.38 -32.55 71.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.923 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.23 -48.22 76.92 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.488 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.5 t -74.85 -33.16 29.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.845 0.355 . . . . 0.0 111.12 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.7 t -70.71 -52.88 24.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.163 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -61.64 -46.01 91.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -57.48 -49.08 76.21 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.534 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 63.7 mt -71.59 -25.2 24.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.891 0.377 . . . . 0.0 111.105 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.5 mt -72.58 -46.52 53.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.93 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.0 mt -52.89 -31.0 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.185 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -85.06 -35.66 21.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.911 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 -53.61 -32.86 52.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.83 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.97 -65.51 0.73 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.876 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -68.52 113.54 6.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.942 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -75.65 -31.01 59.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.924 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 53.58 87.66 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.916 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.3 pt -97.11 33.35 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.11 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 25.8 mtt85 -89.47 61.54 5.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.851 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.87 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.895 0.379 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 156.81 -107.57 0.33 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.472 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 136' ' ' CYS . . . . . . . . . . . . . 1.1 m -156.14 160.48 30.74 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.599 0.714 . . . . 0.0 110.856 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.67 179.32 3.73 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.693 2.262 . . . . 0.0 112.359 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 138' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.89 -179.17 7.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.194 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -164.17 107.64 0.94 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.902 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -52.4 169.74 0.61 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.509 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 141' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 78.63 1.0 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.689 2.259 . . . . 0.0 112.302 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 142' ' ' LYS . . . . . . . . . . . . . 3.7 mmtp 68.24 -77.13 0.05 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.907 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . 0.526 ' HA ' ' C ' ' B' ' 144' ' ' PRO . 56.7 mt -150.31 135.77 10.16 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.669 0.747 . . . . 0.0 111.09 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 144' ' ' PRO . . . . . 0.526 ' C ' ' HA ' ' B' ' 143' ' ' ILE . 53.8 Cg_endo -69.76 161.83 85.39 Favored 'Cis proline' 0 C--N 1.342 0.21 0 C-N-CA 122.711 -1.787 . . . . 0.0 112.365 -0.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 48.4 t -176.34 -75.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.891 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 3.6 mp -94.0 -20.78 6.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.153 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.84 -25.05 67.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.106 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 18.4 m -53.51 -28.37 30.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.13 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . -59.13 -57.91 17.28 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.49 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 150' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -58.17 -46.66 85.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.87 0.367 . . . . 0.0 110.917 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 59.4 t -56.92 -40.57 72.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.11 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -65.18 -41.68 96.79 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.492 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -62.08 -51.45 67.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.84 0.352 . . . . 0.0 111.138 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.58 -52.55 64.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.946 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 3.2 tp -54.93 -54.94 36.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.917 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 19.7 mt -54.16 -45.27 72.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.903 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 4.9 tt -55.12 -46.96 75.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.94 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.77 -39.64 84.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.888 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 58.0 t -63.64 -48.06 88.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.139 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 37.2 t -64.7 -47.47 88.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.123 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.88 -35.73 66.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.088 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.28 -38.74 65.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.963 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.49 -40.83 53.43 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.469 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 54.7 mt -73.66 -38.31 51.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.905 0.383 . . . . 0.0 111.104 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.95 -39.1 85.37 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.491 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 11.6 mt -71.59 -40.42 69.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.885 0.374 . . . . 0.0 110.962 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -68.33 -37.68 80.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.936 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.48 -27.23 58.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.872 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.28 -36.48 66.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.856 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.19 -32.46 71.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.845 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 18.2 mtp85 -71.57 -15.13 62.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.875 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 172' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 62.34 64.83 0.91 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.857 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 55.5 mt -146.24 110.21 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.104 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 23.2 m -141.49 150.75 19.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.165 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.69 128.46 35.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 15.9 tttt -161.61 54.6 0.26 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.881 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 2.4 ttp180 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.854 179.982 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 2.7 m -116.64 160.51 36.17 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.595 0.712 . . . . 0.0 110.893 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -16.87 37.83 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.623 2.215 . . . . 0.0 112.38 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.0 133.29 51.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.094 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -170.36 67.96 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.909 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -82.57 172.33 13.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.902 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.09 102.48 3.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.29 -176.91 0.35 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.062 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.4 t -63.6 147.5 95.49 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.636 0.731 . . . . 0.0 110.863 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 -15.59 37.1 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.708 2.272 . . . . 0.0 112.301 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.8 -16.15 61.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.916 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.9 m -76.3 -35.48 58.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.13 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.9 t -67.8 -37.65 82.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.85 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 54.8 mt -64.4 -50.03 78.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.182 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 63.1 mt -56.56 -42.35 75.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.152 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.9 m -59.18 -50.98 71.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.842 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.5 -49.21 78.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.099 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 62.5 t -53.11 -37.55 27.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.138 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 89.8 t -70.62 -37.93 71.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.135 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.79 -46.1 94.34 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.503 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.2 mp -70.7 -42.3 77.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.87 0.367 . . . . 0.0 111.169 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.7 mt -65.37 -36.15 83.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.918 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.4 mt -67.69 -45.32 75.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.896 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 96.7 t -61.42 -37.82 78.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.133 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 90.1 t -63.85 -51.9 63.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.108 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.2 t -62.6 -53.53 45.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.094 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.47 -32.7 71.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.877 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.99 -47.93 80.88 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.49 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.2 t -75.11 -32.87 27.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.846 0.355 . . . . 0.0 111.11 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 73.7 t -70.9 -53.05 23.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.102 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -62.11 -44.16 97.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.868 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.56 -49.47 76.66 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.457 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 59.6 mt -70.32 -26.15 28.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.87 0.366 . . . . 0.0 111.145 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.6 mt -69.57 -39.5 77.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.95 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 60.8 mt -73.72 -36.85 47.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.115 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.8 mmtt -64.85 -38.47 91.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -52.45 -35.26 51.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.89 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.2 -55.19 7.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.861 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -73.66 179.79 3.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.925 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -158.74 164.85 35.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.901 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.06 167.8 0.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.887 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 26.6 mm 58.58 68.13 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.13 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -94.28 75.15 3.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 179.962 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 . . . . . 0 N--CA 1.458 -0.044 0 CA-C-O 120.948 0.404 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.01 85.55 1.73 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.455 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 136' ' ' CYS . . . . . . . . . . . . . 1.1 m -77.51 160.59 74.69 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.628 0.727 . . . . 0.0 110.845 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 174.4 9.56 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.73 2.287 . . . . 0.0 112.362 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 138' ' ' THR . . . . . . . . . . . . . 14.9 t -146.02 31.86 1.03 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.157 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -163.01 156.03 19.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.898 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -109.72 172.66 16.12 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.502 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 141' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -19.8 35.47 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.685 2.257 . . . . 0.0 112.355 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 142' ' ' LYS . . . . . . . . . . . . . 1.5 tttt 53.52 53.11 12.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.87 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . 0.52 ' HA ' ' C ' ' B' ' 144' ' ' PRO . 71.4 mt 64.99 135.53 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.598 0.713 . . . . 0.0 111.137 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 144' ' ' PRO . . . . . 0.52 ' C ' ' HA ' ' B' ' 143' ' ' ILE . 53.8 Cg_endo -69.73 160.82 87.32 Favored 'Cis proline' 0 C--O 1.231 0.173 0 C-N-CA 122.704 -1.79 . . . . 0.0 112.359 -0.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 2.7 t -179.37 -75.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.88 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 2.4 mp -85.17 -25.44 6.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.102 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -55.09 -26.15 35.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.129 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 40.7 m -52.42 -29.54 24.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.166 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . -59.24 -59.47 10.62 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.476 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 150' ' ' MET . . . . . . . . . . . . . 29.3 mmt -57.97 -47.25 83.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.757 0.313 . . . . 0.0 110.848 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 59.3 t -57.36 -40.42 74.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.125 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -64.07 -43.61 97.03 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.432 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -61.98 -44.19 97.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.85 0.357 . . . . 0.0 111.127 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 2.6 tp -64.84 -48.62 73.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.957 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.91 -55.6 22.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.888 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 27.4 mt -53.7 -44.34 69.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.879 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.11 -47.19 75.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.93 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.37 -39.95 85.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.954 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 45.1 t -63.51 -48.18 88.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.12 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 38.5 t -64.69 -47.48 88.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.157 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.92 -35.31 66.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.152 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.32 -39.06 65.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.941 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.47 -41.03 53.08 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.531 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 54.3 mt -73.2 -38.08 53.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.875 0.369 . . . . 0.0 111.136 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -69.54 -39.12 79.38 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.497 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 5.9 mt -71.4 -38.74 71.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.807 0.337 . . . . 0.0 110.879 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -69.69 -37.02 76.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.902 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -72.55 -35.33 67.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.884 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.87 -20.61 62.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.878 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -13.62 62.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.907 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -87.36 -42.51 12.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.845 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 172' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 179.98 -75.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.852 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 1.3 tt -144.85 134.65 18.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.124 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 76.9 t -91.81 92.23 3.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.129 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.25 -48.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.896 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.42 -42.03 92.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.928 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 179.982 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.7 m -98.6 160.58 27.63 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.58 0.705 . . . . 0.0 110.865 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 91.5 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.718 2.279 . . . . 0.0 112.317 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -166.17 -172.08 2.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.12 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.27 44.34 0.42 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.914 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -76.01 -20.59 57.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.917 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -165.12 79.98 0.34 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.904 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -174.93 -169.41 0.4 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.07 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.0 t 66.81 142.59 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.668 0.747 . . . . 0.0 110.906 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -12.15 32.32 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.715 2.277 . . . . 0.0 112.324 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.49 -17.04 64.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.891 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.5 m -75.91 -37.9 58.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.154 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.2 t -66.73 -40.94 88.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.866 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 53.0 mt -55.89 -40.97 65.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.1 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 75.7 mt -57.94 -42.11 81.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.146 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.2 m -66.04 -41.5 90.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.877 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.13 -51.0 59.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.1 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 66.0 t -53.14 -46.2 55.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.129 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 84.8 t -64.96 -36.19 77.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.139 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.69 -46.08 94.96 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.506 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.8 mp -70.68 -42.92 77.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.799 0.333 . . . . 0.0 111.091 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.5 mp -65.07 -35.84 82.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.5 mt -67.8 -45.12 75.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 95.4 t -62.06 -36.81 76.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.107 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 89.7 t -64.56 -51.74 63.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.139 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.4 t -62.65 -53.34 48.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.122 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.3 mt -60.24 -37.42 80.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.09 -50.52 66.98 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.499 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.0 t -70.95 -39.53 75.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.859 0.362 . . . . 0.0 111.126 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.8 t -62.53 -53.15 50.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.144 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -61.93 -39.94 93.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.888 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -55.65 -49.56 64.91 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.46 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 64.4 mt -64.13 -46.79 92.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.862 0.363 . . . . 0.0 111.153 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -56.4 -49.5 74.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.949 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.4 mt -57.04 -31.05 35.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.157 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.1 mmmt -85.07 -22.69 28.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.916 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 9.1 mtp85 -67.74 -28.69 67.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.851 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -64.89 -25.68 67.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.87 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -64.99 -75.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.923 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -165.09 -46.18 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.929 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.96 -177.89 3.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.877 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.5 pp -134.74 -37.9 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.139 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? 54.2 84.52 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.918 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.527 0.063 0 CA-C-O 120.869 0.366 . . . . 0.0 110.815 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -157.85 105.73 0.28 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.515 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 136' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -155.6 160.49 30.8 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.626 0.727 . . . . 0.0 110.885 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.76 -178.44 2.34 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.683 2.256 . . . . 0.0 112.344 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 138' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.41 109.67 10.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.147 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -156.96 159.54 38.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.912 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -66.85 177.04 19.85 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.49 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 141' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 97.65 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.728 2.285 . . . . 0.0 112.367 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 142' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.78 -1.34 42.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.86 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . 0.514 ' HA ' ' C ' ' B' ' 144' ' ' PRO . 1.9 mt 64.36 139.58 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.647 0.737 . . . . 0.0 111.152 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 144' ' ' PRO . . . . . 0.514 ' C ' ' HA ' ' B' ' 143' ' ' ILE . 54.4 Cg_endo -69.74 159.08 90.21 Favored 'Cis proline' 0 C--N 1.342 0.192 0 C-N-CA 122.717 -1.784 . . . . 0.0 112.387 -0.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 178.65 -75.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.861 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 27.3 mt -93.27 -18.46 7.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.15 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.34 -21.2 66.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.117 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 16.0 m -51.26 -30.36 17.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.135 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . -54.65 -54.06 35.21 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.505 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 150' ' ' MET . . . . . . . . . . . . . 27.3 mmt -58.62 -51.04 71.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.805 0.336 . . . . 0.0 110.922 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 59.2 t -55.19 -40.41 55.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.094 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -63.26 -41.61 99.52 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.434 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -63.45 -46.58 85.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.799 0.333 . . . . 0.0 111.121 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.96 -46.75 87.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.861 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 4.3 tp -54.59 -53.61 52.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.898 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 3.3 mt -56.75 -44.79 82.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.939 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 1.1 tt -54.99 -46.98 75.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.906 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 1.1 tt -67.64 -39.82 84.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.953 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 93.2 t -63.58 -48.04 88.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.108 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 38.2 t -64.69 -47.45 88.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.128 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.85 -35.74 66.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.103 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 1.4 tp -73.37 -38.77 65.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.934 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.37 -40.82 54.17 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.47 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 54.5 mt -73.59 -38.53 52.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.872 0.367 . . . . 0.0 111.134 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -67.88 -40.64 89.25 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.476 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 7.5 mt -70.36 -42.44 71.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.887 0.375 . . . . 0.0 110.924 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -65.88 -37.49 86.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.835 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.0 -26.32 59.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.911 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -82.14 -15.84 51.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.847 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -54.84 -26.74 37.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -145.02 17.21 1.58 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.854 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 172' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 51.72 44.06 29.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.876 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 5.4 tt -75.56 132.64 32.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.107 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 10.8 p -102.39 151.85 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.108 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 175' ' ' ARG . . . . . . . . . . . . . 7.1 ttm180 -156.88 107.04 2.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.89 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 9.1 tptt 62.74 41.25 9.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.898 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.869 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 63.11 160.59 0.12 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.624 0.726 . . . . 0.0 110.862 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -20.45 34.65 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.698 2.266 . . . . 0.0 112.319 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.6 170.69 0.24 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.076 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -169.73 116.41 0.57 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.871 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -75.97 100.46 4.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.914 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -74.82 75.34 2.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.846 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -164.78 -170.48 2.0 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.06 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.7 t 62.93 72.94 0.54 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.682 0.753 . . . . 0.0 110.847 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 -15.66 37.46 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.717 2.278 . . . . 0.0 112.356 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.7 tt -72.62 -16.2 61.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.948 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.0 m -76.35 -35.59 58.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.087 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 t -67.97 -38.06 82.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.833 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.8 mt -62.32 -48.42 88.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.086 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 61.8 mt -55.4 -49.88 69.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.152 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.8 m -54.81 -45.61 74.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.821 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.77 -51.27 60.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.115 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.5 t -53.04 -37.74 27.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.097 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 81.7 t -71.32 -37.12 64.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.124 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.87 -46.01 94.49 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.494 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.2 mp -70.76 -42.43 77.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.84 0.352 . . . . 0.0 111.103 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.1 mt -65.33 -35.91 82.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.953 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.4 mt -67.86 -45.5 74.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.941 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 98.4 t -61.33 -37.68 78.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.139 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 87.9 t -64.05 -51.42 69.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.121 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.9 t -63.3 -53.59 43.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.155 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mt -60.44 -32.57 71.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.936 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.2 -47.97 79.62 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.475 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.7 t -75.08 -33.01 27.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.883 0.373 . . . . 0.0 111.125 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 73.4 t -70.89 -53.04 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.145 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -62.03 -45.1 95.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.835 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.13 -49.02 79.35 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.451 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 63.9 mt -71.63 -24.88 23.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.868 0.366 . . . . 0.0 111.157 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.7 mt -73.31 -47.95 38.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.898 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.6 mt -51.75 -49.84 34.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.13 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.7 -36.05 79.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.903 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.72 -26.71 62.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.892 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -72.92 -40.69 65.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -66.72 -73.87 0.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -156.03 -58.92 0.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.924 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.4 tttm 54.63 78.23 0.18 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.894 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 5.4 tp -155.02 -40.8 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.184 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 22.8 ptt180 -147.65 -178.77 6.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.904 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.911 0.386 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 101.47 30.18 6.0 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.481 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 136' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 63.2 160.55 0.12 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.631 0.729 . . . . 0.0 110.9 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.74 143.18 50.12 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.702 2.268 . . . . 0.0 112.355 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 138' ' ' THR . . . . . . . . . . . . . 20.1 p -149.66 27.45 0.81 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.158 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -149.02 101.91 3.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.863 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -75.89 168.24 54.77 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.478 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 141' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 167.97 22.85 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.66 2.24 . . . . 0.0 112.385 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 142' ' ' LYS . . . . . . . . . . . . . 19.6 mttp -150.76 42.76 0.8 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.914 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . 0.535 ' HA ' ' C ' ' B' ' 144' ' ' PRO . 2.1 mt -134.24 138.99 31.64 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.642 0.734 . . . . 0.0 111.127 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 144' ' ' PRO . . . . . 0.535 ' C ' ' HA ' ' B' ' 143' ' ' ILE . 54.0 Cg_endo -69.75 -169.98 5.49 Favored 'Cis proline' 0 C--N 1.342 0.211 0 C-N-CA 122.649 -1.813 . . . . 0.0 112.374 -0.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 12.9 p -56.06 -21.58 22.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.854 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 39.0 mt -88.48 -23.38 6.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.113 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -51.41 -35.28 38.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.102 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 64.0 m -52.41 -34.11 46.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.14 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . -53.12 -55.53 23.63 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.517 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 150' ' ' MET . . . . . . . . . . . . . 22.3 mmt -62.37 -45.25 93.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.811 0.339 . . . . 0.0 110.872 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 59.1 t -55.61 -40.39 59.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.122 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -68.63 -39.77 86.25 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.503 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -60.68 -48.43 81.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.806 0.336 . . . . 0.0 111.098 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 1.1 tp -60.94 -55.32 34.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.953 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.31 -55.08 31.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.929 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 13.5 mt -51.94 -45.5 64.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.955 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.06 -46.56 75.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.914 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 3.5 tt -68.03 -39.65 83.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.903 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 47.1 t -63.85 -47.81 89.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.151 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 37.9 t -64.8 -47.41 88.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.121 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.9 -36.17 67.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.11 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.4 -38.48 65.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.919 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.09 -41.24 54.72 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.509 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 58.1 mt -73.64 -39.16 53.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.894 0.378 . . . . 0.0 111.122 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -67.74 -38.59 89.85 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.483 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 12.5 mt -72.64 -38.83 67.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.898 0.38 . . . . 0.0 110.947 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -67.88 -39.88 83.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.856 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.05 -55.12 6.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.88 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.31 -27.11 33.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.862 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.0 -44.62 74.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 53.9 mtm180 -94.76 20.8 8.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.877 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 172' ' ' HIS . . . . . . . . . . . . . 19.8 m80 51.0 61.86 3.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -144.55 126.24 9.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.123 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 6.5 p -153.34 23.5 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.148 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 175' ' ' ARG . . . . . . . . . . . . . 30.4 ptt85 -72.91 179.62 3.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.874 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -169.6 -68.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.885 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.888 179.99 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.2 m -152.06 160.59 31.25 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.616 0.722 . . . . 0.0 110.856 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 135.51 30.66 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.7 2.267 . . . . 0.0 112.375 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -167.01 -50.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.095 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 69.3 -75.45 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 62.41 174.29 0.14 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.854 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.0 tpt85 -165.99 151.33 8.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.866 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -172.82 159.63 4.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.089 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.3 t -68.74 147.5 97.94 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.619 0.723 . . . . 0.0 110.854 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -15.47 37.09 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.725 2.283 . . . . 0.0 112.331 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 tt -72.84 -16.11 61.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.912 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.9 m -76.34 -35.38 58.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.102 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.1 t -68.39 -37.22 80.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.854 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 80.6 mt -63.09 -48.38 88.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.139 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 57.2 mt -54.97 -44.74 75.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.094 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.6 m -59.66 -48.2 82.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.869 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.76 -48.97 78.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.087 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 62.5 t -53.2 -40.46 38.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.15 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 66.8 t -69.55 -35.19 65.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.101 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.97 -46.11 92.28 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.47 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.1 mp -70.87 -43.15 77.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.912 0.387 . . . . 0.0 111.143 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -65.27 -32.96 74.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.929 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.6 mt -69.37 -48.65 60.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.91 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 91.7 t -59.22 -38.39 74.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.136 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 91.1 t -63.88 -51.35 70.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.155 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.3 t -63.02 -53.53 45.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.139 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mt -60.5 -32.97 71.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.912 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.74 -47.69 84.07 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.534 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.5 t -75.08 -32.91 27.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.839 0.352 . . . . 0.0 111.152 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 73.8 t -70.81 -53.05 23.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.107 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -62.6 -42.57 99.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -59.34 -49.59 76.91 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.498 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 55.7 mt -69.51 -24.91 27.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.813 0.339 . . . . 0.0 111.056 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 14.2 mt -71.56 -36.87 71.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 71.8 mt -83.78 -37.29 13.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.129 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -55.02 -43.8 74.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.926 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.2 mtp180 -52.23 -60.71 2.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.889 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.5 ttt-85 -84.98 55.03 3.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.886 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.73 -175.93 1.84 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.915 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 56.14 56.63 5.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.946 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.26 54.84 3.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.927 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.3 mp 57.56 71.4 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.135 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -89.0 -58.35 2.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.874 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 . . . . . 0 N--CA 1.458 -0.064 0 CA-C-O 120.921 0.391 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 168.95 -145.98 9.91 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.462 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 136' ' ' CYS . . . . . . . . . . . . . 4.6 p -157.93 156.59 28.49 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.648 0.737 . . . . 0.0 110.877 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 -28.17 25.45 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.708 2.272 . . . . 0.0 112.347 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 138' ' ' THR . . . . . . . . . . . . . 1.2 m 63.13 28.06 15.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.146 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -75.54 130.82 39.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.846 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 57.13 84.9 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.506 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 141' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 -40.02 5.7 Favored 'Trans proline' 0 N--CA 1.465 -0.166 0 C-N-CA 122.706 2.271 . . . . 0.0 112.322 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 142' ' ' LYS . . . . . . . . . . . . . 5.4 mtpp 62.76 90.08 0.08 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.897 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . 0.547 ' HA ' ' C ' ' B' ' 144' ' ' PRO . 0.5 OUTLIER -54.06 140.23 52.6 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.642 0.734 . . . . 0.0 111.108 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 144' ' ' PRO . . . . . 0.547 ' C ' ' HA ' ' B' ' 143' ' ' ILE . 53.7 Cg_endo -69.76 158.66 90.77 Favored 'Cis proline' 0 C--N 1.342 0.19 0 C-N-CA 122.619 -1.825 . . . . 0.0 112.364 -0.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.39 -75.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.857 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 63.0 mt -96.51 -21.82 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.129 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.82 -24.75 64.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.103 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 69.4 m -51.71 -29.83 19.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.11 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . -53.95 -55.72 24.45 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.5 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 150' ' ' MET . . . . . . . . . . . . . 28.7 mmt -57.15 -49.07 77.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.802 0.334 . . . . 0.0 110.889 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 59.4 t -57.85 -40.26 75.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.143 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -63.27 -40.03 98.55 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.527 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -65.95 -41.82 90.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.816 0.341 . . . . 0.0 111.12 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 2.5 tp -64.12 -51.95 61.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.923 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 5.7 tp -52.31 -49.93 63.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.897 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 69.5 mt -57.37 -44.23 84.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.92 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 5.1 tt -55.04 -47.52 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.899 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 2.7 tt -67.1 -39.98 86.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.909 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 91.0 t -63.42 -48.22 88.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.173 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 38.5 t -64.63 -47.37 89.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.113 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.85 -35.63 66.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.071 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 6.3 tp -73.4 -38.85 65.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.885 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.39 -40.78 54.12 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.456 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 54.6 mt -73.66 -38.49 51.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.894 0.378 . . . . 0.0 111.124 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.16 -40.1 88.15 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.54 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 11.8 mt -70.84 -41.72 71.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.837 0.351 . . . . 0.0 110.928 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -67.12 -37.36 83.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.87 -26.02 60.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.852 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.95 -26.27 47.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.88 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.15 -24.33 67.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.881 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 50.87 45.41 27.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 172' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -146.93 26.85 1.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.875 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 3.5 pt -89.19 -177.82 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.112 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 6.7 m -152.11 28.15 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.109 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 175' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -84.15 176.43 8.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.857 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -155.5 -60.28 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.859 -179.991 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 4.5 p -136.03 156.59 76.93 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.626 0.727 . . . . 0.0 110.853 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 131.89 22.18 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.635 2.223 . . . . 0.0 112.341 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.53 -29.42 67.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.133 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -172.41 -173.03 0.99 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.844 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -148.07 124.85 11.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.905 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.96 113.01 0.19 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.855 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -172.73 -170.06 0.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.094 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.3 t -55.51 147.57 38.43 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.688 0.756 . . . . 0.0 110.836 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -15.49 37.19 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.71 2.273 . . . . 0.0 112.316 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.76 -16.19 61.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.923 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.0 m -76.3 -35.59 58.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.134 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.1 t -68.2 -39.38 82.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.841 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 27.5 mt -59.84 -46.12 94.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.16 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 60.7 mt -56.97 -48.65 81.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.138 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 51.1 m -56.06 -45.94 79.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.48 -51.09 64.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.11 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 78.1 t -53.18 -38.38 30.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.193 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 93.2 t -69.94 -38.03 74.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.151 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.48 -46.14 94.42 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.536 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.2 mp -70.62 -42.68 77.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.868 0.366 . . . . 0.0 111.133 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.2 mt -65.14 -35.97 82.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.922 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.1 mt -67.72 -45.8 73.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.903 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 92.2 t -60.93 -37.96 78.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.172 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.4 t -63.65 -51.89 64.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.121 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 62.0 t -62.39 -53.48 46.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.137 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mt -60.32 -33.83 72.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.89 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.84 -49.08 75.76 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.483 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.0 t -73.12 -32.84 40.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.887 0.375 . . . . 0.0 111.17 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.0 t -70.37 -45.76 73.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.124 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -63.92 -48.61 75.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.838 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -57.16 -49.54 71.4 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.493 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 62.3 mt -67.1 -28.44 42.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.82 0.343 . . . . 0.0 111.11 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.5 mt -67.51 -38.24 83.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.882 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 39.0 mt -63.74 -36.54 76.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.118 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.8 mmtt -84.97 -27.08 26.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.3 mmt85 -58.16 -23.28 54.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.885 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.9 ttm180 -64.95 -25.03 67.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.873 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -65.04 139.26 58.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.877 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -64.98 -38.77 92.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.2 mttp -75.23 86.87 2.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 41.7 pt -150.83 34.64 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.134 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.6 ttp180 -157.57 150.88 23.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.881 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 . . . . . 0 N--CA 1.458 -0.074 0 CA-C-O 120.895 0.379 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 141.32 -140.36 10.24 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.48 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 136' ' ' CYS . . . . . . . . . . . . . 19.8 t -159.3 69.26 3.29 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.602 0.715 . . . . 0.0 110.819 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.85 166.52 27.42 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.662 2.241 . . . . 0.0 112.313 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 138' ' ' THR . . . . . . . . . . . . . 2.1 p -150.87 -62.83 0.19 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.128 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -147.17 -48.66 0.18 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 59.67 -165.39 10.87 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.518 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 141' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -168.96 0.3 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.668 2.245 . . . . 0.0 112.348 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 142' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -144.85 16.06 1.58 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.886 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . 0.531 ' HA ' ' C ' ' B' ' 144' ' ' PRO . 46.9 mt -150.85 136.57 10.65 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.582 0.706 . . . . 0.0 111.135 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 144' ' ' PRO . . . . . 0.531 ' C ' ' HA ' ' B' ' 143' ' ' ILE . 54.0 Cg_endo -69.73 157.54 91.86 Favored 'Cis proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.715 -1.785 . . . . 0.0 112.368 -0.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 1.9 p 179.05 -160.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.84 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 3.2 mp -51.25 -22.13 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.115 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -56.08 -32.33 64.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.112 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 48.1 m -54.2 -25.64 23.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.134 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . -57.12 -49.48 71.7 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.482 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 150' ' ' MET . . . . . . . . . . . . . 30.2 mmt -62.46 -51.71 66.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.796 0.332 . . . . 0.0 110.863 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 57.9 t -57.82 -40.1 74.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.098 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -64.79 -41.79 97.4 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.494 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -62.34 -49.03 77.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.869 0.366 . . . . 0.0 111.121 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 1.4 tt -68.45 -45.58 72.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.94 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 19.6 tp -60.55 -55.35 34.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.928 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 32.7 mt -51.95 -47.16 64.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.897 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.33 -46.36 72.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.902 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.36 -39.79 81.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 92.2 t -63.44 -47.63 90.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.109 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 34.8 t -64.01 -47.97 88.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.112 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.17 -36.98 66.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.101 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 4.6 tp -73.25 -38.13 66.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -71.8 -40.98 57.16 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.467 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 58.1 mt -74.2 -39.77 50.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.84 0.353 . . . . 0.0 111.087 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -66.78 -38.39 93.02 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.528 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 12.4 mt -72.26 -45.47 60.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.843 0.354 . . . . 0.0 110.93 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -60.52 -37.7 82.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.94 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.91 -25.67 59.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.86 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -75.07 -23.75 58.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.92 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 2.2 mtp85 -56.43 -25.55 50.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.869 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 171' ' ' ARG . . . . . 0.401 ' O ' ' CG ' ' B' ' 172' ' ' HIS . 8.8 mmm180 -67.04 -13.8 62.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.888 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 172' ' ' HIS . . . . . 0.401 ' CG ' ' O ' ' B' ' 171' ' ' ARG . 46.6 p-80 41.6 38.36 0.89 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.814 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 4.2 tt -78.16 143.0 13.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.131 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 18.5 m -83.79 55.12 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.142 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 175' ' ' ARG . . . . . . . . . . . . . 6.4 ttt85 -84.52 -28.98 26.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.87 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 58.8 90.91 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.94 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.904 179.997 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.7 m . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.875 0.369 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.81 -48.45 81.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.12 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.433 HG12 HD12 ' A' ' 62' ' ' LEU . 62.1 t -53.1 -38.13 29.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.131 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.422 HG12 HD12 ' A' ' 63' ' ' LEU . 64.8 t -70.25 -37.42 71.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.11 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.635 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -63.12 -46.09 94.02 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.525 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.698 ' O ' HG23 ' A' ' 65' ' ' VAL . 3.2 mp -70.9 -42.38 77.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.874 0.369 . . . . 0.0 111.117 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.491 ' O ' HG23 ' A' ' 66' ' ' VAL . 12.1 mt -65.43 -34.94 79.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.888 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.422 HD12 HG12 ' A' ' 59' ' ' VAL . 12.0 mt -68.41 -46.76 69.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.936 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 60' ' ' GLY . 97.0 t -60.3 -38.3 77.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.118 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 61' ' ' ILE . 89.9 t -63.65 -51.82 65.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.125 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.556 ' O ' HG23 ' A' ' 70' ' ' VAL . 62.0 t -62.52 -53.58 45.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.114 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.9 mt -60.33 -32.83 71.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.929 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.89 -47.92 81.29 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.458 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.433 HG12 HD12 ' A' ' 73' ' ' ILE . 95.6 t -75.07 -33.02 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.816 0.341 . . . . 0.0 111.08 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 66' ' ' VAL . 73.9 t -70.71 -53.05 23.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.118 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -61.95 -44.29 97.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.5 -49.5 76.18 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.505 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.433 HD12 HG12 ' A' ' 69' ' ' VAL . 58.9 mt . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 120.879 0.371 . . . . 0.0 111.135 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.841 0.353 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.51 -53.79 31.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.954 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 155' ' ' LEU . . . . . 0.607 ' O ' HG23 ' B' ' 159' ' ' VAL . 0.4 OUTLIER -52.1 -55.43 20.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 156' ' ' LEU . . . . . 0.703 ' O ' HG23 ' B' ' 160' ' ' VAL . 10.8 mt -52.2 -45.22 65.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.922 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 1.4 tt -55.05 -46.99 75.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.942 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.78 -39.51 84.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.922 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 159' ' ' VAL . . . . . 0.607 HG23 ' O ' ' B' ' 155' ' ' LEU . 69.6 t -63.8 -47.98 88.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.068 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 160' ' ' VAL . . . . . 0.703 HG23 ' O ' ' B' ' 156' ' ' LEU . 36.5 t -64.76 -47.54 88.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.132 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.91 -35.69 66.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.046 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 1.7 tp -73.32 -38.82 65.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.887 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.4 -40.91 53.77 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.529 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 54.8 mt -73.59 -38.31 51.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.857 0.36 . . . . 0.0 111.104 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -69.06 -39.03 84.6 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.467 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 10.9 mt -71.66 -39.6 70.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.907 0.384 . . . . 0.0 110.907 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -69.41 -37.62 77.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.864 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.42 -28.58 59.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.88 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 14.2 ttt180 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.92 -179.946 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.8 m . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.907 0.384 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.58 -50.55 64.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.072 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.554 ' O ' HD13 ' A' ' 62' ' ' LEU . 66.1 t -53.2 -44.75 53.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.128 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 65.6 t -65.9 -35.53 75.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.127 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.615 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -62.83 -46.23 94.06 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.47 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.722 ' O ' HG23 ' A' ' 65' ' ' VAL . 2.9 mp -70.6 -42.85 78.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.893 0.378 . . . . 0.0 111.088 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.554 HD13 ' O ' ' A' ' 58' ' ' VAL . 8.5 mp -65.23 -35.25 80.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.92 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.994 HD13 HD22 ' B' ' 157' ' ' LEU . 12.5 mt -67.84 -46.33 72.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.931 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 60' ' ' GLY . 84.9 t -60.89 -37.88 77.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.1 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 61' ' ' ILE . 89.7 t -63.38 -53.02 50.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.127 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.549 ' O ' HG23 ' A' ' 70' ' ' VAL . 59.9 t -61.12 -53.39 49.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.161 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 mt -60.3 -33.33 72.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.937 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.25 -47.96 83.43 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.486 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.493 HG12 HD12 ' A' ' 73' ' ' ILE . 96.8 t -74.91 -33.22 29.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.873 0.368 . . . . 0.0 111.079 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 66' ' ' VAL . 72.7 t -70.37 -46.93 69.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.074 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -64.56 -48.84 73.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.911 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -56.62 -47.27 85.9 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.472 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.493 HD12 HG12 ' A' ' 69' ' ' VAL . 67.4 mt . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 120.896 0.379 . . . . 0.0 111.13 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.792 0.33 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 11.9 tp -68.18 -50.02 57.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.915 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 155' ' ' LEU . . . . . 0.629 ' O ' HG23 ' B' ' 159' ' ' VAL . 7.8 tp -57.36 -53.4 58.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.927 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 156' ' ' LEU . . . . . 0.696 ' O ' HG23 ' B' ' 160' ' ' VAL . 16.5 mt -53.28 -45.73 68.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 157' ' ' LEU . . . . . 0.994 HD22 HD13 ' A' ' 63' ' ' LEU . 12.4 tp -54.96 -46.4 75.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.92 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 1.3 tt -68.05 -39.94 82.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.871 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 159' ' ' VAL . . . . . 0.629 HG23 ' O ' ' B' ' 155' ' ' LEU . 74.6 t -63.59 -48.02 88.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.129 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 160' ' ' VAL . . . . . 0.696 HG23 ' O ' ' B' ' 156' ' ' LEU . 36.0 t -64.59 -47.5 88.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.101 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.87 -35.82 66.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.073 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 1.3 tp -73.33 -38.8 65.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.916 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.19 -40.89 55.05 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.505 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 54.8 mt -73.63 -38.75 52.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.907 0.384 . . . . 0.0 111.107 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -67.27 -40.95 92.13 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.471 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 11.5 mt -70.32 -41.08 73.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.853 0.359 . . . . 0.0 110.894 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -67.54 -37.43 82.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.878 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.65 -25.69 57.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.902 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 3.2 mmt85 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.897 -179.954 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.6 m . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.839 0.352 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.11 -51.15 62.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.133 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.49 ' O ' HD23 ' A' ' 62' ' ' LEU . 97.5 t -53.35 -46.75 58.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.106 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 87.5 t -63.32 -35.88 73.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.137 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.593 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -62.95 -46.3 93.85 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.444 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.696 ' O ' HG23 ' A' ' 65' ' ' VAL . 2.8 mp -71.12 -42.85 75.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.814 0.34 . . . . 0.0 111.118 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.592 ' O ' HG23 ' A' ' 66' ' ' VAL . 4.0 mm? -65.32 -32.92 74.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.5 mt -69.55 -49.26 55.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.934 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 60' ' ' GLY . 95.3 t -58.36 -39.05 72.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.122 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 61' ' ' ILE . 93.5 t -63.7 -51.04 75.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.121 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 62' ' ' LEU . 61.2 t -63.31 -53.56 44.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.185 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.0 mt -60.37 -32.84 71.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.926 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.02 -47.92 80.81 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.487 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.466 HG12 HD12 ' A' ' 73' ' ' ILE . 99.5 t -75.01 -32.94 27.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.825 0.345 . . . . 0.0 111.123 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 66' ' ' VAL . 72.6 t -70.76 -51.44 36.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.118 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -62.42 -45.68 91.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.87 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -57.86 -49.2 76.69 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.542 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.466 HD12 HG12 ' A' ' 69' ' ' VAL . 59.8 mt . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.87 0.367 . . . . 0.0 111.114 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.783 0.325 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 7.6 tp -61.87 -41.58 98.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.886 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 155' ' ' LEU . . . . . 0.705 ' O ' HG23 ' B' ' 159' ' ' VAL . 0.4 OUTLIER -61.36 -55.03 36.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.926 179.893 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 156' ' ' LEU . . . . . 0.699 ' O ' HG23 ' B' ' 160' ' ' VAL . 15.9 mt -52.4 -46.36 66.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 3.6 tp -54.69 -46.55 74.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.869 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.09 -40.15 82.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.946 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 159' ' ' VAL . . . . . 0.705 HG23 ' O ' ' B' ' 155' ' ' LEU . 54.8 t -63.18 -47.74 90.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.105 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 160' ' ' VAL . . . . . 0.699 HG23 ' O ' ' B' ' 156' ' ' LEU . 36.2 t -64.87 -47.86 86.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.147 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.59 -35.13 65.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.154 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 1.1 tp -72.18 -39.76 68.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.956 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.23 -44.1 44.86 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.545 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 51.9 mt -69.4 -36.97 74.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.879 0.371 . . . . 0.0 111.161 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -71.37 -39.61 61.49 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.501 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 12.6 mt -72.13 -29.75 64.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.878 0.371 . . . . 0.0 110.899 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -81.27 -36.02 30.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.842 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.5 -29.54 61.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.913 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.862 0.363 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.642 ' HA ' HD13 ' B' ' 156' ' ' LEU . . . -62.0 -50.12 73.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.051 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.472 HG12 HD12 ' A' ' 62' ' ' LEU . 62.5 t -52.99 -37.5 26.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.124 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.542 HG12 HD12 ' A' ' 63' ' ' LEU . 89.8 t -70.72 -38.01 71.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.148 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.671 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -62.77 -46.03 94.51 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.443 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.715 ' O ' HG23 ' A' ' 65' ' ' VAL . 3.2 mp -70.69 -42.38 77.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.901 0.381 . . . . 0.0 111.159 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.472 HD12 HG12 ' A' ' 58' ' ' VAL . 11.9 mt -65.41 -36.11 82.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.889 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.542 HD12 HG12 ' A' ' 59' ' ' VAL . 11.3 mt -67.79 -45.19 75.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.912 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 60' ' ' GLY . 99.9 t -61.53 -37.71 78.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.101 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 61' ' ' ILE . 89.4 t -63.95 -51.84 64.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.12 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.54 ' O ' HG23 ' A' ' 70' ' ' VAL . 60.2 t -62.64 -53.45 46.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.17 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.1 mt -60.37 -33.62 72.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.897 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.08 -48.25 81.7 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.474 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.3 t -75.07 -32.93 27.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.913 0.387 . . . . 0.0 111.115 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 66' ' ' VAL . 56.5 t -70.1 -52.13 33.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.164 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -63.08 -43.37 98.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.9 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.57 -48.67 83.21 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.472 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 58.1 mt . . . . . 0 C--N 1.328 -0.335 0 CA-C-O 120.91 0.386 . . . . 0.0 111.15 -179.989 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.851 0.358 . . . . 0.0 111.116 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 11.0 tp -65.55 -53.84 36.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.944 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 155' ' ' LEU . . . . . 0.708 ' O ' HG23 ' B' ' 159' ' ' VAL . 18.3 tp -52.74 -54.87 27.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 156' ' ' LEU . . . . . 0.708 ' O ' HG23 ' B' ' 160' ' ' VAL . 4.1 mt -53.4 -44.12 68.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.927 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 8.0 tp -54.98 -48.07 73.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.905 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.91 -39.51 87.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.933 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 159' ' ' VAL . . . . . 0.708 HG23 ' O ' ' B' ' 155' ' ' LEU . 50.0 t -63.52 -48.43 86.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.132 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 160' ' ' VAL . . . . . 0.708 HG23 ' O ' ' B' ' 156' ' ' LEU . 37.1 t -64.37 -47.45 89.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.177 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.77 -35.73 66.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.084 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.36 -38.85 65.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.37 -40.85 54.1 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.453 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 54.6 mt -73.6 -38.53 52.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.88 0.371 . . . . 0.0 111.112 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.71 -39.14 86.33 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.495 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 10.6 mt -71.66 -40.14 69.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.836 0.351 . . . . 0.0 110.926 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -68.79 -37.46 79.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.32 -28.61 61.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.872 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.888 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.3 m . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 120.892 0.377 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.05 -50.38 68.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.089 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 62.1 t -53.04 -37.32 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.119 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 92.0 t -71.09 -37.83 68.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.129 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.669 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -62.78 -46.07 94.41 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.438 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.706 ' O ' HG23 ' A' ' 65' ' ' VAL . 3.2 mp -70.7 -42.36 77.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.822 0.344 . . . . 0.0 111.105 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.434 ' O ' HG23 ' A' ' 66' ' ' VAL . 12.1 mt -65.41 -36.01 82.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.4 mt -67.69 -45.65 74.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.969 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 60' ' ' GLY . 99.8 t -61.14 -38.05 78.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.075 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 61' ' ' ILE . 89.5 t -63.56 -52.36 58.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.137 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.552 ' O ' HG23 ' A' ' 70' ' ' VAL . 60.2 t -61.99 -53.47 47.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.072 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.34 -32.9 71.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.78 -48.39 77.32 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.49 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.477 HG12 HD12 ' A' ' 73' ' ' ILE . 94.2 t -74.45 -33.38 32.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.86 0.362 . . . . 0.0 111.085 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 66' ' ' VAL . 72.6 t -70.32 -51.33 39.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.073 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -62.49 -46.25 89.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.905 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -57.35 -48.85 77.48 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.507 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.477 HD12 HG12 ' A' ' 69' ' ' VAL . 61.0 mt . . . . . 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 0.0 111.118 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.826 0.346 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 2.2 tt -63.87 -54.91 27.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 155' ' ' LEU . . . . . 0.706 ' O ' HG23 ' B' ' 159' ' ' VAL . 0.4 OUTLIER -51.96 -56.53 13.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.917 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 156' ' ' LEU . . . . . 0.705 ' O ' HG23 ' B' ' 160' ' ' VAL . 14.3 mt -52.18 -45.7 65.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.899 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 4.3 tt -54.87 -47.21 74.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.86 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 5.2 tp -67.78 -39.3 84.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 159' ' ' VAL . . . . . 0.706 HG23 ' O ' ' B' ' 155' ' ' LEU . 54.7 t -63.77 -47.92 88.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.131 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 160' ' ' VAL . . . . . 0.705 HG23 ' O ' ' B' ' 156' ' ' LEU . 36.6 t -64.46 -47.7 88.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.148 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.61 -36.37 66.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.121 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.37 -38.37 65.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.929 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.05 -41.0 55.66 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.468 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 58.2 mt -74.04 -39.28 50.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.901 0.381 . . . . 0.0 111.126 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -67.54 -38.46 90.57 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.484 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 12.5 mt -72.43 -42.13 65.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.886 0.374 . . . . 0.0 110.937 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -65.95 -38.03 87.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.867 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.15 -26.39 53.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.884 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.927 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.3 m . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.855 0.36 . . . . 0.0 110.798 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.93 -50.8 67.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.065 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.563 HG12 HD12 ' A' ' 62' ' ' LEU . 62.7 t -53.04 -37.71 27.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.155 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.439 HG12 HD12 ' A' ' 63' ' ' LEU . 92.3 t -70.46 -37.87 71.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.148 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.674 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -62.83 -46.09 94.35 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.474 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.711 ' O ' HG23 ' A' ' 65' ' ' VAL . 3.2 mp -70.78 -42.29 77.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.865 0.364 . . . . 0.0 111.132 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.563 HD12 HG12 ' A' ' 58' ' ' VAL . 11.2 mt -65.41 -36.02 82.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.439 HD12 HG12 ' A' ' 59' ' ' VAL . 12.1 mt -67.71 -45.64 74.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.932 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 60' ' ' GLY . 99.6 t -61.02 -38.15 78.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.121 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 61' ' ' ILE . 92.1 t -63.52 -52.29 59.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.156 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.551 ' O ' HG23 ' A' ' 70' ' ' VAL . 60.2 t -62.12 -53.51 46.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.116 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.39 -32.43 71.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.29 -48.2 76.85 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.495 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.478 HG12 HD12 ' A' ' 73' ' ' ILE . 92.7 t -74.92 -33.22 29.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.854 0.359 . . . . 0.0 111.106 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 66' ' ' VAL . 74.6 t -70.72 -52.77 25.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.171 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -61.68 -46.23 90.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.939 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -57.62 -48.9 78.18 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.456 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.478 HD12 HG12 ' A' ' 69' ' ' VAL . 67.9 mt . . . . . 0 C--N 1.328 -0.347 0 CA-C-O 120.87 0.367 . . . . 0.0 111.137 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.791 0.329 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.98 -52.59 48.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.891 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 155' ' ' LEU . . . . . 0.656 ' O ' HG23 ' B' ' 159' ' ' VAL . 0.5 OUTLIER -53.06 -54.7 31.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.896 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 156' ' ' LEU . . . . . 0.703 ' O ' HG23 ' B' ' 160' ' ' VAL . 23.0 mt -52.49 -45.8 66.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 3.2 tt -54.81 -47.37 74.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.946 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.67 -39.25 84.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.909 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 159' ' ' VAL . . . . . 0.656 HG23 ' O ' ' B' ' 155' ' ' LEU . 67.2 t -63.76 -48.0 88.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.167 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 160' ' ' VAL . . . . . 0.703 HG23 ' O ' ' B' ' 156' ' ' LEU . 37.1 t -64.44 -47.66 88.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.109 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.59 -36.41 66.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.121 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 2.9 tp -73.32 -38.39 65.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.936 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -71.98 -41.02 55.97 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.454 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 58.2 mt -74.07 -39.41 50.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.855 0.359 . . . . 0.0 111.121 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -67.37 -38.52 91.31 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.513 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 6.7 mt -72.41 -46.02 57.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.806 0.336 . . . . 0.0 110.898 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -61.44 -37.79 84.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.903 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.81 -26.08 54.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.876 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 21.0 mtt180 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.846 -179.905 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.2 m . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.857 0.361 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.1 -49.71 74.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.114 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.761 HG12 HD12 ' A' ' 62' ' ' LEU . 61.5 t -53.05 -37.55 27.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.138 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 90.5 t -70.81 -37.64 69.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.118 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.671 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -62.99 -46.08 94.29 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.441 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.724 ' O ' HG23 ' A' ' 65' ' ' VAL . 3.2 mp -70.79 -42.23 77.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.879 0.371 . . . . 0.0 111.14 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.761 HD12 HG12 ' A' ' 58' ' ' VAL . 6.7 mt -65.39 -36.11 82.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.914 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.4 mt -67.67 -45.66 74.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.936 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 60' ' ' GLY . 97.6 t -61.02 -38.04 78.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.149 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 61' ' ' ILE . 90.3 t -63.58 -52.18 60.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.122 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.548 ' O ' HG23 ' A' ' 70' ' ' VAL . 59.9 t -62.38 -53.49 46.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.091 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.2 mt -60.38 -32.55 71.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.923 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.23 -48.22 76.92 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.488 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.478 HG12 HD12 ' A' ' 73' ' ' ILE . 96.5 t -74.85 -33.16 29.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.845 0.355 . . . . 0.0 111.12 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 66' ' ' VAL . 72.7 t -70.71 -52.88 24.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.163 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -61.64 -46.01 91.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -57.48 -49.08 76.21 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.534 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.478 HD12 HG12 ' A' ' 69' ' ' VAL . 63.7 mt . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 120.891 0.377 . . . . 0.0 111.105 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.84 0.352 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.58 -52.55 64.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.946 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 155' ' ' LEU . . . . . 0.701 ' O ' HG23 ' B' ' 159' ' ' VAL . 3.2 tp -54.93 -54.94 36.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.917 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 156' ' ' LEU . . . . . 0.699 ' O ' HG23 ' B' ' 160' ' ' VAL . 19.7 mt -54.16 -45.27 72.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.903 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 4.9 tt -55.12 -46.96 75.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.94 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.77 -39.64 84.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.888 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 159' ' ' VAL . . . . . 0.701 HG23 ' O ' ' B' ' 155' ' ' LEU . 58.0 t -63.64 -48.06 88.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.139 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 160' ' ' VAL . . . . . 0.699 HG23 ' O ' ' B' ' 156' ' ' LEU . 37.2 t -64.7 -47.47 88.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.123 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.88 -35.73 66.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.088 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.28 -38.74 65.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.963 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.49 -40.83 53.43 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.469 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 54.7 mt -73.66 -38.31 51.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.905 0.383 . . . . 0.0 111.104 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.95 -39.1 85.37 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.491 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 11.6 mt -71.59 -40.42 69.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.885 0.374 . . . . 0.0 110.962 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -68.33 -37.68 80.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.936 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.48 -27.23 58.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.872 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.856 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.9 m . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.871 0.367 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.5 -49.21 78.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.099 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.738 HG12 HD12 ' A' ' 62' ' ' LEU . 62.5 t -53.11 -37.55 27.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.138 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 89.8 t -70.62 -37.93 71.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.135 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.682 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -62.79 -46.1 94.34 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.503 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.71 ' O ' HG23 ' A' ' 65' ' ' VAL . 3.2 mp -70.7 -42.3 77.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.87 0.367 . . . . 0.0 111.169 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.738 HD12 HG12 ' A' ' 58' ' ' VAL . 7.7 mt -65.37 -36.15 83.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.918 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.4 mt -67.69 -45.32 75.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.896 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 60' ' ' GLY . 96.7 t -61.42 -37.82 78.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.133 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 61' ' ' ILE . 90.1 t -63.85 -51.9 63.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.108 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.548 ' O ' HG23 ' A' ' 70' ' ' VAL . 60.2 t -62.6 -53.53 45.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.094 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.47 -32.7 71.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.877 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.99 -47.93 80.88 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.49 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.432 HG12 HD12 ' A' ' 73' ' ' ILE . 95.2 t -75.11 -32.87 27.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.846 0.355 . . . . 0.0 111.11 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 66' ' ' VAL . 73.7 t -70.9 -53.05 23.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.102 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -62.11 -44.16 97.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.868 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.56 -49.47 76.66 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.457 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.432 HD12 HG12 ' A' ' 69' ' ' VAL . 59.6 mt . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 120.87 0.366 . . . . 0.0 111.145 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.85 0.357 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 2.6 tp -64.84 -48.62 73.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.957 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 155' ' ' LEU . . . . . 0.718 ' O ' HG23 ' B' ' 159' ' ' VAL . 0.8 OUTLIER -52.91 -55.6 22.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.888 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 156' ' ' LEU . . . . . 0.699 ' O ' HG23 ' B' ' 160' ' ' VAL . 27.4 mt -53.7 -44.34 69.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.879 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.11 -47.19 75.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.93 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.37 -39.95 85.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.954 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 159' ' ' VAL . . . . . 0.718 HG23 ' O ' ' B' ' 155' ' ' LEU . 45.1 t -63.51 -48.18 88.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.12 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 160' ' ' VAL . . . . . 0.699 HG23 ' O ' ' B' ' 156' ' ' LEU . 38.5 t -64.69 -47.48 88.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.157 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.92 -35.31 66.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.152 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.32 -39.06 65.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.941 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.47 -41.03 53.08 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.531 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 54.3 mt -73.2 -38.08 53.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.875 0.369 . . . . 0.0 111.136 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -69.54 -39.12 79.38 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.497 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 5.9 mt -71.4 -38.74 71.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.807 0.337 . . . . 0.0 110.879 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -69.69 -37.02 76.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.902 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -72.55 -35.33 67.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.884 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.878 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.2 m . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.875 0.369 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.13 -51.0 59.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.1 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.557 ' O ' HD13 ' A' ' 62' ' ' LEU . 66.0 t -53.14 -46.2 55.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.129 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 84.8 t -64.96 -36.19 77.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.139 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.67 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -61.69 -46.08 94.96 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.506 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.713 ' O ' HG23 ' A' ' 65' ' ' VAL . 2.8 mp -70.68 -42.92 77.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.799 0.333 . . . . 0.0 111.091 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.557 HD13 ' O ' ' A' ' 58' ' ' VAL . 8.5 mp -65.07 -35.84 82.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.5 mt -67.8 -45.12 75.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 60' ' ' GLY . 95.4 t -62.06 -36.81 76.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.107 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 61' ' ' ILE . 89.7 t -64.56 -51.74 63.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.139 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.555 ' O ' HG23 ' A' ' 70' ' ' VAL . 60.4 t -62.65 -53.34 48.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.122 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.3 mt -60.24 -37.42 80.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.09 -50.52 66.98 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.499 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.0 t -70.95 -39.53 75.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.859 0.362 . . . . 0.0 111.126 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 66' ' ' VAL . 62.8 t -62.53 -53.15 50.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.144 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -61.93 -39.94 93.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.888 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -55.65 -49.56 64.91 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.46 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 64.4 mt . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 120.862 0.363 . . . . 0.0 111.153 -179.957 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.799 0.333 . . . . 0.0 111.121 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.96 -46.75 87.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.861 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 155' ' ' LEU . . . . . 0.7 ' O ' HG23 ' B' ' 159' ' ' VAL . 4.3 tp -54.59 -53.61 52.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.898 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 156' ' ' LEU . . . . . 0.702 ' O ' HG23 ' B' ' 160' ' ' VAL . 3.3 mt -56.75 -44.79 82.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.939 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 1.1 tt -54.99 -46.98 75.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.906 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 1.1 tt -67.64 -39.82 84.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.953 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 159' ' ' VAL . . . . . 0.7 HG23 ' O ' ' B' ' 155' ' ' LEU . 93.2 t -63.58 -48.04 88.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.108 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 160' ' ' VAL . . . . . 0.702 HG23 ' O ' ' B' ' 156' ' ' LEU . 38.2 t -64.69 -47.45 88.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.128 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.85 -35.74 66.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.103 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 1.4 tp -73.37 -38.77 65.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.934 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.37 -40.82 54.17 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.47 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 54.5 mt -73.59 -38.53 52.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.872 0.367 . . . . 0.0 111.134 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -67.88 -40.64 89.25 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.476 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 7.5 mt -70.36 -42.44 71.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.887 0.375 . . . . 0.0 110.924 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -65.88 -37.49 86.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.835 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.0 -26.32 59.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.911 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.847 -179.94 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.8 m . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.848 0.356 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.77 -51.27 60.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.115 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.5 t -53.04 -37.74 27.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.097 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 81.7 t -71.32 -37.12 64.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.124 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.682 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -62.87 -46.01 94.49 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.494 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.715 ' O ' HG23 ' A' ' 65' ' ' VAL . 3.2 mp -70.76 -42.43 77.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.84 0.352 . . . . 0.0 111.103 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.453 ' O ' HG23 ' A' ' 66' ' ' VAL . 12.1 mt -65.33 -35.91 82.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.953 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.4 mt -67.86 -45.5 74.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.941 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 60' ' ' GLY . 98.4 t -61.33 -37.68 78.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.139 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 61' ' ' ILE . 87.9 t -64.05 -51.42 69.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.121 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.551 ' O ' HG23 ' A' ' 70' ' ' VAL . 61.9 t -63.3 -53.59 43.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.155 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mt -60.44 -32.57 71.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.936 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.2 -47.97 79.62 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.475 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.471 HG12 HD12 ' A' ' 73' ' ' ILE . 95.7 t -75.08 -33.01 27.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.883 0.373 . . . . 0.0 111.125 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 66' ' ' VAL . 73.4 t -70.89 -53.04 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.145 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -62.03 -45.1 95.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.835 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.13 -49.02 79.35 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.451 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.471 HD12 HG12 ' A' ' 69' ' ' VAL . 63.9 mt . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 120.868 0.366 . . . . 0.0 111.157 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.806 0.336 . . . . 0.0 111.098 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 1.1 tp -60.94 -55.32 34.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.953 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 155' ' ' LEU . . . . . 0.694 ' O ' HG23 ' B' ' 159' ' ' VAL . 0.3 OUTLIER -54.31 -55.08 31.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.929 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 156' ' ' LEU . . . . . 0.699 ' O ' HG23 ' B' ' 160' ' ' VAL . 13.5 mt -51.94 -45.5 64.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.955 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 157' ' ' LEU . . . . . 0.441 HD13 ' O ' ' B' ' 157' ' ' LEU . 0.3 OUTLIER -55.06 -46.56 75.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.914 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 158' ' ' LEU . . . . . 0.504 HD23 ' O ' ' B' ' 158' ' ' LEU . 3.5 tt -68.03 -39.65 83.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.903 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 159' ' ' VAL . . . . . 0.694 HG23 ' O ' ' B' ' 155' ' ' LEU . 47.1 t -63.85 -47.81 89.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.151 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 160' ' ' VAL . . . . . 0.699 HG23 ' O ' ' B' ' 156' ' ' LEU . 37.9 t -64.8 -47.41 88.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.121 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.9 -36.17 67.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.11 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.4 -38.48 65.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.919 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.09 -41.24 54.72 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.509 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 58.1 mt -73.64 -39.16 53.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.894 0.378 . . . . 0.0 111.122 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -67.74 -38.59 89.85 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.483 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 12.5 mt -72.64 -38.83 67.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.898 0.38 . . . . 0.0 110.947 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -67.88 -39.88 83.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.856 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.05 -55.12 6.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.88 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.862 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.6 m . . . . . 0 N--CA 1.458 -0.062 0 CA-C-O 120.923 0.392 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.76 -48.97 78.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.087 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 62.5 t -53.2 -40.46 38.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.15 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 66.8 t -69.55 -35.19 65.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.101 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.598 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -63.97 -46.11 92.28 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.47 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.708 ' O ' HG23 ' A' ' 65' ' ' VAL . 3.1 mp -70.87 -43.15 77.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.912 0.387 . . . . 0.0 111.143 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.566 ' O ' HG23 ' A' ' 66' ' ' VAL . 3.5 mm? -65.27 -32.96 74.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.929 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.872 HD13 HD12 ' B' ' 157' ' ' LEU . 12.6 mt -69.37 -48.65 60.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.91 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 60' ' ' GLY . 91.7 t -59.22 -38.39 74.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.136 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 61' ' ' ILE . 91.1 t -63.88 -51.35 70.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.155 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 62' ' ' LEU . 61.3 t -63.02 -53.53 45.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.139 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mt -60.5 -32.97 71.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.912 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.74 -47.69 84.07 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.534 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.5 t -75.08 -32.91 27.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.839 0.352 . . . . 0.0 111.152 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 66' ' ' VAL . 73.8 t -70.81 -53.05 23.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.107 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -62.6 -42.57 99.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -59.34 -49.59 76.91 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.498 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 55.7 mt . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 120.813 0.339 . . . . 0.0 111.056 -179.918 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.816 0.341 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 2.5 tp -64.12 -51.95 61.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.923 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 155' ' ' LEU . . . . . 0.705 ' O ' HG23 ' B' ' 159' ' ' VAL . 5.7 tp -52.31 -49.93 63.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.897 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 156' ' ' LEU . . . . . 0.705 ' O ' HG23 ' B' ' 160' ' ' VAL . 69.5 mt -57.37 -44.23 84.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.92 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 157' ' ' LEU . . . . . 0.872 HD12 HD13 ' A' ' 63' ' ' LEU . 5.1 tt -55.04 -47.52 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.899 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 2.7 tt -67.1 -39.98 86.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.909 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 159' ' ' VAL . . . . . 0.705 HG23 ' O ' ' B' ' 155' ' ' LEU . 91.0 t -63.42 -48.22 88.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.173 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 160' ' ' VAL . . . . . 0.705 HG23 ' O ' ' B' ' 156' ' ' LEU . 38.5 t -64.63 -47.37 89.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.113 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.85 -35.63 66.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.071 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 6.3 tp -73.4 -38.85 65.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.885 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.39 -40.78 54.12 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.456 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 54.6 mt -73.66 -38.49 51.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.894 0.378 . . . . 0.0 111.124 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.16 -40.1 88.15 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.54 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 11.8 mt -70.84 -41.72 71.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.837 0.351 . . . . 0.0 110.928 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -67.12 -37.36 83.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.87 -26.02 60.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.852 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.88 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 51.1 m . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.885 0.374 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.48 -51.09 64.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.11 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.595 HG12 HD12 ' A' ' 62' ' ' LEU . 78.1 t -53.18 -38.38 30.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.193 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.656 HG12 HD12 ' A' ' 63' ' ' LEU . 93.2 t -69.94 -38.03 74.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.151 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.688 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -62.48 -46.14 94.42 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.536 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.71 ' O ' HG23 ' A' ' 65' ' ' VAL . 3.2 mp -70.62 -42.68 77.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.868 0.366 . . . . 0.0 111.133 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.595 HD12 HG12 ' A' ' 58' ' ' VAL . 10.2 mt -65.14 -35.97 82.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.922 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.656 HD12 HG12 ' A' ' 59' ' ' VAL . 10.1 mt -67.72 -45.8 73.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.903 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.688 HG23 ' O ' ' A' ' 60' ' ' GLY . 92.2 t -60.93 -37.96 78.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.172 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 61' ' ' ILE . 95.4 t -63.65 -51.89 64.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.121 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.554 ' O ' HG23 ' A' ' 70' ' ' VAL . 62.0 t -62.39 -53.48 46.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.137 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mt -60.32 -33.83 72.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.89 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.84 -49.08 75.76 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.483 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.469 HG12 HD12 ' A' ' 73' ' ' ILE . 94.0 t -73.12 -32.84 40.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.887 0.375 . . . . 0.0 111.17 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 66' ' ' VAL . 70.0 t -70.37 -45.76 73.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.124 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -63.92 -48.61 75.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.838 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -57.16 -49.54 71.4 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.493 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.469 HD12 HG12 ' A' ' 69' ' ' VAL . 62.3 mt . . . . . 0 C--N 1.329 -0.321 0 CA-C-O 120.82 0.343 . . . . 0.0 111.11 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 153' ' ' ALA . . . . . 0.503 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.869 0.366 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 1.4 tt -68.45 -45.58 72.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.94 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 155' ' ' LEU . . . . . 0.623 ' O ' HG23 ' B' ' 159' ' ' VAL . 19.6 tp -60.55 -55.35 34.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.928 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 156' ' ' LEU . . . . . 0.707 ' O ' HG23 ' B' ' 160' ' ' VAL . 32.7 mt -51.95 -47.16 64.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.897 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.33 -46.36 72.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.902 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.36 -39.79 81.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 159' ' ' VAL . . . . . 0.623 HG23 ' O ' ' B' ' 155' ' ' LEU . 92.2 t -63.44 -47.63 90.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.109 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 160' ' ' VAL . . . . . 0.707 HG23 ' O ' ' B' ' 156' ' ' LEU . 34.8 t -64.01 -47.97 88.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.112 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.17 -36.98 66.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.101 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 4.6 tp -73.25 -38.13 66.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -71.8 -40.98 57.16 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.467 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 58.1 mt -74.2 -39.77 50.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.84 0.353 . . . . 0.0 111.087 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -66.78 -38.39 93.02 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.528 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 12.4 mt -72.26 -45.47 60.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.843 0.354 . . . . 0.0 110.93 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -60.52 -37.7 82.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.94 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.91 -25.67 59.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.86 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.92 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.529 -0.229 . . . . 0.0 112.529 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.2 m -85.94 160.5 52.34 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.578 0.704 . . . . 0.0 110.939 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 144.42 54.05 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.717 2.278 . . . . 0.0 112.327 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.38 170.17 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.14 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -71.42 177.87 3.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.888 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -159.2 177.86 10.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.892 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -174.03 38.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.851 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -156.03 -174.4 4.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.131 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.2 t 62.33 72.58 0.61 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.647 0.737 . . . . 0.0 110.86 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -15.51 37.05 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.655 2.236 . . . . 0.0 112.32 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.86 -16.11 61.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.893 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.668 HG21 ' HB ' ' B' ' 148' ' ' THR . 3.9 m -76.32 -35.74 58.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.143 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.7 t -67.41 -36.68 81.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.849 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.655 ' O ' HG23 ' A' ' 58' ' ' VAL . 85.6 mt -66.52 -51.58 55.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.127 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.696 ' O ' HG23 ' A' ' 59' ' ' VAL . 60.5 mt -55.75 -42.16 68.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.112 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.7 m -59.91 -50.8 72.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.892 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.81 -48.45 81.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.12 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 54' ' ' ILE . 62.1 t -53.1 -38.13 29.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.131 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 55' ' ' ILE . 64.8 t -70.25 -37.42 71.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.11 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.635 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -63.12 -46.09 94.02 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.525 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.698 ' O ' HG23 ' A' ' 65' ' ' VAL . 3.2 mp -70.9 -42.38 77.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.874 0.369 . . . . 0.0 111.117 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.491 ' O ' HG23 ' A' ' 66' ' ' VAL . 12.1 mt -65.43 -34.94 79.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.888 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.422 HD12 HG12 ' A' ' 59' ' ' VAL . 12.0 mt -68.41 -46.76 69.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.936 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 60' ' ' GLY . 97.0 t -60.3 -38.3 77.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.118 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 61' ' ' ILE . 89.9 t -63.65 -51.82 65.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.125 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.556 ' O ' HG23 ' A' ' 70' ' ' VAL . 62.0 t -62.52 -53.58 45.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.114 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.9 mt -60.33 -32.83 71.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.929 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.89 -47.92 81.29 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.458 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.433 HG12 HD12 ' A' ' 73' ' ' ILE . 95.6 t -75.07 -33.02 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.816 0.341 . . . . 0.0 111.08 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 66' ' ' VAL . 73.9 t -70.71 -53.05 23.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.118 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.488 ' CE2' HD11 ' A' ' 75' ' ' ILE . 4.7 t80 -61.95 -44.29 97.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.5 -49.5 76.18 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.505 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.433 HD12 HG12 ' A' ' 69' ' ' VAL . 58.9 mt -70.13 -25.98 28.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.879 0.371 . . . . 0.0 111.135 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.6 mt -70.21 -36.8 74.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.95 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.488 HD11 ' CE2' ' A' ' 71' ' ' PHE . 78.0 mt -84.51 -37.44 12.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.1 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.35 -47.37 75.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.889 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.19 -33.47 41.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.892 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.3 ttm180 -71.27 -34.46 70.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -67.75 -68.22 0.4 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -155.64 171.99 19.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.1 118.92 24.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.91 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 7.7 tp -104.32 -29.25 2.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.133 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -82.23 60.07 4.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.882 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 21.0 mttt . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.908 -179.982 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.932 0.396 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 160.7 -166.28 35.41 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.512 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 136' ' ' CYS . . . . . . . . . . . . . 60.1 m 55.65 72.02 1.12 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.646 0.736 . . . . 0.0 110.875 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -18.95 36.74 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.71 2.274 . . . . 0.0 112.329 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 138' ' ' THR . . . . . . . . . . . . . 1.1 m 63.15 29.67 16.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.131 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 61.8 -177.91 0.12 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.899 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -167.02 -83.66 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.499 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 141' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 82.04 0.77 Allowed 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.723 2.282 . . . . 0.0 112.328 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 142' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -151.69 119.91 6.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.895 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 0.664 HG23 ' HA ' ' B' ' 144' ' ' PRO . 51.0 mm -51.84 137.16 35.38 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.652 0.739 . . . . 0.0 111.14 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 144' ' ' PRO . . . . . 0.664 ' HA ' HG23 ' B' ' 143' ' ' ILE . 53.5 Cg_endo -69.8 157.54 92.06 Favored 'Cis proline' 0 C--N 1.342 0.201 0 C-N-CA 122.719 -1.784 . . . . 0.0 112.316 -0.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 11.5 t -177.33 -75.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.857 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 32.5 mm -82.71 -25.5 8.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.148 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -52.5 -30.99 33.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.114 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 148' ' ' THR . . . . . 0.668 ' HB ' HG21 ' A' ' 52' ' ' THR . 72.6 m -53.05 -29.99 33.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.21 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . -55.32 -54.77 32.12 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.486 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 150' ' ' MET . . . . . . . . . . . . . 29.6 mmt -58.16 -51.02 71.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.795 0.331 . . . . 0.0 110.902 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 59.3 t -56.61 -40.35 68.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.129 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -62.06 -42.18 99.72 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.453 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -65.36 -43.67 90.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.841 0.353 . . . . 0.0 111.117 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.51 -53.79 31.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.954 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 155' ' ' LEU . . . . . 0.607 ' O ' HG23 ' B' ' 159' ' ' VAL . 0.4 OUTLIER -52.1 -55.43 20.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 156' ' ' LEU . . . . . 0.703 ' O ' HG23 ' B' ' 160' ' ' VAL . 10.8 mt -52.2 -45.22 65.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.922 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 1.4 tt -55.05 -46.99 75.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.942 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.78 -39.51 84.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.922 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 159' ' ' VAL . . . . . 0.607 HG23 ' O ' ' B' ' 155' ' ' LEU . 69.6 t -63.8 -47.98 88.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.068 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 160' ' ' VAL . . . . . 0.703 HG23 ' O ' ' B' ' 156' ' ' LEU . 36.5 t -64.76 -47.54 88.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.132 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.91 -35.69 66.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.046 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 1.7 tp -73.32 -38.82 65.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.887 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.4 -40.91 53.77 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.529 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 54.8 mt -73.59 -38.31 51.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.857 0.36 . . . . 0.0 111.104 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -69.06 -39.03 84.6 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.467 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 10.9 mt -71.66 -39.6 70.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.907 0.384 . . . . 0.0 110.907 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -69.41 -37.62 77.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.864 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.42 -28.58 59.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.88 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 14.2 ttt180 -85.05 -24.74 28.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.92 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -25.02 58.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.855 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 171' ' ' ARG . . . . . 0.408 ' NE ' HD12 ' B' ' 173' ' ' ILE . 74.1 mtm180 -94.79 21.22 7.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.857 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 172' ' ' HIS . . . . . . . . . . . . . 48.6 t60 53.43 31.79 12.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.86 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 173' ' ' ILE . . . . . 0.408 HD12 ' NE ' ' B' ' 171' ' ' ARG . 81.9 mt -95.02 88.27 2.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.102 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 174' ' ' VAL . . . . . 0.461 HG22 ' H ' ' B' ' 176' ' ' LYS . 7.6 p -104.86 141.71 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.163 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 175' ' ' ARG . . . . . . . . . . . . . 8.5 ptt180 -76.24 -36.94 58.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.877 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 176' ' ' LYS . . . . . 0.461 ' H ' HG22 ' B' ' 174' ' ' VAL . 2.0 tppm? -156.35 147.54 22.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.883 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.846 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -70.37 160.54 80.82 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.61 0.719 . . . . 0.0 110.851 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 108.68 2.13 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.713 2.276 . . . . 0.0 112.366 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.89 -169.74 0.19 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.13 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -174.11 139.35 0.63 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -164.95 -178.99 5.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.887 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -164.91 82.91 0.38 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.89 -4.16 39.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.093 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.4 t -155.01 70.55 5.73 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.679 0.752 . . . . 0.0 110.856 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -15.57 37.32 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.703 2.269 . . . . 0.0 112.361 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.51 ' HA ' HD12 ' A' ' 54' ' ' ILE . 0.2 OUTLIER -72.76 -16.18 61.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.846 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.0 m -76.28 -34.85 59.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.119 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 t -68.96 -38.72 79.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.876 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.689 ' O ' HG23 ' A' ' 58' ' ' VAL . 43.6 mt -60.59 -45.94 96.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.117 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.645 ' O ' HG23 ' A' ' 59' ' ' VAL . 65.7 mt -56.82 -46.21 83.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.135 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.8 m -58.56 -45.16 89.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.872 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.58 -50.55 64.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.072 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 54' ' ' ILE . 66.1 t -53.2 -44.75 53.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.128 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 55' ' ' ILE . 65.6 t -65.9 -35.53 75.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.127 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.615 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -62.83 -46.23 94.06 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.47 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.722 ' O ' HG23 ' A' ' 65' ' ' VAL . 2.9 mp -70.6 -42.85 78.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.893 0.378 . . . . 0.0 111.088 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.554 HD13 ' O ' ' A' ' 58' ' ' VAL . 8.5 mp -65.23 -35.25 80.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.92 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.994 HD13 HD22 ' B' ' 157' ' ' LEU . 12.5 mt -67.84 -46.33 72.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.931 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 60' ' ' GLY . 84.9 t -60.89 -37.88 77.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.1 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 61' ' ' ILE . 89.7 t -63.38 -53.02 50.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.127 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.549 ' O ' HG23 ' A' ' 70' ' ' VAL . 59.9 t -61.12 -53.39 49.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.161 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 mt -60.3 -33.33 72.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.937 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.25 -47.96 83.43 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.486 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.493 HG12 HD12 ' A' ' 73' ' ' ILE . 96.8 t -74.91 -33.22 29.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.873 0.368 . . . . 0.0 111.079 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 66' ' ' VAL . 72.7 t -70.37 -46.93 69.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.074 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -64.56 -48.84 73.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.911 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -56.62 -47.27 85.9 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.472 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.493 HD12 HG12 ' A' ' 69' ' ' VAL . 67.4 mt -72.02 -26.25 24.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.896 0.379 . . . . 0.0 111.13 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.544 HD12 HG12 ' A' ' 70' ' ' VAL . 11.8 mt -69.77 -37.59 76.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.924 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 51.4 mt -70.82 -35.17 59.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.152 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.1 -50.94 67.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.932 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.9 mtt85 -74.88 -23.56 58.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -64.92 -69.84 0.27 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -67.88 -74.92 0.11 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.924 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -160.42 -74.84 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.891 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -165.02 65.49 0.13 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 24.5 mt 64.57 68.25 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.099 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -165.01 151.82 10.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.879 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.9 tttm . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.891 179.973 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.866 0.365 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -110.54 -137.64 7.6 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.463 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 136' ' ' CYS . . . . . . . . . . . . . 1.8 m 58.28 69.88 1.37 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.61 0.719 . . . . 0.0 110.907 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.85 107.94 1.99 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.645 2.23 . . . . 0.0 112.318 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 138' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.54 101.39 3.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.161 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -155.19 176.16 12.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.884 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -131.53 176.31 19.22 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.506 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 141' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 100.68 0.83 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.719 2.28 . . . . 0.0 112.354 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 142' ' ' LYS . . . . . . . . . . . . . 3.9 tttm -148.77 38.52 0.84 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.877 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 0.58 HG23 ' HA ' ' B' ' 144' ' ' PRO . 2.8 mt 65.02 135.4 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.629 0.728 . . . . 0.0 111.12 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 144' ' ' PRO . . . . . 0.58 ' HA ' HG23 ' B' ' 143' ' ' ILE . 53.6 Cg_endo -69.8 159.09 90.38 Favored 'Cis proline' 0 C--N 1.342 0.196 0 C-N-CA 122.617 -1.826 . . . . 0.0 112.374 -0.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 2.1 t 177.46 -33.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.874 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 34.3 mt -123.33 -32.94 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.135 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.16 -24.01 60.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.105 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 93.3 m -53.35 -27.95 26.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.17 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . -55.52 -54.49 34.26 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.49 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 150' ' ' MET . . . . . . . . . . . . . 18.0 mmt -61.81 -46.6 88.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.784 0.326 . . . . 0.0 110.839 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 59.9 t -55.96 -40.54 63.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.089 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -66.45 -42.17 93.91 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.478 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -60.25 -45.65 92.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.792 0.33 . . . . 0.0 111.125 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 11.9 tp -68.18 -50.02 57.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.915 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 155' ' ' LEU . . . . . 0.629 ' O ' HG23 ' B' ' 159' ' ' VAL . 7.8 tp -57.36 -53.4 58.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.927 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 156' ' ' LEU . . . . . 0.696 ' O ' HG23 ' B' ' 160' ' ' VAL . 16.5 mt -53.28 -45.73 68.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 157' ' ' LEU . . . . . 0.994 HD22 HD13 ' A' ' 63' ' ' LEU . 12.4 tp -54.96 -46.4 75.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.92 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 1.3 tt -68.05 -39.94 82.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.871 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 159' ' ' VAL . . . . . 0.629 HG23 ' O ' ' B' ' 155' ' ' LEU . 74.6 t -63.59 -48.02 88.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.129 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 160' ' ' VAL . . . . . 0.696 HG23 ' O ' ' B' ' 156' ' ' LEU . 36.0 t -64.59 -47.5 88.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.101 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.87 -35.82 66.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.073 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 1.3 tp -73.33 -38.8 65.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.916 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.19 -40.89 55.05 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.505 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 54.8 mt -73.63 -38.75 52.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.907 0.384 . . . . 0.0 111.107 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -67.27 -40.95 92.13 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.471 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 11.5 mt -70.32 -41.08 73.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.853 0.359 . . . . 0.0 110.894 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -67.54 -37.43 82.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.878 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.65 -25.69 57.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.902 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 3.2 mmt85 -82.23 -14.24 55.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.897 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.13 -24.82 43.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.861 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -144.86 25.74 1.42 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.833 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 172' ' ' HIS . . . . . 0.558 ' C ' HD12 ' B' ' 173' ' ' ILE . 0.6 OUTLIER 51.91 32.87 10.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.869 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 173' ' ' ILE . . . . . 0.558 HD12 ' C ' ' B' ' 172' ' ' HIS . 3.9 mp 63.15 98.29 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.141 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 12.6 m -104.99 24.67 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.118 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 175' ' ' ARG . . . . . . . . . . . . . 8.3 mtp85 -84.96 -59.46 2.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.922 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -169.6 -64.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.88 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.872 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 63.09 160.53 0.12 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.636 0.731 . . . . 0.0 110.869 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 82.57 0.74 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.702 2.268 . . . . 0.0 112.357 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -174.93 50.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.089 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -156.57 -44.43 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.866 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 61.97 102.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.896 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.7 ttp180 -64.98 -169.86 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.881 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -155.1 90.02 1.25 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.062 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.1 t 66.85 142.57 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.691 0.757 . . . . 0.0 110.857 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -12.45 32.87 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.661 2.241 . . . . 0.0 112.333 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.409 ' HA ' HD12 ' A' ' 54' ' ' ILE . 0.3 OUTLIER -67.21 -17.04 64.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.898 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.7 m -75.98 -38.2 57.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.15 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.6 t -66.35 -40.57 89.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.891 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.659 ' O ' HG23 ' A' ' 58' ' ' VAL . 70.3 mt -56.32 -42.7 74.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.161 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.621 ' O ' HG23 ' A' ' 59' ' ' VAL . 67.6 mt -57.35 -45.71 85.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.129 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.6 m -60.99 -44.65 97.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.11 -51.15 62.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.133 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 54' ' ' ILE . 97.5 t -53.35 -46.75 58.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.106 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 55' ' ' ILE . 87.5 t -63.32 -35.88 73.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.137 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.593 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -62.95 -46.3 93.85 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.444 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.696 ' O ' HG23 ' A' ' 65' ' ' VAL . 2.8 mp -71.12 -42.85 75.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.814 0.34 . . . . 0.0 111.118 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.592 ' O ' HG23 ' A' ' 66' ' ' VAL . 4.0 mm? -65.32 -32.92 74.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.5 mt -69.55 -49.26 55.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.934 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 60' ' ' GLY . 95.3 t -58.36 -39.05 72.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.122 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 61' ' ' ILE . 93.5 t -63.7 -51.04 75.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.121 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 62' ' ' LEU . 61.2 t -63.31 -53.56 44.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.185 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.0 mt -60.37 -32.84 71.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.926 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.02 -47.92 80.81 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.487 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.466 HG12 HD12 ' A' ' 73' ' ' ILE . 99.5 t -75.01 -32.94 27.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.825 0.345 . . . . 0.0 111.123 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 66' ' ' VAL . 72.6 t -70.76 -51.44 36.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.118 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -62.42 -45.68 91.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.87 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -57.86 -49.2 76.69 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.542 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.466 HD12 HG12 ' A' ' 69' ' ' VAL . 59.8 mt -70.06 -31.17 46.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.87 0.367 . . . . 0.0 111.114 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.7 mt -64.54 -35.23 80.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.924 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 73.2 mt -86.21 -33.48 7.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.157 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.67 -47.61 83.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.857 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -55.07 -28.08 49.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.881 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.5 -26.57 67.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.892 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 68.0 mm-40 -154.7 107.33 2.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -65.96 95.59 0.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.903 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.7 ttmm -94.1 123.83 37.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.931 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 24.1 mt -136.9 -48.21 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.11 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 58.4 -174.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.828 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.856 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.897 0.38 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -129.05 65.24 0.59 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.494 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 136' ' ' CYS . . . . . . . . . . . . . 1.3 m -77.79 160.54 74.11 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.633 0.73 . . . . 0.0 110.857 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -173.03 0.64 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.662 2.241 . . . . 0.0 112.375 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 138' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.09 121.78 11.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.124 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -76.01 -61.29 1.99 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.862 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -155.42 84.9 0.14 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.465 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 141' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -170.76 0.41 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.681 2.254 . . . . 0.0 112.352 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 142' ' ' LYS . . . . . 0.576 ' C ' HD12 ' B' ' 143' ' ' ILE . 1.3 tttt 64.06 108.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 0.576 HD12 ' C ' ' B' ' 142' ' ' LYS . 2.5 mp 49.07 87.93 0.12 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.654 0.74 . . . . 0.0 111.111 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 144' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 159.37 89.78 Favored 'Cis proline' 0 C--N 1.342 0.185 0 C-N-CA 122.686 -1.798 . . . . 0.0 112.316 -0.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 33.2 t 179.28 -77.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.825 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 29.3 mm -105.23 -17.55 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.151 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -82.57 -21.61 35.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.133 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 86.8 m -52.75 -30.32 32.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.137 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . -52.25 -49.37 50.87 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.47 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 150' ' ' MET . . . . . . . . . . . . . 20.8 mmt -61.92 -51.14 69.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.837 0.351 . . . . 0.0 110.87 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 60.8 t -55.57 -40.78 60.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.176 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -62.56 -43.31 99.19 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.467 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -62.1 -46.93 86.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.783 0.325 . . . . 0.0 111.059 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 7.6 tp -61.87 -41.58 98.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.886 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 155' ' ' LEU . . . . . 0.705 ' O ' HG23 ' B' ' 159' ' ' VAL . 0.4 OUTLIER -61.36 -55.03 36.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.926 179.893 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 156' ' ' LEU . . . . . 0.699 ' O ' HG23 ' B' ' 160' ' ' VAL . 15.9 mt -52.4 -46.36 66.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 3.6 tp -54.69 -46.55 74.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.869 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.09 -40.15 82.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.946 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 159' ' ' VAL . . . . . 0.705 HG23 ' O ' ' B' ' 155' ' ' LEU . 54.8 t -63.18 -47.74 90.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.105 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 160' ' ' VAL . . . . . 0.699 HG23 ' O ' ' B' ' 156' ' ' LEU . 36.2 t -64.87 -47.86 86.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.147 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.59 -35.13 65.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.154 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 1.1 tp -72.18 -39.76 68.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.956 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.23 -44.1 44.86 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.545 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 51.9 mt -69.4 -36.97 74.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.879 0.371 . . . . 0.0 111.161 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -71.37 -39.61 61.49 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.501 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 12.6 mt -72.13 -29.75 64.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.878 0.371 . . . . 0.0 110.899 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -81.27 -36.02 30.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.842 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.5 -29.54 61.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.913 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -15.37 58.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 3.8 ppt_? -54.94 -24.89 25.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.877 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.3 -19.56 47.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.902 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 172' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.85 71.95 0.82 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.868 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 27.2 mt -74.7 138.26 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.187 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 63.4 t -135.56 93.59 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.14 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 175' ' ' ARG . . . . . . . . . . . . . 14.7 ptt85 -160.11 -172.21 3.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.879 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.34 125.49 0.75 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.878 179.975 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.456 -0.258 . . . . 0.0 112.456 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 20.4 m 64.37 153.65 0.12 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.605 0.716 . . . . 0.0 110.876 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 86.58 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.681 2.254 . . . . 0.0 112.336 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -175.09 -36.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.095 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 63.96 158.11 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.885 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 62.11 164.96 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.915 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -165.04 -76.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -175.27 -169.06 0.36 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.122 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.0 t 63.95 68.3 0.87 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.607 0.718 . . . . 0.0 110.827 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 -15.61 37.28 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.723 2.282 . . . . 0.0 112.326 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.56 -16.2 61.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.911 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.498 HG21 ' HB ' ' B' ' 148' ' ' THR . 4.0 m -76.16 -34.05 59.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.145 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.6 t -69.04 -36.86 78.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.85 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.67 ' O ' HG23 ' A' ' 58' ' ' VAL . 48.5 mt -66.55 -50.33 67.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.134 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.692 ' O ' HG23 ' A' ' 59' ' ' VAL . 65.4 mt -57.79 -44.52 86.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.156 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.5 m -57.75 -48.47 79.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.847 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.642 ' HA ' HD13 ' B' ' 156' ' ' LEU . . . -62.0 -50.12 73.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.051 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 54' ' ' ILE . 62.5 t -52.99 -37.5 26.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.124 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 55' ' ' ILE . 89.8 t -70.72 -38.01 71.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.148 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.671 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -62.77 -46.03 94.51 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.443 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.715 ' O ' HG23 ' A' ' 65' ' ' VAL . 3.2 mp -70.69 -42.38 77.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.901 0.381 . . . . 0.0 111.159 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.472 HD12 HG12 ' A' ' 58' ' ' VAL . 11.9 mt -65.41 -36.11 82.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.889 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.542 HD12 HG12 ' A' ' 59' ' ' VAL . 11.3 mt -67.79 -45.19 75.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.912 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 60' ' ' GLY . 99.9 t -61.53 -37.71 78.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.101 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 61' ' ' ILE . 89.4 t -63.95 -51.84 64.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.12 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.54 ' O ' HG23 ' A' ' 70' ' ' VAL . 60.2 t -62.64 -53.45 46.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.17 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.1 mt -60.37 -33.62 72.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.897 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.08 -48.25 81.7 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.474 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.3 t -75.07 -32.93 27.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.913 0.387 . . . . 0.0 111.115 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 66' ' ' VAL . 56.5 t -70.1 -52.13 33.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.164 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -63.08 -43.37 98.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.9 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.57 -48.67 83.21 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.472 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 58.1 mt -70.87 -25.51 26.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.91 0.386 . . . . 0.0 111.15 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.1 mt -70.65 -39.75 73.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.891 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 57.0 mt -73.27 -44.87 54.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.1 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.1 mmmm -61.12 -27.64 68.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.875 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.37 -35.15 73.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.889 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -52.35 56.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.896 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -72.68 170.37 14.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.939 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -155.77 70.41 0.71 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.954 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.39 117.08 3.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.934 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.3 mp -93.02 -66.45 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.156 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 57.39 -177.32 0.06 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.891 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 7.5 tttp . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.914 179.943 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 . . . . . 0 CA--C 1.527 0.071 0 CA-C-O 120.873 0.368 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 156.27 -25.72 0.54 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.475 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 136' ' ' CYS . . . . . . . . . . . . . 1.6 m -78.12 160.48 73.42 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.633 0.73 . . . . 0.0 110.871 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -174.7 0.95 Allowed 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.694 2.263 . . . . 0.0 112.353 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 138' ' ' THR . . . . . . . . . . . . . 4.3 p -76.62 -58.84 3.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.161 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -76.12 -73.29 0.28 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.889 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 86.91 170.49 46.87 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.509 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 141' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -177.67 1.99 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.717 2.278 . . . . 0.0 112.35 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 142' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -146.81 66.27 1.17 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.929 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 0.566 HG23 ' HA ' ' B' ' 144' ' ' PRO . 47.5 mm 64.76 135.46 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.661 0.743 . . . . 0.0 111.142 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 144' ' ' PRO . . . . . 0.566 ' HA ' HG23 ' B' ' 143' ' ' ILE . 53.7 Cg_endo -69.77 160.75 87.52 Favored 'Cis proline' 0 C--N 1.341 0.164 0 C-N-CA 122.62 -1.825 . . . . 0.0 112.369 -0.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.4 -76.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.827 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 2.6 mp -84.18 -25.09 7.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.137 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -54.62 -27.57 40.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.118 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 148' ' ' THR . . . . . 0.498 ' HB ' HG21 ' A' ' 52' ' ' THR . 70.0 m -52.9 -28.97 25.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.123 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . -56.69 -58.41 14.6 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.524 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 150' ' ' MET . . . . . . . . . . . . . 30.6 mmt -58.25 -45.95 86.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.801 0.334 . . . . 0.0 110.927 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 59.4 t -57.27 -40.26 72.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.12 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -65.8 -41.77 95.48 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.485 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -63.04 -38.3 90.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.851 0.358 . . . . 0.0 111.116 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 11.0 tp -65.55 -53.84 36.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.944 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 155' ' ' LEU . . . . . 0.708 ' O ' HG23 ' B' ' 159' ' ' VAL . 18.3 tp -52.74 -54.87 27.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 156' ' ' LEU . . . . . 0.708 ' O ' HG23 ' B' ' 160' ' ' VAL . 4.1 mt -53.4 -44.12 68.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.927 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 8.0 tp -54.98 -48.07 73.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.905 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.91 -39.51 87.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.933 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 159' ' ' VAL . . . . . 0.708 HG23 ' O ' ' B' ' 155' ' ' LEU . 50.0 t -63.52 -48.43 86.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.132 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 160' ' ' VAL . . . . . 0.708 HG23 ' O ' ' B' ' 156' ' ' LEU . 37.1 t -64.37 -47.45 89.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.177 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.77 -35.73 66.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.084 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.36 -38.85 65.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.37 -40.85 54.1 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.453 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 54.6 mt -73.6 -38.53 52.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.88 0.371 . . . . 0.0 111.112 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.71 -39.14 86.33 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.495 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 10.6 mt -71.66 -40.14 69.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.836 0.351 . . . . 0.0 110.926 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -68.79 -37.46 79.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.32 -28.61 61.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.872 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.25 -21.65 59.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.888 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -69.39 -19.94 63.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.867 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 35.7 mtm-85 -144.96 30.86 1.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.882 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 172' ' ' HIS . . . . . 0.555 ' CE1' HG23 ' B' ' 173' ' ' ILE . 2.1 p-80 -74.97 -22.49 58.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.812 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 173' ' ' ILE . . . . . 0.555 HG23 ' CE1' ' B' ' 172' ' ' HIS . 34.1 pt -74.93 -25.09 18.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.128 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 174' ' ' VAL . . . . . 0.419 HG13 HG13 ' B' ' 173' ' ' ILE . 28.3 m -98.99 160.11 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.118 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 175' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.25 71.73 2.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.873 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 9.2 mttm 52.66 89.08 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.896 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.852 -179.997 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.7 m -83.99 160.57 57.63 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.595 0.712 . . . . 0.0 110.88 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 149.15 66.48 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.678 2.252 . . . . 0.0 112.363 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.57 -75.18 0.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.073 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -169.89 -45.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.919 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 60.35 -176.67 0.11 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.934 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.0 mpp_? -73.86 177.91 5.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.902 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -169.97 140.65 2.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.101 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.5 t -57.23 147.43 57.31 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.663 0.744 . . . . 0.0 110.869 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 -15.47 37.35 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.7 2.267 . . . . 0.0 112.365 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.88 -16.23 61.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.892 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.9 m -76.28 -35.54 58.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.133 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 t -67.87 -38.98 83.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.85 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.663 ' O ' HG23 ' A' ' 58' ' ' VAL . 49.1 mt -62.53 -48.32 88.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.139 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.695 ' O ' HG23 ' A' ' 59' ' ' VAL . 72.4 mt -59.99 -43.99 93.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.128 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.3 m -56.2 -47.11 78.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.867 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.05 -50.38 68.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.089 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 54' ' ' ILE . 62.1 t -53.04 -37.32 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.119 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.695 HG23 ' O ' ' A' ' 55' ' ' ILE . 92.0 t -71.09 -37.83 68.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.129 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.669 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -62.78 -46.07 94.41 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.438 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.706 ' O ' HG23 ' A' ' 65' ' ' VAL . 3.2 mp -70.7 -42.36 77.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.822 0.344 . . . . 0.0 111.105 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.434 ' O ' HG23 ' A' ' 66' ' ' VAL . 12.1 mt -65.41 -36.01 82.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.4 mt -67.69 -45.65 74.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.969 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 60' ' ' GLY . 99.8 t -61.14 -38.05 78.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.075 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 61' ' ' ILE . 89.5 t -63.56 -52.36 58.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.137 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.552 ' O ' HG23 ' A' ' 70' ' ' VAL . 60.2 t -61.99 -53.47 47.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.072 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.34 -32.9 71.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.78 -48.39 77.32 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.49 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.477 HG12 HD12 ' A' ' 73' ' ' ILE . 94.2 t -74.45 -33.38 32.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.86 0.362 . . . . 0.0 111.085 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 66' ' ' VAL . 72.6 t -70.32 -51.33 39.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.073 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -62.49 -46.25 89.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.905 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -57.35 -48.85 77.48 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.507 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.477 HD12 HG12 ' A' ' 69' ' ' VAL . 61.0 mt -70.83 -25.14 25.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 0.0 111.118 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.422 HD12 HG12 ' A' ' 70' ' ' VAL . 13.4 mt -70.43 -34.42 72.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.94 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 77.9 mt -80.1 -33.16 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.127 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.7 mtmm -78.37 -38.21 42.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.897 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.06 -25.63 62.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.873 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 -64.99 -70.02 0.26 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.851 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -70.85 -74.54 0.14 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.932 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -160.27 -74.62 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.931 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -165.03 -170.11 1.85 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.856 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 6.5 tp -104.94 -30.19 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.153 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 60.16 174.78 0.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.908 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 3.4 tttt . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.946 179.906 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.885 0.374 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 175.07 40.18 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.505 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 136' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -158.76 160.57 29.23 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.597 0.713 . . . . 0.0 110.831 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 175.09 8.6 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.675 2.25 . . . . 0.0 112.32 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 138' ' ' THR . . . . . . . . . . . . . 35.0 p -87.81 134.6 33.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.172 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.72 112.63 3.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.863 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -160.5 171.48 36.69 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.496 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 141' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 172.36 12.8 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.63 2.22 . . . . 0.0 112.363 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 142' ' ' LYS . . . . . . . . . . . . . 27.6 mttt -66.97 96.96 0.46 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.875 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 0.53 ' HA ' ' C ' ' B' ' 144' ' ' PRO . 2.1 mt 64.47 139.52 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.636 0.731 . . . . 0.0 111.097 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 144' ' ' PRO . . . . . 0.53 ' C ' ' HA ' ' B' ' 143' ' ' ILE . 53.9 Cg_endo -69.75 159.25 89.96 Favored 'Cis proline' 0 C--O 1.231 0.174 0 C-N-CA 122.677 -1.801 . . . . 0.0 112.38 -0.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 178.73 -76.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.87 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 146' ' ' ILE . . . . . 0.463 ' H ' HD12 ' B' ' 146' ' ' ILE . 3.5 mp -94.81 -20.81 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.129 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.07 -25.78 66.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.109 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 85.9 m -53.81 -27.51 29.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.137 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . -55.74 -53.02 44.58 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.442 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 150' ' ' MET . . . . . . . . . . . . . 28.9 mmt -57.13 -51.8 67.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.805 0.336 . . . . 0.0 110.887 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 59.5 t -57.47 -40.42 74.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.148 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -60.04 -43.79 97.88 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.502 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -64.69 -46.65 81.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.826 0.346 . . . . 0.0 111.126 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 2.2 tt -63.87 -54.91 27.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 155' ' ' LEU . . . . . 0.706 ' O ' HG23 ' B' ' 159' ' ' VAL . 0.4 OUTLIER -51.96 -56.53 13.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.917 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 156' ' ' LEU . . . . . 0.705 ' O ' HG23 ' B' ' 160' ' ' VAL . 14.3 mt -52.18 -45.7 65.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.899 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 4.3 tt -54.87 -47.21 74.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.86 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 5.2 tp -67.78 -39.3 84.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 159' ' ' VAL . . . . . 0.706 HG23 ' O ' ' B' ' 155' ' ' LEU . 54.7 t -63.77 -47.92 88.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.131 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 160' ' ' VAL . . . . . 0.705 HG23 ' O ' ' B' ' 156' ' ' LEU . 36.6 t -64.46 -47.7 88.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.148 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.61 -36.37 66.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.121 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.37 -38.37 65.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.929 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.05 -41.0 55.66 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.468 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 58.2 mt -74.04 -39.28 50.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.901 0.381 . . . . 0.0 111.126 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -67.54 -38.46 90.57 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.484 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 12.5 mt -72.43 -42.13 65.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.886 0.374 . . . . 0.0 110.937 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -65.95 -38.03 87.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.867 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.15 -26.39 53.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.884 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.26 -26.25 66.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.927 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 5.2 mtt-85 -67.41 -26.08 66.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.875 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 52.04 29.81 6.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 172' ' ' HIS . . . . . . . . . . . . . 13.5 m80 51.32 86.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.865 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 50.1 mm -77.45 -72.35 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.095 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 12.0 p -96.73 -29.49 3.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.134 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 175' ' ' ARG . . . . . . . . . . . . . 3.9 ttp180 -174.29 -65.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.871 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.33 147.91 3.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.933 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.856 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.2 m -151.72 160.51 31.56 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.632 0.73 . . . . 0.0 110.842 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 -23.88 30.5 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.64 2.227 . . . . 0.0 112.374 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.06 -170.84 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.131 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -160.74 -65.56 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.896 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 54.95 -170.15 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.46 28.09 0.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.856 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.78 -171.27 1.03 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.092 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.1 t 62.72 72.08 0.63 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.65 0.738 . . . . 0.0 110.867 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 -15.46 37.2 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.691 2.261 . . . . 0.0 112.359 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.82 -16.15 61.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.966 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.0 m -76.35 -35.5 58.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.146 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.9 t -67.98 -39.34 83.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.851 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.694 ' O ' HG23 ' A' ' 58' ' ' VAL . 54.7 mt -62.12 -48.05 90.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.114 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.683 ' O ' HG23 ' A' ' 59' ' ' VAL . 72.1 mt -61.24 -45.11 99.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.156 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.3 m -54.23 -47.92 71.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.798 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.93 -50.8 67.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.065 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 54' ' ' ILE . 62.7 t -53.04 -37.71 27.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.155 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 55' ' ' ILE . 92.3 t -70.46 -37.87 71.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.148 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.674 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -62.83 -46.09 94.35 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.474 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.711 ' O ' HG23 ' A' ' 65' ' ' VAL . 3.2 mp -70.78 -42.29 77.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.865 0.364 . . . . 0.0 111.132 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.563 HD12 HG12 ' A' ' 58' ' ' VAL . 11.2 mt -65.41 -36.02 82.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.439 HD12 HG12 ' A' ' 59' ' ' VAL . 12.1 mt -67.71 -45.64 74.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.932 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 60' ' ' GLY . 99.6 t -61.02 -38.15 78.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.121 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 61' ' ' ILE . 92.1 t -63.52 -52.29 59.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.156 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.551 ' O ' HG23 ' A' ' 70' ' ' VAL . 60.2 t -62.12 -53.51 46.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.116 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.39 -32.43 71.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.29 -48.2 76.85 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.495 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.478 HG12 HD12 ' A' ' 73' ' ' ILE . 92.7 t -74.92 -33.22 29.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.854 0.359 . . . . 0.0 111.106 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.569 HG12 HD12 ' A' ' 74' ' ' LEU . 74.6 t -70.72 -52.77 25.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.171 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.685 ' CE2' HD11 ' A' ' 75' ' ' ILE . 6.9 t80 -61.68 -46.23 90.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.939 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -57.62 -48.9 78.18 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.456 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.478 HD12 HG12 ' A' ' 69' ' ' VAL . 67.9 mt -72.49 -26.1 23.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.87 0.367 . . . . 0.0 111.137 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.569 HD12 HG12 ' A' ' 70' ' ' VAL . 12.5 mt -70.47 -42.07 71.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.933 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.685 HD11 ' CE2' ' A' ' 71' ' ' PHE . 49.9 mt -69.91 -35.02 62.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.112 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.5 mmtt -64.87 -43.43 92.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.924 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 67.6 mtt180 -66.87 -30.89 71.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.818 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.62 -53.0 25.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -174.66 125.96 0.3 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.897 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.09 134.68 54.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.925 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.42 160.62 22.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.93 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 5.6 tp -134.95 -40.02 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.137 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 60.18 50.94 5.94 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.887 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 7.3 tptp . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.927 179.982 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.891 0.377 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 83.0 133.89 2.12 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.485 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 136' ' ' CYS . . . . . . . . . . . . . 6.6 p -161.92 72.56 2.38 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.594 0.712 . . . . 0.0 110.924 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 105.81 1.54 Allowed 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.696 2.264 . . . . 0.0 112.348 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 138' ' ' THR . . . . . . . . . . . . . 8.3 t -84.81 143.8 28.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.155 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -164.75 129.25 2.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 135.32 -166.12 24.54 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.477 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 141' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 -172.8 0.61 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.681 2.254 . . . . 0.0 112.325 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 142' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -152.98 119.0 5.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.898 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 0.561 HG23 ' HA ' ' B' ' 144' ' ' PRO . 61.5 mt 65.23 135.33 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.616 0.722 . . . . 0.0 111.14 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 144' ' ' PRO . . . . . 0.561 ' HA ' HG23 ' B' ' 143' ' ' ILE . 53.1 Cg_endo -69.82 -167.21 3.64 Favored 'Cis proline' 0 C--N 1.341 0.18 0 C-N-CA 122.656 -1.81 . . . . 0.0 112.308 -0.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 75.09 4.9 4.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.814 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 10.8 mm -133.49 -39.61 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.14 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -51.67 -29.87 19.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.127 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 89.1 m -53.62 -27.78 28.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.193 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . -55.91 -53.46 42.0 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.505 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 150' ' ' MET . . . . . . . . . . . . . 30.3 mmt -57.86 -52.01 67.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.757 0.313 . . . . 0.0 110.877 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 58.9 t -55.96 -40.37 62.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.139 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -61.33 -43.53 99.24 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.513 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -63.61 -47.15 82.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.791 0.329 . . . . 0.0 111.068 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.98 -52.59 48.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.891 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 155' ' ' LEU . . . . . 0.656 ' O ' HG23 ' B' ' 159' ' ' VAL . 0.5 OUTLIER -53.06 -54.7 31.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.896 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 156' ' ' LEU . . . . . 0.703 ' O ' HG23 ' B' ' 160' ' ' VAL . 23.0 mt -52.49 -45.8 66.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 3.2 tt -54.81 -47.37 74.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.946 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.67 -39.25 84.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.909 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 159' ' ' VAL . . . . . 0.656 HG23 ' O ' ' B' ' 155' ' ' LEU . 67.2 t -63.76 -48.0 88.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.167 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 160' ' ' VAL . . . . . 0.703 HG23 ' O ' ' B' ' 156' ' ' LEU . 37.1 t -64.44 -47.66 88.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.109 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.59 -36.41 66.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.121 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 2.9 tp -73.32 -38.39 65.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.936 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -71.98 -41.02 55.97 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.454 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 58.2 mt -74.07 -39.41 50.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.855 0.359 . . . . 0.0 111.121 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -67.37 -38.52 91.31 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.513 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 6.7 mt -72.41 -46.02 57.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.806 0.336 . . . . 0.0 110.898 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -61.44 -37.79 84.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.903 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.81 -26.08 54.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.876 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 21.0 mtt180 -79.41 -30.69 42.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.846 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.84 -30.72 70.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 52.6 mtp85 -77.48 -15.32 59.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.903 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 172' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 54.61 31.1 14.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.84 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 36.2 mm 62.05 74.9 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.18 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 12.1 p -99.05 -27.99 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.138 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 175' ' ' ARG . . . . . . . . . . . . . 13.3 ttm-85 -156.75 160.72 39.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.828 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 14.1 tttm -161.08 123.4 3.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.892 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.876 -179.998 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 4.6 p -137.42 156.57 75.0 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.677 0.751 . . . . 0.0 110.887 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 160.93 47.88 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.7 2.267 . . . . 0.0 112.375 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.28 -58.62 7.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.087 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -69.72 156.94 38.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.903 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -146.27 77.68 1.49 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.922 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.5 ptp85 -72.66 147.74 45.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.842 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -173.85 166.71 4.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.102 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.3 t -61.31 147.53 87.09 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.684 0.754 . . . . 0.0 110.879 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -15.54 37.07 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.679 2.252 . . . . 0.0 112.372 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.79 -16.15 61.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.9 m -76.32 -35.6 58.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.164 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 t -67.79 -38.47 83.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.671 ' O ' HG23 ' A' ' 58' ' ' VAL . 78.8 mt -63.06 -49.02 85.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.132 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.702 ' O ' HG23 ' A' ' 59' ' ' VAL . 63.5 mt -58.51 -43.77 87.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.16 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.2 m -56.79 -49.25 75.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.863 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.1 -49.71 74.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.114 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.761 HG12 HD12 ' A' ' 62' ' ' LEU . 61.5 t -53.05 -37.55 27.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.138 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.702 HG23 ' O ' ' A' ' 55' ' ' ILE . 90.5 t -70.81 -37.64 69.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.118 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.671 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -62.99 -46.08 94.29 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.441 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.724 ' O ' HG23 ' A' ' 65' ' ' VAL . 3.2 mp -70.79 -42.23 77.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.879 0.371 . . . . 0.0 111.14 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.761 HD12 HG12 ' A' ' 58' ' ' VAL . 6.7 mt -65.39 -36.11 82.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.914 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.4 mt -67.67 -45.66 74.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.936 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 60' ' ' GLY . 97.6 t -61.02 -38.04 78.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.149 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 61' ' ' ILE . 90.3 t -63.58 -52.18 60.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.122 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.548 ' O ' HG23 ' A' ' 70' ' ' VAL . 59.9 t -62.38 -53.49 46.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.091 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.2 mt -60.38 -32.55 71.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.923 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.23 -48.22 76.92 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.488 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.478 HG12 HD12 ' A' ' 73' ' ' ILE . 96.5 t -74.85 -33.16 29.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.845 0.355 . . . . 0.0 111.12 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 66' ' ' VAL . 72.7 t -70.71 -52.88 24.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.163 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.69 ' CD2' HD11 ' A' ' 75' ' ' ILE . 8.2 t80 -61.64 -46.01 91.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.426 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -57.48 -49.08 76.21 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.534 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.478 HD12 HG12 ' A' ' 69' ' ' VAL . 63.7 mt -71.59 -25.2 24.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.891 0.377 . . . . 0.0 111.105 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.539 HD12 HG12 ' A' ' 70' ' ' VAL . 12.5 mt -72.58 -46.52 53.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.93 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.69 HD11 ' CD2' ' A' ' 71' ' ' PHE . 11.0 mt -52.89 -31.0 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.185 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -85.06 -35.66 21.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.911 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 -53.61 -32.86 52.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.83 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.97 -65.51 0.73 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.876 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -68.52 113.54 6.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.942 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.498 ' HG3' HG23 ' A' ' 82' ' ' ILE . 2.0 pt20 -75.65 -31.01 59.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.924 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 53.58 87.66 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.916 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.498 HG23 ' HG3' ' A' ' 80' ' ' GLN . 1.3 pt -97.11 33.35 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.11 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 25.8 mtt85 -89.47 61.54 5.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.851 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.87 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.895 0.379 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 156.81 -107.57 0.33 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.472 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 136' ' ' CYS . . . . . . . . . . . . . 1.1 m -156.14 160.48 30.74 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.599 0.714 . . . . 0.0 110.856 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.67 179.32 3.73 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.693 2.262 . . . . 0.0 112.359 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 138' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.89 -179.17 7.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.194 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -164.17 107.64 0.94 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.902 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -52.4 169.74 0.61 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.509 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 141' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 78.63 1.0 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.689 2.259 . . . . 0.0 112.302 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 142' ' ' LYS . . . . . . . . . . . . . 3.7 mmtp 68.24 -77.13 0.05 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.907 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 0.607 HG23 ' HA ' ' B' ' 144' ' ' PRO . 56.7 mt -150.31 135.77 10.16 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.669 0.747 . . . . 0.0 111.09 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 144' ' ' PRO . . . . . 0.607 ' HA ' HG23 ' B' ' 143' ' ' ILE . 53.8 Cg_endo -69.76 161.83 85.39 Favored 'Cis proline' 0 C--N 1.342 0.21 0 C-N-CA 122.711 -1.787 . . . . 0.0 112.365 -0.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 145' ' ' SER . . . . . 0.403 ' HB3' HD12 ' B' ' 146' ' ' ILE . 48.4 t -176.34 -75.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.891 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 146' ' ' ILE . . . . . 0.459 ' H ' HD12 ' B' ' 146' ' ' ILE . 3.6 mp -94.0 -20.78 6.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.153 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.84 -25.05 67.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.106 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 18.4 m -53.51 -28.37 30.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.13 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . -59.13 -57.91 17.28 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.49 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 150' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -58.17 -46.66 85.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.87 0.367 . . . . 0.0 110.917 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 59.4 t -56.92 -40.57 72.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.11 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -65.18 -41.68 96.79 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.492 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -62.08 -51.45 67.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.84 0.352 . . . . 0.0 111.138 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.58 -52.55 64.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.946 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 155' ' ' LEU . . . . . 0.701 ' O ' HG23 ' B' ' 159' ' ' VAL . 3.2 tp -54.93 -54.94 36.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.917 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 156' ' ' LEU . . . . . 0.699 ' O ' HG23 ' B' ' 160' ' ' VAL . 19.7 mt -54.16 -45.27 72.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.903 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 4.9 tt -55.12 -46.96 75.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.94 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.77 -39.64 84.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.888 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 159' ' ' VAL . . . . . 0.701 HG23 ' O ' ' B' ' 155' ' ' LEU . 58.0 t -63.64 -48.06 88.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.139 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 160' ' ' VAL . . . . . 0.699 HG23 ' O ' ' B' ' 156' ' ' LEU . 37.2 t -64.7 -47.47 88.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.123 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.88 -35.73 66.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.088 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.28 -38.74 65.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.963 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.49 -40.83 53.43 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.469 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 54.7 mt -73.66 -38.31 51.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.905 0.383 . . . . 0.0 111.104 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.95 -39.1 85.37 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.491 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 11.6 mt -71.59 -40.42 69.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.885 0.374 . . . . 0.0 110.962 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -68.33 -37.68 80.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.936 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.48 -27.23 58.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.872 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.28 -36.48 66.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.856 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.19 -32.46 71.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.845 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 18.2 mtp85 -71.57 -15.13 62.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.875 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 172' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 62.34 64.83 0.91 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.857 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 55.5 mt -146.24 110.21 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.104 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 23.2 m -141.49 150.75 19.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.165 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.69 128.46 35.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 15.9 tttt -161.61 54.6 0.26 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.881 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 2.4 ttp180 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.854 179.982 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 2.7 m -116.64 160.51 36.17 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.595 0.712 . . . . 0.0 110.893 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -16.87 37.83 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.623 2.215 . . . . 0.0 112.38 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.0 133.29 51.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.094 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -170.36 67.96 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.909 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -82.57 172.33 13.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.902 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.09 102.48 3.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.29 -176.91 0.35 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.062 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.4 t -63.6 147.5 95.49 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.636 0.731 . . . . 0.0 110.863 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 -15.59 37.1 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.708 2.272 . . . . 0.0 112.301 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.8 -16.15 61.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.916 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.659 HG21 ' HB ' ' B' ' 148' ' ' THR . 3.9 m -76.3 -35.48 58.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.13 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.9 t -67.8 -37.65 82.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.85 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.658 ' O ' HG23 ' A' ' 58' ' ' VAL . 54.8 mt -64.4 -50.03 78.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.182 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.69 ' O ' HG23 ' A' ' 59' ' ' VAL . 63.1 mt -56.56 -42.35 75.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.152 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.9 m -59.18 -50.98 71.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.842 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.5 -49.21 78.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.099 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.738 HG12 HD12 ' A' ' 62' ' ' LEU . 62.5 t -53.11 -37.55 27.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.138 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 55' ' ' ILE . 89.8 t -70.62 -37.93 71.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.135 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.682 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -62.79 -46.1 94.34 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.503 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.71 ' O ' HG23 ' A' ' 65' ' ' VAL . 3.2 mp -70.7 -42.3 77.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.87 0.367 . . . . 0.0 111.169 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.738 HD12 HG12 ' A' ' 58' ' ' VAL . 7.7 mt -65.37 -36.15 83.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.918 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.4 mt -67.69 -45.32 75.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.896 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 60' ' ' GLY . 96.7 t -61.42 -37.82 78.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.133 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 61' ' ' ILE . 90.1 t -63.85 -51.9 63.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.108 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.548 ' O ' HG23 ' A' ' 70' ' ' VAL . 60.2 t -62.6 -53.53 45.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.094 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.47 -32.7 71.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.877 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.99 -47.93 80.88 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.49 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.432 HG12 HD12 ' A' ' 73' ' ' ILE . 95.2 t -75.11 -32.87 27.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.846 0.355 . . . . 0.0 111.11 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 66' ' ' VAL . 73.7 t -70.9 -53.05 23.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.102 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.471 ' CE2' HD11 ' A' ' 75' ' ' ILE . 5.3 t80 -62.11 -44.16 97.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.868 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.56 -49.47 76.66 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.457 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.432 HD12 HG12 ' A' ' 69' ' ' VAL . 59.6 mt -70.32 -26.15 28.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.87 0.366 . . . . 0.0 111.145 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.6 mt -69.57 -39.5 77.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.95 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.471 HD11 ' CE2' ' A' ' 71' ' ' PHE . 60.8 mt -73.72 -36.85 47.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.115 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.8 mmtt -64.85 -38.47 91.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -52.45 -35.26 51.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.89 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.2 -55.19 7.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.861 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -73.66 179.79 3.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.925 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -158.74 164.85 35.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.901 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.06 167.8 0.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.887 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 26.6 mm 58.58 68.13 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.13 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -94.28 75.15 3.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 179.962 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 . . . . . 0 N--CA 1.458 -0.044 0 CA-C-O 120.948 0.404 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.01 85.55 1.73 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.455 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 136' ' ' CYS . . . . . . . . . . . . . 1.1 m -77.51 160.59 74.69 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.628 0.727 . . . . 0.0 110.845 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 174.4 9.56 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.73 2.287 . . . . 0.0 112.362 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 138' ' ' THR . . . . . . . . . . . . . 14.9 t -146.02 31.86 1.03 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.157 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -163.01 156.03 19.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.898 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -109.72 172.66 16.12 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.502 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 141' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -19.8 35.47 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.685 2.257 . . . . 0.0 112.355 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 142' ' ' LYS . . . . . . . . . . . . . 1.5 tttt 53.52 53.11 12.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.87 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 0.582 HG23 ' HA ' ' B' ' 144' ' ' PRO . 71.4 mt 64.99 135.53 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.598 0.713 . . . . 0.0 111.137 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 144' ' ' PRO . . . . . 0.582 ' HA ' HG23 ' B' ' 143' ' ' ILE . 53.8 Cg_endo -69.73 160.82 87.32 Favored 'Cis proline' 0 C--O 1.231 0.173 0 C-N-CA 122.704 -1.79 . . . . 0.0 112.359 -0.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 2.7 t -179.37 -75.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.88 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 2.4 mp -85.17 -25.44 6.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.102 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -55.09 -26.15 35.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.129 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 148' ' ' THR . . . . . 0.659 ' HB ' HG21 ' A' ' 52' ' ' THR . 40.7 m -52.42 -29.54 24.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.166 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . -59.24 -59.47 10.62 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.476 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 150' ' ' MET . . . . . . . . . . . . . 29.3 mmt -57.97 -47.25 83.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.757 0.313 . . . . 0.0 110.848 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 59.3 t -57.36 -40.42 74.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.125 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -64.07 -43.61 97.03 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.432 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -61.98 -44.19 97.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.85 0.357 . . . . 0.0 111.127 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 2.6 tp -64.84 -48.62 73.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.957 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 155' ' ' LEU . . . . . 0.718 ' O ' HG23 ' B' ' 159' ' ' VAL . 0.8 OUTLIER -52.91 -55.6 22.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.888 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 156' ' ' LEU . . . . . 0.699 ' O ' HG23 ' B' ' 160' ' ' VAL . 27.4 mt -53.7 -44.34 69.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.879 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.11 -47.19 75.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.93 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.37 -39.95 85.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.954 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 159' ' ' VAL . . . . . 0.718 HG23 ' O ' ' B' ' 155' ' ' LEU . 45.1 t -63.51 -48.18 88.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.12 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 160' ' ' VAL . . . . . 0.699 HG23 ' O ' ' B' ' 156' ' ' LEU . 38.5 t -64.69 -47.48 88.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.157 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.92 -35.31 66.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.152 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.32 -39.06 65.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.941 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.47 -41.03 53.08 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.531 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 54.3 mt -73.2 -38.08 53.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.875 0.369 . . . . 0.0 111.136 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 165' ' ' GLY . . . . . 0.659 ' O ' HG21 ' B' ' 174' ' ' VAL . . . -69.54 -39.12 79.38 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.497 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 5.9 mt -71.4 -38.74 71.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.807 0.337 . . . . 0.0 110.879 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -69.69 -37.02 76.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.902 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -72.55 -35.33 67.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.884 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.87 -20.61 62.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.878 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -13.62 62.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.907 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -87.36 -42.51 12.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.845 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 172' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 179.98 -75.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.852 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 1.3 tt -144.85 134.65 18.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.124 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 174' ' ' VAL . . . . . 0.659 HG21 ' O ' ' B' ' 165' ' ' GLY . 76.9 t -91.81 92.23 3.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.129 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.25 -48.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.896 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.42 -42.03 92.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.928 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 179.982 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.7 m -98.6 160.58 27.63 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.58 0.705 . . . . 0.0 110.865 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 91.5 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.718 2.279 . . . . 0.0 112.317 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -166.17 -172.08 2.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.12 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.27 44.34 0.42 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.914 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -76.01 -20.59 57.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.917 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -165.12 79.98 0.34 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.904 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -174.93 -169.41 0.4 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.07 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.0 t 66.81 142.59 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.668 0.747 . . . . 0.0 110.906 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -12.15 32.32 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.715 2.277 . . . . 0.0 112.324 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.546 ' HA ' HD12 ' A' ' 54' ' ' ILE . 0.3 OUTLIER -67.49 -17.04 64.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.891 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.5 m -75.91 -37.9 58.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.154 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.2 t -66.73 -40.94 88.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.866 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.675 ' O ' HG23 ' A' ' 58' ' ' VAL . 53.0 mt -55.89 -40.97 65.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.1 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.609 ' O ' HG23 ' A' ' 59' ' ' VAL . 75.7 mt -57.94 -42.11 81.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.146 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.2 m -66.04 -41.5 90.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.877 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.13 -51.0 59.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.1 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 54' ' ' ILE . 66.0 t -53.14 -46.2 55.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.129 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 55' ' ' ILE . 84.8 t -64.96 -36.19 77.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.139 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.67 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -61.69 -46.08 94.96 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.506 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.713 ' O ' HG23 ' A' ' 65' ' ' VAL . 2.8 mp -70.68 -42.92 77.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.799 0.333 . . . . 0.0 111.091 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.557 HD13 ' O ' ' A' ' 58' ' ' VAL . 8.5 mp -65.07 -35.84 82.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.5 mt -67.8 -45.12 75.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 60' ' ' GLY . 95.4 t -62.06 -36.81 76.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.107 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 61' ' ' ILE . 89.7 t -64.56 -51.74 63.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.139 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.555 ' O ' HG23 ' A' ' 70' ' ' VAL . 60.4 t -62.65 -53.34 48.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.122 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.3 mt -60.24 -37.42 80.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.09 -50.52 66.98 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.499 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.0 t -70.95 -39.53 75.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.859 0.362 . . . . 0.0 111.126 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 66' ' ' VAL . 62.8 t -62.53 -53.15 50.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.144 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.767 ' CD2' HD11 ' A' ' 75' ' ' ILE . 1.3 t80 -61.93 -39.94 93.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.888 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -55.65 -49.56 64.91 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.46 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 64.4 mt -64.13 -46.79 92.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.862 0.363 . . . . 0.0 111.153 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -56.4 -49.5 74.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.949 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.767 HD11 ' CD2' ' A' ' 71' ' ' PHE . 21.4 mt -57.04 -31.05 35.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.157 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.1 mmmt -85.07 -22.69 28.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.916 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 9.1 mtp85 -67.74 -28.69 67.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.851 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -64.89 -25.68 67.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.87 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -64.99 -75.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.923 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -165.09 -46.18 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.929 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.96 -177.89 3.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.877 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.475 HD12 ' N ' ' A' ' 84' ' ' LYS . 2.5 pp -134.74 -37.9 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.139 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.434 ' N ' HD12 ' A' ' 82' ' ' ILE . 2.9 tmt_? 54.2 84.52 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.918 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.475 ' N ' HD12 ' A' ' 82' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.527 0.063 0 CA-C-O 120.869 0.366 . . . . 0.0 110.815 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -157.85 105.73 0.28 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.515 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 136' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -155.6 160.49 30.8 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.626 0.727 . . . . 0.0 110.885 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.76 -178.44 2.34 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.683 2.256 . . . . 0.0 112.344 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 138' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.41 109.67 10.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.147 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -156.96 159.54 38.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.912 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -66.85 177.04 19.85 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.49 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 141' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 97.65 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.728 2.285 . . . . 0.0 112.367 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 142' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.78 -1.34 42.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.86 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 0.52 ' HA ' ' C ' ' B' ' 144' ' ' PRO . 1.9 mt 64.36 139.58 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.647 0.737 . . . . 0.0 111.152 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 144' ' ' PRO . . . . . 0.52 ' C ' ' HA ' ' B' ' 143' ' ' ILE . 54.4 Cg_endo -69.74 159.08 90.21 Favored 'Cis proline' 0 C--N 1.342 0.192 0 C-N-CA 122.717 -1.784 . . . . 0.0 112.387 -0.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 178.65 -75.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.861 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 27.3 mt -93.27 -18.46 7.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.15 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.34 -21.2 66.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.117 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 16.0 m -51.26 -30.36 17.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.135 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . -54.65 -54.06 35.21 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.505 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 150' ' ' MET . . . . . . . . . . . . . 27.3 mmt -58.62 -51.04 71.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.805 0.336 . . . . 0.0 110.922 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 59.2 t -55.19 -40.41 55.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.094 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -63.26 -41.61 99.52 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.434 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -63.45 -46.58 85.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.799 0.333 . . . . 0.0 111.121 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.96 -46.75 87.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.861 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 155' ' ' LEU . . . . . 0.7 ' O ' HG23 ' B' ' 159' ' ' VAL . 4.3 tp -54.59 -53.61 52.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.898 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 156' ' ' LEU . . . . . 0.702 ' O ' HG23 ' B' ' 160' ' ' VAL . 3.3 mt -56.75 -44.79 82.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.939 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 1.1 tt -54.99 -46.98 75.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.906 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 1.1 tt -67.64 -39.82 84.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.953 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 159' ' ' VAL . . . . . 0.7 HG23 ' O ' ' B' ' 155' ' ' LEU . 93.2 t -63.58 -48.04 88.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.108 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 160' ' ' VAL . . . . . 0.702 HG23 ' O ' ' B' ' 156' ' ' LEU . 38.2 t -64.69 -47.45 88.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.128 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.85 -35.74 66.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.103 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 1.4 tp -73.37 -38.77 65.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.934 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.37 -40.82 54.17 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.47 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 54.5 mt -73.59 -38.53 52.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.872 0.367 . . . . 0.0 111.134 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -67.88 -40.64 89.25 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.476 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 7.5 mt -70.36 -42.44 71.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.887 0.375 . . . . 0.0 110.924 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -65.88 -37.49 86.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.835 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 168' ' ' MET . . . . . 0.537 ' SD ' HG23 ' B' ' 173' ' ' ILE . 0.0 OUTLIER -75.0 -26.32 59.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.911 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -82.14 -15.84 51.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.847 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -54.84 -26.74 37.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -145.02 17.21 1.58 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.854 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 172' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 51.72 44.06 29.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.876 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 173' ' ' ILE . . . . . 0.537 HG23 ' SD ' ' B' ' 168' ' ' MET . 5.4 tt -75.56 132.64 32.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.107 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 10.8 p -102.39 151.85 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.108 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 175' ' ' ARG . . . . . . . . . . . . . 7.1 ttm180 -156.88 107.04 2.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.89 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 9.1 tptt 62.74 41.25 9.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.898 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.869 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 63.11 160.59 0.12 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.624 0.726 . . . . 0.0 110.862 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -20.45 34.65 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.698 2.266 . . . . 0.0 112.319 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.6 170.69 0.24 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.076 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -169.73 116.41 0.57 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.871 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -75.97 100.46 4.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.914 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -74.82 75.34 2.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.846 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -164.78 -170.48 2.0 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.06 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.7 t 62.93 72.94 0.54 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.682 0.753 . . . . 0.0 110.847 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 -15.66 37.46 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.717 2.278 . . . . 0.0 112.356 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.793 ' HA ' HD12 ' A' ' 54' ' ' ILE . 1.7 tt -72.62 -16.2 61.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.948 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.536 HG21 ' HB ' ' B' ' 148' ' ' THR . 4.0 m -76.35 -35.59 58.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.087 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 t -67.97 -38.06 82.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.833 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.793 HD12 ' HA ' ' A' ' 51' ' ' LEU . 7.8 mt -62.32 -48.42 88.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.086 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.682 ' O ' HG23 ' A' ' 59' ' ' VAL . 61.8 mt -55.4 -49.88 69.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.152 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.8 m -54.81 -45.61 74.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.821 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.77 -51.27 60.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.115 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 54' ' ' ILE . 63.5 t -53.04 -37.74 27.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.097 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 55' ' ' ILE . 81.7 t -71.32 -37.12 64.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.124 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.682 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -62.87 -46.01 94.49 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.494 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.715 ' O ' HG23 ' A' ' 65' ' ' VAL . 3.2 mp -70.76 -42.43 77.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.84 0.352 . . . . 0.0 111.103 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.453 ' O ' HG23 ' A' ' 66' ' ' VAL . 12.1 mt -65.33 -35.91 82.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.953 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.4 mt -67.86 -45.5 74.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.941 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 60' ' ' GLY . 98.4 t -61.33 -37.68 78.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.139 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 61' ' ' ILE . 87.9 t -64.05 -51.42 69.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.121 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.551 ' O ' HG23 ' A' ' 70' ' ' VAL . 61.9 t -63.3 -53.59 43.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.155 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mt -60.44 -32.57 71.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.936 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.2 -47.97 79.62 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.475 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.471 HG12 HD12 ' A' ' 73' ' ' ILE . 95.7 t -75.08 -33.01 27.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.883 0.373 . . . . 0.0 111.125 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 66' ' ' VAL . 73.4 t -70.89 -53.04 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.145 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.596 ' CD2' HD11 ' A' ' 75' ' ' ILE . 6.1 t80 -62.03 -45.1 95.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.835 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.426 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -58.13 -49.02 79.35 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.451 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.471 HD12 HG12 ' A' ' 69' ' ' VAL . 63.9 mt -71.63 -24.88 23.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.868 0.366 . . . . 0.0 111.157 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.43 HD12 HG12 ' A' ' 70' ' ' VAL . 12.7 mt -73.31 -47.95 38.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.898 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.596 HD11 ' CD2' ' A' ' 71' ' ' PHE . 8.6 mt -51.75 -49.84 34.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.13 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.7 -36.05 79.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.903 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.72 -26.71 62.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.892 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -72.92 -40.69 65.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -66.72 -73.87 0.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -156.03 -58.92 0.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.924 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.4 tttm 54.63 78.23 0.18 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.894 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 5.4 tp -155.02 -40.8 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.184 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 22.8 ptt180 -147.65 -178.77 6.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.904 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.911 0.386 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 101.47 30.18 6.0 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.481 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 136' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 63.2 160.55 0.12 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.631 0.729 . . . . 0.0 110.9 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.74 143.18 50.12 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.702 2.268 . . . . 0.0 112.355 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 138' ' ' THR . . . . . . . . . . . . . 20.1 p -149.66 27.45 0.81 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.158 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -149.02 101.91 3.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.863 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -75.89 168.24 54.77 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.478 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 141' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 167.97 22.85 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.66 2.24 . . . . 0.0 112.385 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 142' ' ' LYS . . . . . . . . . . . . . 19.6 mttp -150.76 42.76 0.8 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.914 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 0.539 ' HA ' ' C ' ' B' ' 144' ' ' PRO . 2.1 mt -134.24 138.99 31.64 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.642 0.734 . . . . 0.0 111.127 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 144' ' ' PRO . . . . . 0.539 ' C ' ' HA ' ' B' ' 143' ' ' ILE . 54.0 Cg_endo -69.75 -169.98 5.49 Favored 'Cis proline' 0 C--N 1.342 0.211 0 C-N-CA 122.649 -1.813 . . . . 0.0 112.374 -0.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 12.9 p -56.06 -21.58 22.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.854 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 39.0 mt -88.48 -23.38 6.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.113 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -51.41 -35.28 38.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.102 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 148' ' ' THR . . . . . 0.536 ' HB ' HG21 ' A' ' 52' ' ' THR . 64.0 m -52.41 -34.11 46.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.14 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . -53.12 -55.53 23.63 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.517 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 150' ' ' MET . . . . . . . . . . . . . 22.3 mmt -62.37 -45.25 93.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.811 0.339 . . . . 0.0 110.872 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 59.1 t -55.61 -40.39 59.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.122 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -68.63 -39.77 86.25 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.503 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -60.68 -48.43 81.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.806 0.336 . . . . 0.0 111.098 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 1.1 tp -60.94 -55.32 34.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.953 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 155' ' ' LEU . . . . . 0.694 ' O ' HG23 ' B' ' 159' ' ' VAL . 0.3 OUTLIER -54.31 -55.08 31.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.929 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 156' ' ' LEU . . . . . 0.699 ' O ' HG23 ' B' ' 160' ' ' VAL . 13.5 mt -51.94 -45.5 64.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.955 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 157' ' ' LEU . . . . . 0.441 HD13 ' O ' ' B' ' 157' ' ' LEU . 0.3 OUTLIER -55.06 -46.56 75.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.914 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.504 HD23 ' O ' ' B' ' 158' ' ' LEU . 3.5 tt -68.03 -39.65 83.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.903 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 159' ' ' VAL . . . . . 0.694 HG23 ' O ' ' B' ' 155' ' ' LEU . 47.1 t -63.85 -47.81 89.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.151 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 160' ' ' VAL . . . . . 0.699 HG23 ' O ' ' B' ' 156' ' ' LEU . 37.9 t -64.8 -47.41 88.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.121 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.9 -36.17 67.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.11 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.4 -38.48 65.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.919 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.09 -41.24 54.72 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.509 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 58.1 mt -73.64 -39.16 53.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.894 0.378 . . . . 0.0 111.122 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -67.74 -38.59 89.85 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.483 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 12.5 mt -72.64 -38.83 67.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.898 0.38 . . . . 0.0 110.947 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -67.88 -39.88 83.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.856 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.05 -55.12 6.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.88 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.31 -27.11 33.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.862 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.0 -44.62 74.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 53.9 mtm180 -94.76 20.8 8.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.877 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 172' ' ' HIS . . . . . . . . . . . . . 19.8 m80 51.0 61.86 3.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -144.55 126.24 9.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.123 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 174' ' ' VAL . . . . . 0.438 ' O ' HG22 ' B' ' 174' ' ' VAL . 6.5 p -153.34 23.5 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.148 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 175' ' ' ARG . . . . . . . . . . . . . 30.4 ptt85 -72.91 179.62 3.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.874 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -169.6 -68.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.885 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.888 179.99 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.2 m -152.06 160.59 31.25 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.616 0.722 . . . . 0.0 110.856 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 135.51 30.66 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.7 2.267 . . . . 0.0 112.375 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -167.01 -50.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.095 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 69.3 -75.45 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 62.41 174.29 0.14 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.854 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.0 tpt85 -165.99 151.33 8.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.866 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -172.82 159.63 4.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.089 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.3 t -68.74 147.5 97.94 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.619 0.723 . . . . 0.0 110.854 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -15.47 37.09 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.725 2.283 . . . . 0.0 112.331 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.402 ' O ' HD23 ' A' ' 51' ' ' LEU . 1.3 tt -72.84 -16.11 61.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.912 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.9 m -76.34 -35.38 58.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.102 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.1 t -68.39 -37.22 80.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.854 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.676 ' O ' HG23 ' A' ' 58' ' ' VAL . 80.6 mt -63.09 -48.38 88.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.139 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.659 ' O ' HG23 ' A' ' 59' ' ' VAL . 57.2 mt -54.97 -44.74 75.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.094 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.6 m -59.66 -48.2 82.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.869 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.76 -48.97 78.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.087 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 54' ' ' ILE . 62.5 t -53.2 -40.46 38.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.15 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 55' ' ' ILE . 66.8 t -69.55 -35.19 65.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.101 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.598 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -63.97 -46.11 92.28 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.47 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.708 ' O ' HG23 ' A' ' 65' ' ' VAL . 3.1 mp -70.87 -43.15 77.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.912 0.387 . . . . 0.0 111.143 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.566 ' O ' HG23 ' A' ' 66' ' ' VAL . 3.5 mm? -65.27 -32.96 74.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.929 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.872 HD13 HD12 ' B' ' 157' ' ' LEU . 12.6 mt -69.37 -48.65 60.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.91 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 60' ' ' GLY . 91.7 t -59.22 -38.39 74.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.136 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 61' ' ' ILE . 91.1 t -63.88 -51.35 70.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.155 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 62' ' ' LEU . 61.3 t -63.02 -53.53 45.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.139 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mt -60.5 -32.97 71.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.912 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.74 -47.69 84.07 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.534 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.5 t -75.08 -32.91 27.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.839 0.352 . . . . 0.0 111.152 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 66' ' ' VAL . 73.8 t -70.81 -53.05 23.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.107 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -62.6 -42.57 99.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -59.34 -49.59 76.91 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.498 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 55.7 mt -69.51 -24.91 27.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.813 0.339 . . . . 0.0 111.056 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 14.2 mt -71.56 -36.87 71.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 71.8 mt -83.78 -37.29 13.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.129 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -55.02 -43.8 74.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.926 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.2 mtp180 -52.23 -60.71 2.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.889 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.5 ttt-85 -84.98 55.03 3.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.886 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.73 -175.93 1.84 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.915 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 56.14 56.63 5.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.946 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.455 ' C ' HD12 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -88.26 54.84 3.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.927 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.455 HD12 ' C ' ' A' ' 81' ' ' LYS . 3.3 mp 57.56 71.4 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.135 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -89.0 -58.35 2.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.874 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 . . . . . 0 N--CA 1.458 -0.064 0 CA-C-O 120.921 0.391 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 168.95 -145.98 9.91 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.462 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 136' ' ' CYS . . . . . . . . . . . . . 4.6 p -157.93 156.59 28.49 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.648 0.737 . . . . 0.0 110.877 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 -28.17 25.45 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.708 2.272 . . . . 0.0 112.347 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 138' ' ' THR . . . . . . . . . . . . . 1.2 m 63.13 28.06 15.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.146 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -75.54 130.82 39.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.846 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 57.13 84.9 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.506 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 141' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 -40.02 5.7 Favored 'Trans proline' 0 N--CA 1.465 -0.166 0 C-N-CA 122.706 2.271 . . . . 0.0 112.322 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 142' ' ' LYS . . . . . . . . . . . . . 5.4 mtpp 62.76 90.08 0.08 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.897 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 0.548 ' HA ' ' C ' ' B' ' 144' ' ' PRO . 0.5 OUTLIER -54.06 140.23 52.6 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.642 0.734 . . . . 0.0 111.108 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 144' ' ' PRO . . . . . 0.548 ' C ' ' HA ' ' B' ' 143' ' ' ILE . 53.7 Cg_endo -69.76 158.66 90.77 Favored 'Cis proline' 0 C--N 1.342 0.19 0 C-N-CA 122.619 -1.825 . . . . 0.0 112.364 -0.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.39 -75.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.857 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 63.0 mt -96.51 -21.82 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.129 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.82 -24.75 64.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.103 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 69.4 m -51.71 -29.83 19.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.11 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . -53.95 -55.72 24.45 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.5 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 150' ' ' MET . . . . . . . . . . . . . 28.7 mmt -57.15 -49.07 77.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.802 0.334 . . . . 0.0 110.889 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 59.4 t -57.85 -40.26 75.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.143 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -63.27 -40.03 98.55 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.527 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -65.95 -41.82 90.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.816 0.341 . . . . 0.0 111.12 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 2.5 tp -64.12 -51.95 61.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.923 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 155' ' ' LEU . . . . . 0.705 ' O ' HG23 ' B' ' 159' ' ' VAL . 5.7 tp -52.31 -49.93 63.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.897 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 156' ' ' LEU . . . . . 0.705 ' O ' HG23 ' B' ' 160' ' ' VAL . 69.5 mt -57.37 -44.23 84.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.92 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 157' ' ' LEU . . . . . 0.872 HD12 HD13 ' A' ' 63' ' ' LEU . 5.1 tt -55.04 -47.52 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.899 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 2.7 tt -67.1 -39.98 86.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.909 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 159' ' ' VAL . . . . . 0.705 HG23 ' O ' ' B' ' 155' ' ' LEU . 91.0 t -63.42 -48.22 88.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.173 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 160' ' ' VAL . . . . . 0.705 HG23 ' O ' ' B' ' 156' ' ' LEU . 38.5 t -64.63 -47.37 89.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.113 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.85 -35.63 66.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.071 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 6.3 tp -73.4 -38.85 65.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.885 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.39 -40.78 54.12 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.456 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 54.6 mt -73.66 -38.49 51.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.894 0.378 . . . . 0.0 111.124 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.16 -40.1 88.15 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.54 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 11.8 mt -70.84 -41.72 71.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.837 0.351 . . . . 0.0 110.928 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -67.12 -37.36 83.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.87 -26.02 60.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.852 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.95 -26.27 47.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.88 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.15 -24.33 67.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.881 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 50.87 45.41 27.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 172' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -146.93 26.85 1.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.875 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 173' ' ' ILE . . . . . 0.41 HD12 ' CG ' ' B' ' 175' ' ' ARG . 3.5 pt -89.19 -177.82 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.112 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 6.7 m -152.11 28.15 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.109 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 175' ' ' ARG . . . . . 0.41 ' CG ' HD12 ' B' ' 173' ' ' ILE . 2.8 ptm180 -84.15 176.43 8.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.857 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -155.5 -60.28 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.859 -179.991 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 4.5 p -136.03 156.59 76.93 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.626 0.727 . . . . 0.0 110.853 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 131.89 22.18 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.635 2.223 . . . . 0.0 112.341 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.53 -29.42 67.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.133 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -172.41 -173.03 0.99 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.844 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -148.07 124.85 11.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.905 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.96 113.01 0.19 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.855 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -172.73 -170.06 0.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.094 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.3 t -55.51 147.57 38.43 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.688 0.756 . . . . 0.0 110.836 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -15.49 37.19 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.71 2.273 . . . . 0.0 112.316 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.622 ' HA ' HD12 ' A' ' 54' ' ' ILE . 0.2 OUTLIER -72.76 -16.19 61.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.923 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.0 m -76.3 -35.59 58.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.134 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.1 t -68.2 -39.38 82.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.841 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.67 ' O ' HG23 ' A' ' 58' ' ' VAL . 27.5 mt -59.84 -46.12 94.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.16 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.676 ' O ' HG23 ' A' ' 59' ' ' VAL . 60.7 mt -56.97 -48.65 81.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.138 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 51.1 m -56.06 -45.94 79.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.48 -51.09 64.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.11 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 54' ' ' ILE . 78.1 t -53.18 -38.38 30.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.193 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 55' ' ' ILE . 93.2 t -69.94 -38.03 74.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.151 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.688 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -62.48 -46.14 94.42 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.536 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.71 ' O ' HG23 ' A' ' 65' ' ' VAL . 3.2 mp -70.62 -42.68 77.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.868 0.366 . . . . 0.0 111.133 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.595 HD12 HG12 ' A' ' 58' ' ' VAL . 10.2 mt -65.14 -35.97 82.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.922 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.656 HD12 HG12 ' A' ' 59' ' ' VAL . 10.1 mt -67.72 -45.8 73.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.903 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.688 HG23 ' O ' ' A' ' 60' ' ' GLY . 92.2 t -60.93 -37.96 78.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.172 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 61' ' ' ILE . 95.4 t -63.65 -51.89 64.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.121 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.554 ' O ' HG23 ' A' ' 70' ' ' VAL . 62.0 t -62.39 -53.48 46.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.137 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mt -60.32 -33.83 72.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.89 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.84 -49.08 75.76 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.483 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.469 HG12 HD12 ' A' ' 73' ' ' ILE . 94.0 t -73.12 -32.84 40.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.887 0.375 . . . . 0.0 111.17 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 66' ' ' VAL . 70.0 t -70.37 -45.76 73.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.124 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -63.92 -48.61 75.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.838 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -57.16 -49.54 71.4 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.493 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.469 HD12 HG12 ' A' ' 69' ' ' VAL . 62.3 mt -67.1 -28.44 42.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.82 0.343 . . . . 0.0 111.11 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.5 mt -67.51 -38.24 83.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.882 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 39.0 mt -63.74 -36.54 76.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.118 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.8 mmtt -84.97 -27.08 26.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.3 mmt85 -58.16 -23.28 54.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.885 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.9 ttm180 -64.95 -25.03 67.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.873 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -65.04 139.26 58.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.877 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -64.98 -38.77 92.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.2 mttp -75.23 86.87 2.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 41.7 pt -150.83 34.64 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.134 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.6 ttp180 -157.57 150.88 23.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.881 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 . . . . . 0 N--CA 1.458 -0.074 0 CA-C-O 120.895 0.379 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 141.32 -140.36 10.24 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.48 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 136' ' ' CYS . . . . . . . . . . . . . 19.8 t -159.3 69.26 3.29 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.602 0.715 . . . . 0.0 110.819 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.85 166.52 27.42 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.662 2.241 . . . . 0.0 112.313 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 138' ' ' THR . . . . . . . . . . . . . 2.1 p -150.87 -62.83 0.19 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.128 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -147.17 -48.66 0.18 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 59.67 -165.39 10.87 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.518 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 141' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -168.96 0.3 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.668 2.245 . . . . 0.0 112.348 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 142' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -144.85 16.06 1.58 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.886 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 0.606 HG23 ' HA ' ' B' ' 144' ' ' PRO . 46.9 mt -150.85 136.57 10.65 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.582 0.706 . . . . 0.0 111.135 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 144' ' ' PRO . . . . . 0.606 ' HA ' HG23 ' B' ' 143' ' ' ILE . 54.0 Cg_endo -69.73 157.54 91.86 Favored 'Cis proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.715 -1.785 . . . . 0.0 112.368 -0.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 1.9 p 179.05 -160.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.84 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 3.2 mp -51.25 -22.13 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.115 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -56.08 -32.33 64.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.112 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 48.1 m -54.2 -25.64 23.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.134 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . -57.12 -49.48 71.7 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.482 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 150' ' ' MET . . . . . . . . . . . . . 30.2 mmt -62.46 -51.71 66.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.796 0.332 . . . . 0.0 110.863 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 57.9 t -57.82 -40.1 74.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.098 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -64.79 -41.79 97.4 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.494 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 153' ' ' ALA . . . . . 0.503 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . -62.34 -49.03 77.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.869 0.366 . . . . 0.0 111.121 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 1.4 tt -68.45 -45.58 72.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.94 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 155' ' ' LEU . . . . . 0.623 ' O ' HG23 ' B' ' 159' ' ' VAL . 19.6 tp -60.55 -55.35 34.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.928 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 156' ' ' LEU . . . . . 0.707 ' O ' HG23 ' B' ' 160' ' ' VAL . 32.7 mt -51.95 -47.16 64.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.897 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.33 -46.36 72.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.902 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.36 -39.79 81.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 159' ' ' VAL . . . . . 0.623 HG23 ' O ' ' B' ' 155' ' ' LEU . 92.2 t -63.44 -47.63 90.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.109 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 160' ' ' VAL . . . . . 0.707 HG23 ' O ' ' B' ' 156' ' ' LEU . 34.8 t -64.01 -47.97 88.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.112 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.17 -36.98 66.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.101 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 4.6 tp -73.25 -38.13 66.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -71.8 -40.98 57.16 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.467 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 58.1 mt -74.2 -39.77 50.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.84 0.353 . . . . 0.0 111.087 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -66.78 -38.39 93.02 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.528 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 12.4 mt -72.26 -45.47 60.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.843 0.354 . . . . 0.0 110.93 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -60.52 -37.7 82.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.94 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.91 -25.67 59.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.86 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -75.07 -23.75 58.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.92 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 2.2 mtp85 -56.43 -25.55 50.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.869 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 171' ' ' ARG . . . . . 0.401 ' O ' ' CG ' ' B' ' 172' ' ' HIS . 8.8 mmm180 -67.04 -13.8 62.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.888 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 172' ' ' HIS . . . . . 0.401 ' CG ' ' O ' ' B' ' 171' ' ' ARG . 46.6 p-80 41.6 38.36 0.89 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.814 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 4.2 tt -78.16 143.0 13.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.131 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 18.5 m -83.79 55.12 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.142 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 175' ' ' ARG . . . . . . . . . . . . . 6.4 ttt85 -84.52 -28.98 26.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.87 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 58.8 90.91 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.94 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.904 179.997 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.7 m . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.875 0.369 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.81 -48.45 81.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.12 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.433 HG12 HD12 ' A' ' 62' ' ' LEU . 62.1 t -53.1 -38.13 29.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.131 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.422 HG12 HD12 ' A' ' 63' ' ' LEU . 64.8 t -70.25 -37.42 71.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.11 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.635 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -63.12 -46.09 94.02 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.525 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.698 ' O ' HG23 ' A' ' 65' ' ' VAL . 3.2 mp -70.9 -42.38 77.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.874 0.369 . . . . 0.0 111.117 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.491 ' O ' HG23 ' A' ' 66' ' ' VAL . 12.1 mt -65.43 -34.94 79.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.888 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.422 HD12 HG12 ' A' ' 59' ' ' VAL . 12.0 mt -68.41 -46.76 69.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.936 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 60' ' ' GLY . 97.0 t -60.3 -38.3 77.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.118 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 61' ' ' ILE . 89.9 t -63.65 -51.82 65.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.125 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.556 ' O ' HG23 ' A' ' 70' ' ' VAL . 62.0 t -62.52 -53.58 45.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.114 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.9 mt -60.33 -32.83 71.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.929 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.89 -47.92 81.29 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.458 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.433 HG12 HD12 ' A' ' 73' ' ' ILE . 95.6 t -75.07 -33.02 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.816 0.341 . . . . 0.0 111.08 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 66' ' ' VAL . 73.9 t -70.71 -53.05 23.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.118 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -61.95 -44.29 97.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.5 -49.5 76.18 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.505 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.433 HD12 HG12 ' A' ' 69' ' ' VAL . 58.9 mt . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 120.879 0.371 . . . . 0.0 111.135 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.841 0.353 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.51 -53.79 31.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.954 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 155' ' ' LEU . . . . . 0.607 ' O ' HG23 ' B' ' 159' ' ' VAL . 0.4 OUTLIER -52.1 -55.43 20.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 156' ' ' LEU . . . . . 0.703 ' O ' HG23 ' B' ' 160' ' ' VAL . 10.8 mt -52.2 -45.22 65.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.922 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 1.4 tt -55.05 -46.99 75.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.942 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.78 -39.51 84.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.922 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . 0.607 HG23 ' O ' ' B' ' 155' ' ' LEU . 69.6 t -63.8 -47.98 88.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.068 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . 0.703 HG23 ' O ' ' B' ' 156' ' ' LEU . 36.5 t -64.76 -47.54 88.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.132 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.91 -35.69 66.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.046 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 1.7 tp -73.32 -38.82 65.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.887 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.4 -40.91 53.77 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.529 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 54.8 mt -73.59 -38.31 51.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.857 0.36 . . . . 0.0 111.104 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -69.06 -39.03 84.6 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.467 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 10.9 mt -71.66 -39.6 70.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.907 0.384 . . . . 0.0 110.907 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -69.41 -37.62 77.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.864 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.42 -28.58 59.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.88 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 14.2 ttt180 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.92 -179.946 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.8 m . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.907 0.384 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.58 -50.55 64.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.072 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.554 ' O ' HD13 ' A' ' 62' ' ' LEU . 66.1 t -53.2 -44.75 53.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.128 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 65.6 t -65.9 -35.53 75.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.127 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.615 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -62.83 -46.23 94.06 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.47 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.722 ' O ' HG23 ' A' ' 65' ' ' VAL . 2.9 mp -70.6 -42.85 78.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.893 0.378 . . . . 0.0 111.088 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.554 HD13 ' O ' ' A' ' 58' ' ' VAL . 8.5 mp -65.23 -35.25 80.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.92 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.994 HD13 HD22 ' B' ' 157' ' ' LEU . 12.5 mt -67.84 -46.33 72.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.931 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 60' ' ' GLY . 84.9 t -60.89 -37.88 77.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.1 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 61' ' ' ILE . 89.7 t -63.38 -53.02 50.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.127 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.549 ' O ' HG23 ' A' ' 70' ' ' VAL . 59.9 t -61.12 -53.39 49.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.161 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 mt -60.3 -33.33 72.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.937 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.25 -47.96 83.43 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.486 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.493 HG12 HD12 ' A' ' 73' ' ' ILE . 96.8 t -74.91 -33.22 29.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.873 0.368 . . . . 0.0 111.079 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 66' ' ' VAL . 72.7 t -70.37 -46.93 69.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.074 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -64.56 -48.84 73.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.911 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -56.62 -47.27 85.9 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.472 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.493 HD12 HG12 ' A' ' 69' ' ' VAL . 67.4 mt . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 120.896 0.379 . . . . 0.0 111.13 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.792 0.33 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 11.9 tp -68.18 -50.02 57.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.915 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 155' ' ' LEU . . . . . 0.629 ' O ' HG23 ' B' ' 159' ' ' VAL . 7.8 tp -57.36 -53.4 58.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.927 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 156' ' ' LEU . . . . . 0.696 ' O ' HG23 ' B' ' 160' ' ' VAL . 16.5 mt -53.28 -45.73 68.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 157' ' ' LEU . . . . . 0.994 HD22 HD13 ' A' ' 63' ' ' LEU . 12.4 tp -54.96 -46.4 75.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.92 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 1.3 tt -68.05 -39.94 82.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.871 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . 0.629 HG23 ' O ' ' B' ' 155' ' ' LEU . 74.6 t -63.59 -48.02 88.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.129 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . 0.696 HG23 ' O ' ' B' ' 156' ' ' LEU . 36.0 t -64.59 -47.5 88.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.101 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.87 -35.82 66.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.073 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 1.3 tp -73.33 -38.8 65.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.916 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.19 -40.89 55.05 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.505 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 54.8 mt -73.63 -38.75 52.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.907 0.384 . . . . 0.0 111.107 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -67.27 -40.95 92.13 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.471 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 11.5 mt -70.32 -41.08 73.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.853 0.359 . . . . 0.0 110.894 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -67.54 -37.43 82.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.878 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.65 -25.69 57.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.902 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 3.2 mmt85 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.897 -179.954 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.6 m . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.839 0.352 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.11 -51.15 62.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.133 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.49 ' O ' HD23 ' A' ' 62' ' ' LEU . 97.5 t -53.35 -46.75 58.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.106 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 87.5 t -63.32 -35.88 73.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.137 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.593 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -62.95 -46.3 93.85 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.444 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.696 ' O ' HG23 ' A' ' 65' ' ' VAL . 2.8 mp -71.12 -42.85 75.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.814 0.34 . . . . 0.0 111.118 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.592 ' O ' HG23 ' A' ' 66' ' ' VAL . 4.0 mm? -65.32 -32.92 74.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.5 mt -69.55 -49.26 55.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.934 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 60' ' ' GLY . 95.3 t -58.36 -39.05 72.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.122 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 61' ' ' ILE . 93.5 t -63.7 -51.04 75.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.121 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 62' ' ' LEU . 61.2 t -63.31 -53.56 44.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.185 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.0 mt -60.37 -32.84 71.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.926 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.02 -47.92 80.81 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.487 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.466 HG12 HD12 ' A' ' 73' ' ' ILE . 99.5 t -75.01 -32.94 27.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.825 0.345 . . . . 0.0 111.123 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 66' ' ' VAL . 72.6 t -70.76 -51.44 36.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.118 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -62.42 -45.68 91.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.87 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -57.86 -49.2 76.69 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.542 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.466 HD12 HG12 ' A' ' 69' ' ' VAL . 59.8 mt . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.87 0.367 . . . . 0.0 111.114 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.783 0.325 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 7.6 tp -61.87 -41.58 98.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.886 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 155' ' ' LEU . . . . . 0.705 ' O ' HG23 ' B' ' 159' ' ' VAL . 0.4 OUTLIER -61.36 -55.03 36.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.926 179.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 156' ' ' LEU . . . . . 0.699 ' O ' HG23 ' B' ' 160' ' ' VAL . 15.9 mt -52.4 -46.36 66.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 3.6 tp -54.69 -46.55 74.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.869 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.09 -40.15 82.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.946 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . 0.705 HG23 ' O ' ' B' ' 155' ' ' LEU . 54.8 t -63.18 -47.74 90.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.105 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . 0.699 HG23 ' O ' ' B' ' 156' ' ' LEU . 36.2 t -64.87 -47.86 86.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.147 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.59 -35.13 65.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.154 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 1.1 tp -72.18 -39.76 68.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.956 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.23 -44.1 44.86 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.545 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 51.9 mt -69.4 -36.97 74.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.879 0.371 . . . . 0.0 111.161 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -71.37 -39.61 61.49 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.501 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 12.6 mt -72.13 -29.75 64.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.878 0.371 . . . . 0.0 110.899 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -81.27 -36.02 30.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.842 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.5 -29.54 61.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.913 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.862 0.363 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.642 ' HA ' HD13 ' B' ' 156' ' ' LEU . . . -62.0 -50.12 73.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.051 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.472 HG12 HD12 ' A' ' 62' ' ' LEU . 62.5 t -52.99 -37.5 26.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.124 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.542 HG12 HD12 ' A' ' 63' ' ' LEU . 89.8 t -70.72 -38.01 71.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.148 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.671 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -62.77 -46.03 94.51 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.443 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.715 ' O ' HG23 ' A' ' 65' ' ' VAL . 3.2 mp -70.69 -42.38 77.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.901 0.381 . . . . 0.0 111.159 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.472 HD12 HG12 ' A' ' 58' ' ' VAL . 11.9 mt -65.41 -36.11 82.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.889 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.542 HD12 HG12 ' A' ' 59' ' ' VAL . 11.3 mt -67.79 -45.19 75.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.912 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 60' ' ' GLY . 99.9 t -61.53 -37.71 78.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.101 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 61' ' ' ILE . 89.4 t -63.95 -51.84 64.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.12 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.54 ' O ' HG23 ' A' ' 70' ' ' VAL . 60.2 t -62.64 -53.45 46.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.17 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.1 mt -60.37 -33.62 72.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.897 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.08 -48.25 81.7 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.474 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.3 t -75.07 -32.93 27.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.913 0.387 . . . . 0.0 111.115 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 66' ' ' VAL . 56.5 t -70.1 -52.13 33.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.164 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -63.08 -43.37 98.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.9 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.57 -48.67 83.21 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.472 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 58.1 mt . . . . . 0 C--N 1.328 -0.335 0 CA-C-O 120.91 0.386 . . . . 0.0 111.15 -179.989 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.851 0.358 . . . . 0.0 111.116 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 11.0 tp -65.55 -53.84 36.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.944 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 155' ' ' LEU . . . . . 0.708 ' O ' HG23 ' B' ' 159' ' ' VAL . 18.3 tp -52.74 -54.87 27.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 156' ' ' LEU . . . . . 0.708 ' O ' HG23 ' B' ' 160' ' ' VAL . 4.1 mt -53.4 -44.12 68.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.927 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 8.0 tp -54.98 -48.07 73.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.905 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.91 -39.51 87.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.933 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . 0.708 HG23 ' O ' ' B' ' 155' ' ' LEU . 50.0 t -63.52 -48.43 86.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.132 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . 0.708 HG23 ' O ' ' B' ' 156' ' ' LEU . 37.1 t -64.37 -47.45 89.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.177 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.77 -35.73 66.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.084 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.36 -38.85 65.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.37 -40.85 54.1 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.453 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 54.6 mt -73.6 -38.53 52.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.88 0.371 . . . . 0.0 111.112 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.71 -39.14 86.33 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.495 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 10.6 mt -71.66 -40.14 69.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.836 0.351 . . . . 0.0 110.926 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -68.79 -37.46 79.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.32 -28.61 61.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.872 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.888 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.3 m . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 120.892 0.377 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.05 -50.38 68.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.089 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 62.1 t -53.04 -37.32 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.119 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 92.0 t -71.09 -37.83 68.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.129 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.669 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -62.78 -46.07 94.41 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.438 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.706 ' O ' HG23 ' A' ' 65' ' ' VAL . 3.2 mp -70.7 -42.36 77.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.822 0.344 . . . . 0.0 111.105 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.434 ' O ' HG23 ' A' ' 66' ' ' VAL . 12.1 mt -65.41 -36.01 82.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.4 mt -67.69 -45.65 74.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.969 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 60' ' ' GLY . 99.8 t -61.14 -38.05 78.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.075 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 61' ' ' ILE . 89.5 t -63.56 -52.36 58.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.137 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.552 ' O ' HG23 ' A' ' 70' ' ' VAL . 60.2 t -61.99 -53.47 47.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.072 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.34 -32.9 71.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.78 -48.39 77.32 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.49 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.477 HG12 HD12 ' A' ' 73' ' ' ILE . 94.2 t -74.45 -33.38 32.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.86 0.362 . . . . 0.0 111.085 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 66' ' ' VAL . 72.6 t -70.32 -51.33 39.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.073 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -62.49 -46.25 89.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.905 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -57.35 -48.85 77.48 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.507 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.477 HD12 HG12 ' A' ' 69' ' ' VAL . 61.0 mt . . . . . 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 0.0 111.118 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.826 0.346 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 2.2 tt -63.87 -54.91 27.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 155' ' ' LEU . . . . . 0.706 ' O ' HG23 ' B' ' 159' ' ' VAL . 0.4 OUTLIER -51.96 -56.53 13.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.917 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 156' ' ' LEU . . . . . 0.705 ' O ' HG23 ' B' ' 160' ' ' VAL . 14.3 mt -52.18 -45.7 65.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.899 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 4.3 tt -54.87 -47.21 74.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.86 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 5.2 tp -67.78 -39.3 84.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . 0.706 HG23 ' O ' ' B' ' 155' ' ' LEU . 54.7 t -63.77 -47.92 88.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.131 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . 0.705 HG23 ' O ' ' B' ' 156' ' ' LEU . 36.6 t -64.46 -47.7 88.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.148 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.61 -36.37 66.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.121 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.37 -38.37 65.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.929 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.05 -41.0 55.66 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.468 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 58.2 mt -74.04 -39.28 50.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.901 0.381 . . . . 0.0 111.126 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -67.54 -38.46 90.57 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.484 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 12.5 mt -72.43 -42.13 65.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.886 0.374 . . . . 0.0 110.937 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -65.95 -38.03 87.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.867 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.15 -26.39 53.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.884 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.927 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.3 m . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.855 0.36 . . . . 0.0 110.798 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.93 -50.8 67.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.065 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.563 HG12 HD12 ' A' ' 62' ' ' LEU . 62.7 t -53.04 -37.71 27.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.155 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.439 HG12 HD12 ' A' ' 63' ' ' LEU . 92.3 t -70.46 -37.87 71.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.148 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.674 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -62.83 -46.09 94.35 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.474 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.711 ' O ' HG23 ' A' ' 65' ' ' VAL . 3.2 mp -70.78 -42.29 77.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.865 0.364 . . . . 0.0 111.132 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.563 HD12 HG12 ' A' ' 58' ' ' VAL . 11.2 mt -65.41 -36.02 82.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.439 HD12 HG12 ' A' ' 59' ' ' VAL . 12.1 mt -67.71 -45.64 74.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.932 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 60' ' ' GLY . 99.6 t -61.02 -38.15 78.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.121 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 61' ' ' ILE . 92.1 t -63.52 -52.29 59.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.156 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.551 ' O ' HG23 ' A' ' 70' ' ' VAL . 60.2 t -62.12 -53.51 46.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.116 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.39 -32.43 71.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.29 -48.2 76.85 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.495 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.478 HG12 HD12 ' A' ' 73' ' ' ILE . 92.7 t -74.92 -33.22 29.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.854 0.359 . . . . 0.0 111.106 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 66' ' ' VAL . 74.6 t -70.72 -52.77 25.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.171 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -61.68 -46.23 90.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.939 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -57.62 -48.9 78.18 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.456 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.478 HD12 HG12 ' A' ' 69' ' ' VAL . 67.9 mt . . . . . 0 C--N 1.328 -0.347 0 CA-C-O 120.87 0.367 . . . . 0.0 111.137 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.791 0.329 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.98 -52.59 48.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.891 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 155' ' ' LEU . . . . . 0.656 ' O ' HG23 ' B' ' 159' ' ' VAL . 0.5 OUTLIER -53.06 -54.7 31.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.896 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 156' ' ' LEU . . . . . 0.703 ' O ' HG23 ' B' ' 160' ' ' VAL . 23.0 mt -52.49 -45.8 66.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 3.2 tt -54.81 -47.37 74.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.946 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.67 -39.25 84.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.909 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . 0.656 HG23 ' O ' ' B' ' 155' ' ' LEU . 67.2 t -63.76 -48.0 88.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.167 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . 0.703 HG23 ' O ' ' B' ' 156' ' ' LEU . 37.1 t -64.44 -47.66 88.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.109 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.59 -36.41 66.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.121 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 2.9 tp -73.32 -38.39 65.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.936 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -71.98 -41.02 55.97 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.454 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 58.2 mt -74.07 -39.41 50.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.855 0.359 . . . . 0.0 111.121 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -67.37 -38.52 91.31 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.513 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 6.7 mt -72.41 -46.02 57.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.806 0.336 . . . . 0.0 110.898 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -61.44 -37.79 84.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.903 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.81 -26.08 54.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.876 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 21.0 mtt180 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.846 -179.905 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.2 m . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.857 0.361 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.1 -49.71 74.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.114 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.761 HG12 HD12 ' A' ' 62' ' ' LEU . 61.5 t -53.05 -37.55 27.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.138 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 90.5 t -70.81 -37.64 69.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.118 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.671 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -62.99 -46.08 94.29 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.441 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.724 ' O ' HG23 ' A' ' 65' ' ' VAL . 3.2 mp -70.79 -42.23 77.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.879 0.371 . . . . 0.0 111.14 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.761 HD12 HG12 ' A' ' 58' ' ' VAL . 6.7 mt -65.39 -36.11 82.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.914 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.4 mt -67.67 -45.66 74.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.936 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 60' ' ' GLY . 97.6 t -61.02 -38.04 78.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.149 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 61' ' ' ILE . 90.3 t -63.58 -52.18 60.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.122 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.548 ' O ' HG23 ' A' ' 70' ' ' VAL . 59.9 t -62.38 -53.49 46.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.091 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.2 mt -60.38 -32.55 71.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.923 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.23 -48.22 76.92 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.488 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.478 HG12 HD12 ' A' ' 73' ' ' ILE . 96.5 t -74.85 -33.16 29.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.845 0.355 . . . . 0.0 111.12 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 66' ' ' VAL . 72.7 t -70.71 -52.88 24.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.163 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -61.64 -46.01 91.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -57.48 -49.08 76.21 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.534 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.478 HD12 HG12 ' A' ' 69' ' ' VAL . 63.7 mt . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 120.891 0.377 . . . . 0.0 111.105 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.84 0.352 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.58 -52.55 64.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.946 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 155' ' ' LEU . . . . . 0.701 ' O ' HG23 ' B' ' 159' ' ' VAL . 3.2 tp -54.93 -54.94 36.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.917 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 156' ' ' LEU . . . . . 0.699 ' O ' HG23 ' B' ' 160' ' ' VAL . 19.7 mt -54.16 -45.27 72.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.903 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 4.9 tt -55.12 -46.96 75.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.94 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.77 -39.64 84.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.888 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . 0.701 HG23 ' O ' ' B' ' 155' ' ' LEU . 58.0 t -63.64 -48.06 88.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.139 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . 0.699 HG23 ' O ' ' B' ' 156' ' ' LEU . 37.2 t -64.7 -47.47 88.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.123 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.88 -35.73 66.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.088 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.28 -38.74 65.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.963 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.49 -40.83 53.43 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.469 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 54.7 mt -73.66 -38.31 51.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.905 0.383 . . . . 0.0 111.104 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.95 -39.1 85.37 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.491 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 11.6 mt -71.59 -40.42 69.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.885 0.374 . . . . 0.0 110.962 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -68.33 -37.68 80.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.936 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.48 -27.23 58.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.872 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.856 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.9 m . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.871 0.367 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.5 -49.21 78.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.099 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.738 HG12 HD12 ' A' ' 62' ' ' LEU . 62.5 t -53.11 -37.55 27.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.138 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 89.8 t -70.62 -37.93 71.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.135 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.682 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -62.79 -46.1 94.34 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.503 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.71 ' O ' HG23 ' A' ' 65' ' ' VAL . 3.2 mp -70.7 -42.3 77.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.87 0.367 . . . . 0.0 111.169 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.738 HD12 HG12 ' A' ' 58' ' ' VAL . 7.7 mt -65.37 -36.15 83.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.918 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.4 mt -67.69 -45.32 75.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.896 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 60' ' ' GLY . 96.7 t -61.42 -37.82 78.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.133 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 61' ' ' ILE . 90.1 t -63.85 -51.9 63.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.108 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.548 ' O ' HG23 ' A' ' 70' ' ' VAL . 60.2 t -62.6 -53.53 45.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.094 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.47 -32.7 71.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.877 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.99 -47.93 80.88 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.49 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.432 HG12 HD12 ' A' ' 73' ' ' ILE . 95.2 t -75.11 -32.87 27.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.846 0.355 . . . . 0.0 111.11 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 66' ' ' VAL . 73.7 t -70.9 -53.05 23.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.102 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -62.11 -44.16 97.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.868 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.56 -49.47 76.66 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.457 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.432 HD12 HG12 ' A' ' 69' ' ' VAL . 59.6 mt . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 120.87 0.366 . . . . 0.0 111.145 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.85 0.357 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 2.6 tp -64.84 -48.62 73.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.957 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 155' ' ' LEU . . . . . 0.718 ' O ' HG23 ' B' ' 159' ' ' VAL . 0.8 OUTLIER -52.91 -55.6 22.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.888 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 156' ' ' LEU . . . . . 0.699 ' O ' HG23 ' B' ' 160' ' ' VAL . 27.4 mt -53.7 -44.34 69.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.879 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.11 -47.19 75.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.93 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.37 -39.95 85.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.954 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . 0.718 HG23 ' O ' ' B' ' 155' ' ' LEU . 45.1 t -63.51 -48.18 88.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.12 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . 0.699 HG23 ' O ' ' B' ' 156' ' ' LEU . 38.5 t -64.69 -47.48 88.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.157 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.92 -35.31 66.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.152 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.32 -39.06 65.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.941 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.47 -41.03 53.08 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.531 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 54.3 mt -73.2 -38.08 53.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.875 0.369 . . . . 0.0 111.136 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -69.54 -39.12 79.38 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.497 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 5.9 mt -71.4 -38.74 71.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.807 0.337 . . . . 0.0 110.879 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -69.69 -37.02 76.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.902 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -72.55 -35.33 67.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.884 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.878 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.2 m . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.875 0.369 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.13 -51.0 59.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.1 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.557 ' O ' HD13 ' A' ' 62' ' ' LEU . 66.0 t -53.14 -46.2 55.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.129 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 84.8 t -64.96 -36.19 77.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.139 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.67 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -61.69 -46.08 94.96 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.506 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.713 ' O ' HG23 ' A' ' 65' ' ' VAL . 2.8 mp -70.68 -42.92 77.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.799 0.333 . . . . 0.0 111.091 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.557 HD13 ' O ' ' A' ' 58' ' ' VAL . 8.5 mp -65.07 -35.84 82.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.5 mt -67.8 -45.12 75.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 60' ' ' GLY . 95.4 t -62.06 -36.81 76.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.107 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 61' ' ' ILE . 89.7 t -64.56 -51.74 63.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.139 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.555 ' O ' HG23 ' A' ' 70' ' ' VAL . 60.4 t -62.65 -53.34 48.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.122 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.3 mt -60.24 -37.42 80.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.09 -50.52 66.98 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.499 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.0 t -70.95 -39.53 75.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.859 0.362 . . . . 0.0 111.126 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 66' ' ' VAL . 62.8 t -62.53 -53.15 50.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.144 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -61.93 -39.94 93.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.888 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -55.65 -49.56 64.91 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.46 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 64.4 mt . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 120.862 0.363 . . . . 0.0 111.153 -179.957 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.799 0.333 . . . . 0.0 111.121 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.96 -46.75 87.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.861 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 155' ' ' LEU . . . . . 0.7 ' O ' HG23 ' B' ' 159' ' ' VAL . 4.3 tp -54.59 -53.61 52.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.898 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 156' ' ' LEU . . . . . 0.702 ' O ' HG23 ' B' ' 160' ' ' VAL . 3.3 mt -56.75 -44.79 82.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.939 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 1.1 tt -54.99 -46.98 75.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.906 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 1.1 tt -67.64 -39.82 84.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.953 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . 0.7 HG23 ' O ' ' B' ' 155' ' ' LEU . 93.2 t -63.58 -48.04 88.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.108 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . 0.702 HG23 ' O ' ' B' ' 156' ' ' LEU . 38.2 t -64.69 -47.45 88.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.128 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.85 -35.74 66.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.103 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 1.4 tp -73.37 -38.77 65.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.934 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.37 -40.82 54.17 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.47 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 54.5 mt -73.59 -38.53 52.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.872 0.367 . . . . 0.0 111.134 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -67.88 -40.64 89.25 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.476 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 7.5 mt -70.36 -42.44 71.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.887 0.375 . . . . 0.0 110.924 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -65.88 -37.49 86.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.835 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.0 -26.32 59.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.911 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.847 -179.94 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.8 m . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.848 0.356 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.77 -51.27 60.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.115 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.5 t -53.04 -37.74 27.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.097 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 81.7 t -71.32 -37.12 64.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.124 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.682 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -62.87 -46.01 94.49 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.494 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.715 ' O ' HG23 ' A' ' 65' ' ' VAL . 3.2 mp -70.76 -42.43 77.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.84 0.352 . . . . 0.0 111.103 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.453 ' O ' HG23 ' A' ' 66' ' ' VAL . 12.1 mt -65.33 -35.91 82.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.953 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.4 mt -67.86 -45.5 74.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.941 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 60' ' ' GLY . 98.4 t -61.33 -37.68 78.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.139 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 61' ' ' ILE . 87.9 t -64.05 -51.42 69.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.121 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.551 ' O ' HG23 ' A' ' 70' ' ' VAL . 61.9 t -63.3 -53.59 43.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.155 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mt -60.44 -32.57 71.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.936 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.2 -47.97 79.62 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.475 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.471 HG12 HD12 ' A' ' 73' ' ' ILE . 95.7 t -75.08 -33.01 27.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.883 0.373 . . . . 0.0 111.125 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 66' ' ' VAL . 73.4 t -70.89 -53.04 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.145 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -62.03 -45.1 95.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.835 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.13 -49.02 79.35 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.451 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.471 HD12 HG12 ' A' ' 69' ' ' VAL . 63.9 mt . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 120.868 0.366 . . . . 0.0 111.157 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.806 0.336 . . . . 0.0 111.098 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 1.1 tp -60.94 -55.32 34.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.953 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 155' ' ' LEU . . . . . 0.694 ' O ' HG23 ' B' ' 159' ' ' VAL . 0.3 OUTLIER -54.31 -55.08 31.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.929 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 156' ' ' LEU . . . . . 0.699 ' O ' HG23 ' B' ' 160' ' ' VAL . 13.5 mt -51.94 -45.5 64.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.955 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 157' ' ' LEU . . . . . 0.441 ' O ' HD13 ' B' ' 157' ' ' LEU . 0.3 OUTLIER -55.06 -46.56 75.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.914 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 158' ' ' LEU . . . . . 0.504 ' O ' HD23 ' B' ' 158' ' ' LEU . 3.5 tt -68.03 -39.65 83.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.903 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . 0.694 HG23 ' O ' ' B' ' 155' ' ' LEU . 47.1 t -63.85 -47.81 89.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.151 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . 0.699 HG23 ' O ' ' B' ' 156' ' ' LEU . 37.9 t -64.8 -47.41 88.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.121 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.9 -36.17 67.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.11 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.4 -38.48 65.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.919 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.09 -41.24 54.72 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.509 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 58.1 mt -73.64 -39.16 53.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.894 0.378 . . . . 0.0 111.122 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -67.74 -38.59 89.85 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.483 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 12.5 mt -72.64 -38.83 67.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.898 0.38 . . . . 0.0 110.947 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -67.88 -39.88 83.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.856 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.05 -55.12 6.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.88 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.862 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.6 m . . . . . 0 N--CA 1.458 -0.062 0 CA-C-O 120.923 0.392 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.76 -48.97 78.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.087 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 62.5 t -53.2 -40.46 38.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.15 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 66.8 t -69.55 -35.19 65.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.101 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.598 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -63.97 -46.11 92.28 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.47 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.708 ' O ' HG23 ' A' ' 65' ' ' VAL . 3.1 mp -70.87 -43.15 77.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.912 0.387 . . . . 0.0 111.143 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.566 ' O ' HG23 ' A' ' 66' ' ' VAL . 3.5 mm? -65.27 -32.96 74.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.929 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.872 HD13 HD12 ' B' ' 157' ' ' LEU . 12.6 mt -69.37 -48.65 60.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.91 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 60' ' ' GLY . 91.7 t -59.22 -38.39 74.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.136 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 61' ' ' ILE . 91.1 t -63.88 -51.35 70.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.155 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 62' ' ' LEU . 61.3 t -63.02 -53.53 45.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.139 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mt -60.5 -32.97 71.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.912 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.74 -47.69 84.07 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.534 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.5 t -75.08 -32.91 27.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.839 0.352 . . . . 0.0 111.152 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 66' ' ' VAL . 73.8 t -70.81 -53.05 23.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.107 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -62.6 -42.57 99.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -59.34 -49.59 76.91 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.498 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 55.7 mt . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 120.813 0.339 . . . . 0.0 111.056 -179.918 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.816 0.341 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 2.5 tp -64.12 -51.95 61.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.923 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 155' ' ' LEU . . . . . 0.705 ' O ' HG23 ' B' ' 159' ' ' VAL . 5.7 tp -52.31 -49.93 63.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.897 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 156' ' ' LEU . . . . . 0.705 ' O ' HG23 ' B' ' 160' ' ' VAL . 69.5 mt -57.37 -44.23 84.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.92 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 157' ' ' LEU . . . . . 0.872 HD12 HD13 ' A' ' 63' ' ' LEU . 5.1 tt -55.04 -47.52 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.899 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 2.7 tt -67.1 -39.98 86.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.909 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . 0.705 HG23 ' O ' ' B' ' 155' ' ' LEU . 91.0 t -63.42 -48.22 88.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.173 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . 0.705 HG23 ' O ' ' B' ' 156' ' ' LEU . 38.5 t -64.63 -47.37 89.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.113 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.85 -35.63 66.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.071 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 6.3 tp -73.4 -38.85 65.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.885 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.39 -40.78 54.12 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.456 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 54.6 mt -73.66 -38.49 51.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.894 0.378 . . . . 0.0 111.124 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.16 -40.1 88.15 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.54 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 11.8 mt -70.84 -41.72 71.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.837 0.351 . . . . 0.0 110.928 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -67.12 -37.36 83.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.87 -26.02 60.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.852 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.88 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 51.1 m . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.885 0.374 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.48 -51.09 64.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.11 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.595 HG12 HD12 ' A' ' 62' ' ' LEU . 78.1 t -53.18 -38.38 30.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.193 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.656 HG12 HD12 ' A' ' 63' ' ' LEU . 93.2 t -69.94 -38.03 74.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.151 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.688 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -62.48 -46.14 94.42 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.536 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.71 ' O ' HG23 ' A' ' 65' ' ' VAL . 3.2 mp -70.62 -42.68 77.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.868 0.366 . . . . 0.0 111.133 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.595 HD12 HG12 ' A' ' 58' ' ' VAL . 10.2 mt -65.14 -35.97 82.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.922 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.656 HD12 HG12 ' A' ' 59' ' ' VAL . 10.1 mt -67.72 -45.8 73.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.903 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.688 HG23 ' O ' ' A' ' 60' ' ' GLY . 92.2 t -60.93 -37.96 78.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.172 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 61' ' ' ILE . 95.4 t -63.65 -51.89 64.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.121 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.554 ' O ' HG23 ' A' ' 70' ' ' VAL . 62.0 t -62.39 -53.48 46.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.137 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mt -60.32 -33.83 72.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.89 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.84 -49.08 75.76 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.483 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.469 HG12 HD12 ' A' ' 73' ' ' ILE . 94.0 t -73.12 -32.84 40.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.887 0.375 . . . . 0.0 111.17 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 66' ' ' VAL . 70.0 t -70.37 -45.76 73.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.124 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -63.92 -48.61 75.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.838 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -57.16 -49.54 71.4 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.493 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.469 HD12 HG12 ' A' ' 69' ' ' VAL . 62.3 mt . . . . . 0 C--N 1.329 -0.321 0 CA-C-O 120.82 0.343 . . . . 0.0 111.11 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 153' ' ' ALA . . . . . 0.503 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.869 0.366 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 1.4 tt -68.45 -45.58 72.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.94 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 155' ' ' LEU . . . . . 0.623 ' O ' HG23 ' B' ' 159' ' ' VAL . 19.6 tp -60.55 -55.35 34.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.928 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 156' ' ' LEU . . . . . 0.707 ' O ' HG23 ' B' ' 160' ' ' VAL . 32.7 mt -51.95 -47.16 64.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.897 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.33 -46.36 72.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.902 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.36 -39.79 81.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . 0.623 HG23 ' O ' ' B' ' 155' ' ' LEU . 92.2 t -63.44 -47.63 90.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.109 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . 0.707 HG23 ' O ' ' B' ' 156' ' ' LEU . 34.8 t -64.01 -47.97 88.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.112 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.17 -36.98 66.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.101 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 4.6 tp -73.25 -38.13 66.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -71.8 -40.98 57.16 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.467 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 58.1 mt -74.2 -39.77 50.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.84 0.353 . . . . 0.0 111.087 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -66.78 -38.39 93.02 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.528 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 12.4 mt -72.26 -45.47 60.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.843 0.354 . . . . 0.0 110.93 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -60.52 -37.7 82.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.94 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.91 -25.67 59.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.86 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.92 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.529 -0.229 . . . . 0.0 112.529 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.2 m -85.94 160.5 52.34 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.578 0.704 . . . . 0.0 110.939 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 144.42 54.05 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.717 2.278 . . . . 0.0 112.327 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.38 170.17 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.14 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -71.42 177.87 3.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.888 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -159.2 177.86 10.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.892 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -174.03 38.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.851 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -156.03 -174.4 4.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.131 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.2 t 62.33 72.58 0.61 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.647 0.737 . . . . 0.0 110.86 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -15.51 37.05 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.655 2.236 . . . . 0.0 112.32 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.86 -16.11 61.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.893 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.668 HG21 ' HB ' ' B' ' 148' ' ' THR . 3.9 m -76.32 -35.74 58.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.143 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.7 t -67.41 -36.68 81.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.849 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.655 ' O ' HG23 ' A' ' 58' ' ' VAL . 85.6 mt -66.52 -51.58 55.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.127 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.696 ' O ' HG23 ' A' ' 59' ' ' VAL . 60.5 mt -55.75 -42.16 68.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.112 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.7 m -59.91 -50.8 72.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.892 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.81 -48.45 81.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.12 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 54' ' ' ILE . 62.1 t -53.1 -38.13 29.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.131 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 55' ' ' ILE . 64.8 t -70.25 -37.42 71.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.11 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.635 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -63.12 -46.09 94.02 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.525 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.698 ' O ' HG23 ' A' ' 65' ' ' VAL . 3.2 mp -70.9 -42.38 77.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.874 0.369 . . . . 0.0 111.117 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.491 ' O ' HG23 ' A' ' 66' ' ' VAL . 12.1 mt -65.43 -34.94 79.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.888 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.422 HD12 HG12 ' A' ' 59' ' ' VAL . 12.0 mt -68.41 -46.76 69.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.936 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 60' ' ' GLY . 97.0 t -60.3 -38.3 77.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.118 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 61' ' ' ILE . 89.9 t -63.65 -51.82 65.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.125 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.556 ' O ' HG23 ' A' ' 70' ' ' VAL . 62.0 t -62.52 -53.58 45.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.114 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.9 mt -60.33 -32.83 71.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.929 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.89 -47.92 81.29 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.458 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.433 HG12 HD12 ' A' ' 73' ' ' ILE . 95.6 t -75.07 -33.02 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.816 0.341 . . . . 0.0 111.08 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 66' ' ' VAL . 73.9 t -70.71 -53.05 23.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.118 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.488 ' CE2' HD11 ' A' ' 75' ' ' ILE . 4.7 t80 -61.95 -44.29 97.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.5 -49.5 76.18 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.505 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.433 HD12 HG12 ' A' ' 69' ' ' VAL . 58.9 mt -70.13 -25.98 28.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.879 0.371 . . . . 0.0 111.135 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.6 mt -70.21 -36.8 74.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.95 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.488 HD11 ' CE2' ' A' ' 71' ' ' PHE . 78.0 mt -84.51 -37.44 12.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.1 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.35 -47.37 75.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.889 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.19 -33.47 41.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.892 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.3 ttm180 -71.27 -34.46 70.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -67.75 -68.22 0.4 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -155.64 171.99 19.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.1 118.92 24.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.91 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 7.7 tp -104.32 -29.25 2.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.133 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -82.23 60.07 4.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.882 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 21.0 mttt . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.908 -179.982 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.932 0.396 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 160.7 -166.28 35.41 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.512 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 136' ' ' CYS . . . . . . . . . . . . . 60.1 m 55.65 72.02 1.12 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.646 0.736 . . . . 0.0 110.875 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -18.95 36.74 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.71 2.274 . . . . 0.0 112.329 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 138' ' ' THR . . . . . . . . . . . . . 1.1 m 63.15 29.67 16.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.131 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 61.8 -177.91 0.12 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.899 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -167.02 -83.66 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.499 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 141' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 82.04 0.77 Allowed 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.723 2.282 . . . . 0.0 112.328 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 142' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -151.69 119.91 6.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.895 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 0.664 HG23 ' HA ' ' B' ' 144' ' ' PRO . 51.0 mm -51.84 137.16 35.38 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.652 0.739 . . . . 0.0 111.14 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 144' ' ' PRO . . . . . 0.664 ' HA ' HG23 ' B' ' 143' ' ' ILE . 53.5 Cg_endo -69.8 157.54 92.06 Favored 'Cis proline' 0 C--N 1.342 0.201 0 C-N-CA 122.719 -1.784 . . . . 0.0 112.316 -0.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 11.5 t -177.33 -75.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.857 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 32.5 mm -82.71 -25.5 8.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.148 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -52.5 -30.99 33.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.114 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . 0.668 ' HB ' HG21 ' A' ' 52' ' ' THR . 72.6 m -53.05 -29.99 33.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.21 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . -55.32 -54.77 32.12 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.486 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 150' ' ' MET . . . . . . . . . . . . . 29.6 mmt -58.16 -51.02 71.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.795 0.331 . . . . 0.0 110.902 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 59.3 t -56.61 -40.35 68.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.129 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -62.06 -42.18 99.72 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.453 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -65.36 -43.67 90.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.841 0.353 . . . . 0.0 111.117 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.51 -53.79 31.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.954 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 155' ' ' LEU . . . . . 0.607 ' O ' HG23 ' B' ' 159' ' ' VAL . 0.4 OUTLIER -52.1 -55.43 20.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 156' ' ' LEU . . . . . 0.703 ' O ' HG23 ' B' ' 160' ' ' VAL . 10.8 mt -52.2 -45.22 65.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.922 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 1.4 tt -55.05 -46.99 75.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.942 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.78 -39.51 84.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.922 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . 0.607 HG23 ' O ' ' B' ' 155' ' ' LEU . 69.6 t -63.8 -47.98 88.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.068 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . 0.703 HG23 ' O ' ' B' ' 156' ' ' LEU . 36.5 t -64.76 -47.54 88.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.132 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.91 -35.69 66.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.046 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 1.7 tp -73.32 -38.82 65.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.887 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.4 -40.91 53.77 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.529 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 54.8 mt -73.59 -38.31 51.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.857 0.36 . . . . 0.0 111.104 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -69.06 -39.03 84.6 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.467 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 10.9 mt -71.66 -39.6 70.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.907 0.384 . . . . 0.0 110.907 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -69.41 -37.62 77.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.864 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.42 -28.58 59.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.88 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 14.2 ttt180 -85.05 -24.74 28.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.92 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -25.02 58.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.855 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 171' ' ' ARG . . . . . 0.408 ' NE ' HD12 ' B' ' 173' ' ' ILE . 74.1 mtm180 -94.79 21.22 7.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.857 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 172' ' ' HIS . . . . . . . . . . . . . 48.6 t60 53.43 31.79 12.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.86 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 173' ' ' ILE . . . . . 0.408 HD12 ' NE ' ' B' ' 171' ' ' ARG . 81.9 mt -95.02 88.27 2.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.102 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 174' ' ' VAL . . . . . 0.461 HG22 ' H ' ' B' ' 176' ' ' LYS . 7.6 p -104.86 141.71 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.163 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 175' ' ' ARG . . . . . . . . . . . . . 8.5 ptt180 -76.24 -36.94 58.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.877 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . 0.461 ' H ' HG22 ' B' ' 174' ' ' VAL . 2.0 tppm? -156.35 147.54 22.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.883 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.846 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -70.37 160.54 80.82 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.61 0.719 . . . . 0.0 110.851 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 108.68 2.13 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.713 2.276 . . . . 0.0 112.366 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.89 -169.74 0.19 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.13 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -174.11 139.35 0.63 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -164.95 -178.99 5.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.887 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -164.91 82.91 0.38 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.89 -4.16 39.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.093 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.4 t -155.01 70.55 5.73 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.679 0.752 . . . . 0.0 110.856 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -15.57 37.32 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.703 2.269 . . . . 0.0 112.361 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.51 ' HA ' HD12 ' A' ' 54' ' ' ILE . 0.2 OUTLIER -72.76 -16.18 61.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.846 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.0 m -76.28 -34.85 59.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.119 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 t -68.96 -38.72 79.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.876 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.689 ' O ' HG23 ' A' ' 58' ' ' VAL . 43.6 mt -60.59 -45.94 96.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.117 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.645 ' O ' HG23 ' A' ' 59' ' ' VAL . 65.7 mt -56.82 -46.21 83.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.135 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.8 m -58.56 -45.16 89.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.872 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.58 -50.55 64.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.072 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 54' ' ' ILE . 66.1 t -53.2 -44.75 53.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.128 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 55' ' ' ILE . 65.6 t -65.9 -35.53 75.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.127 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.615 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -62.83 -46.23 94.06 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.47 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.722 ' O ' HG23 ' A' ' 65' ' ' VAL . 2.9 mp -70.6 -42.85 78.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.893 0.378 . . . . 0.0 111.088 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.554 HD13 ' O ' ' A' ' 58' ' ' VAL . 8.5 mp -65.23 -35.25 80.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.92 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.994 HD13 HD22 ' B' ' 157' ' ' LEU . 12.5 mt -67.84 -46.33 72.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.931 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 60' ' ' GLY . 84.9 t -60.89 -37.88 77.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.1 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 61' ' ' ILE . 89.7 t -63.38 -53.02 50.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.127 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.549 ' O ' HG23 ' A' ' 70' ' ' VAL . 59.9 t -61.12 -53.39 49.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.161 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 mt -60.3 -33.33 72.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.937 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.25 -47.96 83.43 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.486 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.493 HG12 HD12 ' A' ' 73' ' ' ILE . 96.8 t -74.91 -33.22 29.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.873 0.368 . . . . 0.0 111.079 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 66' ' ' VAL . 72.7 t -70.37 -46.93 69.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.074 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -64.56 -48.84 73.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.911 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -56.62 -47.27 85.9 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.472 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.493 HD12 HG12 ' A' ' 69' ' ' VAL . 67.4 mt -72.02 -26.25 24.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.896 0.379 . . . . 0.0 111.13 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.544 HD12 HG12 ' A' ' 70' ' ' VAL . 11.8 mt -69.77 -37.59 76.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.924 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 51.4 mt -70.82 -35.17 59.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.152 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.1 -50.94 67.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.932 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.9 mtt85 -74.88 -23.56 58.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -64.92 -69.84 0.27 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -67.88 -74.92 0.11 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.924 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -160.42 -74.84 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.891 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -165.02 65.49 0.13 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 24.5 mt 64.57 68.25 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.099 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -165.01 151.82 10.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.879 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.9 tttm . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.891 179.973 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.866 0.365 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -110.54 -137.64 7.6 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.463 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 136' ' ' CYS . . . . . . . . . . . . . 1.8 m 58.28 69.88 1.37 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.61 0.719 . . . . 0.0 110.907 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.85 107.94 1.99 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.645 2.23 . . . . 0.0 112.318 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 138' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.54 101.39 3.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.161 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -155.19 176.16 12.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.884 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -131.53 176.31 19.22 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.506 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 141' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 100.68 0.83 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.719 2.28 . . . . 0.0 112.354 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 142' ' ' LYS . . . . . . . . . . . . . 3.9 tttm -148.77 38.52 0.84 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.877 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 0.58 HG23 ' HA ' ' B' ' 144' ' ' PRO . 2.8 mt 65.02 135.4 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.629 0.728 . . . . 0.0 111.12 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 144' ' ' PRO . . . . . 0.58 ' HA ' HG23 ' B' ' 143' ' ' ILE . 53.6 Cg_endo -69.8 159.09 90.38 Favored 'Cis proline' 0 C--N 1.342 0.196 0 C-N-CA 122.617 -1.826 . . . . 0.0 112.374 -0.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 2.1 t 177.46 -33.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.874 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 34.3 mt -123.33 -32.94 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.135 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.16 -24.01 60.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.105 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 93.3 m -53.35 -27.95 26.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.17 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . -55.52 -54.49 34.26 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.49 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 150' ' ' MET . . . . . . . . . . . . . 18.0 mmt -61.81 -46.6 88.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.784 0.326 . . . . 0.0 110.839 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 59.9 t -55.96 -40.54 63.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.089 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -66.45 -42.17 93.91 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.478 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -60.25 -45.65 92.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.792 0.33 . . . . 0.0 111.125 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 11.9 tp -68.18 -50.02 57.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.915 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 155' ' ' LEU . . . . . 0.629 ' O ' HG23 ' B' ' 159' ' ' VAL . 7.8 tp -57.36 -53.4 58.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.927 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 156' ' ' LEU . . . . . 0.696 ' O ' HG23 ' B' ' 160' ' ' VAL . 16.5 mt -53.28 -45.73 68.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 157' ' ' LEU . . . . . 0.994 HD22 HD13 ' A' ' 63' ' ' LEU . 12.4 tp -54.96 -46.4 75.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.92 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 1.3 tt -68.05 -39.94 82.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.871 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . 0.629 HG23 ' O ' ' B' ' 155' ' ' LEU . 74.6 t -63.59 -48.02 88.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.129 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . 0.696 HG23 ' O ' ' B' ' 156' ' ' LEU . 36.0 t -64.59 -47.5 88.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.101 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.87 -35.82 66.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.073 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 1.3 tp -73.33 -38.8 65.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.916 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.19 -40.89 55.05 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.505 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 54.8 mt -73.63 -38.75 52.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.907 0.384 . . . . 0.0 111.107 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -67.27 -40.95 92.13 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.471 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 11.5 mt -70.32 -41.08 73.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.853 0.359 . . . . 0.0 110.894 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -67.54 -37.43 82.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.878 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.65 -25.69 57.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.902 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 3.2 mmt85 -82.23 -14.24 55.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.897 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.13 -24.82 43.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.861 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -144.86 25.74 1.42 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.833 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 172' ' ' HIS . . . . . 0.558 ' C ' HD12 ' B' ' 173' ' ' ILE . 0.6 OUTLIER 51.91 32.87 10.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.869 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 173' ' ' ILE . . . . . 0.558 HD12 ' C ' ' B' ' 172' ' ' HIS . 3.9 mp 63.15 98.29 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.141 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 12.6 m -104.99 24.67 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.118 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 175' ' ' ARG . . . . . . . . . . . . . 8.3 mtp85 -84.96 -59.46 2.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.922 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -169.6 -64.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.88 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.872 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 63.09 160.53 0.12 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.636 0.731 . . . . 0.0 110.869 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 82.57 0.74 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.702 2.268 . . . . 0.0 112.357 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -174.93 50.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.089 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -156.57 -44.43 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.866 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 61.97 102.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.896 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.7 ttp180 -64.98 -169.86 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.881 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -155.1 90.02 1.25 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.062 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.1 t 66.85 142.57 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.691 0.757 . . . . 0.0 110.857 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -12.45 32.87 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.661 2.241 . . . . 0.0 112.333 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.409 ' HA ' HD12 ' A' ' 54' ' ' ILE . 0.3 OUTLIER -67.21 -17.04 64.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.898 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.7 m -75.98 -38.2 57.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.15 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.6 t -66.35 -40.57 89.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.891 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.659 ' O ' HG23 ' A' ' 58' ' ' VAL . 70.3 mt -56.32 -42.7 74.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.161 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.621 ' O ' HG23 ' A' ' 59' ' ' VAL . 67.6 mt -57.35 -45.71 85.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.129 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.6 m -60.99 -44.65 97.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.11 -51.15 62.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.133 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 54' ' ' ILE . 97.5 t -53.35 -46.75 58.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.106 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 55' ' ' ILE . 87.5 t -63.32 -35.88 73.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.137 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.593 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -62.95 -46.3 93.85 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.444 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.696 ' O ' HG23 ' A' ' 65' ' ' VAL . 2.8 mp -71.12 -42.85 75.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.814 0.34 . . . . 0.0 111.118 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.592 ' O ' HG23 ' A' ' 66' ' ' VAL . 4.0 mm? -65.32 -32.92 74.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.5 mt -69.55 -49.26 55.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.934 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 60' ' ' GLY . 95.3 t -58.36 -39.05 72.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.122 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 61' ' ' ILE . 93.5 t -63.7 -51.04 75.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.121 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 62' ' ' LEU . 61.2 t -63.31 -53.56 44.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.185 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.0 mt -60.37 -32.84 71.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.926 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.02 -47.92 80.81 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.487 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.466 HG12 HD12 ' A' ' 73' ' ' ILE . 99.5 t -75.01 -32.94 27.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.825 0.345 . . . . 0.0 111.123 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 66' ' ' VAL . 72.6 t -70.76 -51.44 36.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.118 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -62.42 -45.68 91.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.87 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -57.86 -49.2 76.69 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.542 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.466 HD12 HG12 ' A' ' 69' ' ' VAL . 59.8 mt -70.06 -31.17 46.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.87 0.367 . . . . 0.0 111.114 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.7 mt -64.54 -35.23 80.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.924 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 73.2 mt -86.21 -33.48 7.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.157 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.67 -47.61 83.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.857 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -55.07 -28.08 49.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.881 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.5 -26.57 67.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.892 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 68.0 mm-40 -154.7 107.33 2.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -65.96 95.59 0.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.903 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.7 ttmm -94.1 123.83 37.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.931 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 24.1 mt -136.9 -48.21 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.11 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 58.4 -174.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.828 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.856 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.897 0.38 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -129.05 65.24 0.59 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.494 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 136' ' ' CYS . . . . . . . . . . . . . 1.3 m -77.79 160.54 74.11 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.633 0.73 . . . . 0.0 110.857 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -173.03 0.64 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.662 2.241 . . . . 0.0 112.375 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 138' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.09 121.78 11.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.124 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -76.01 -61.29 1.99 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.862 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -155.42 84.9 0.14 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.465 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 141' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -170.76 0.41 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.681 2.254 . . . . 0.0 112.352 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 142' ' ' LYS . . . . . 0.576 ' C ' HD12 ' B' ' 143' ' ' ILE . 1.3 tttt 64.06 108.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 0.576 HD12 ' C ' ' B' ' 142' ' ' LYS . 2.5 mp 49.07 87.93 0.12 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.654 0.74 . . . . 0.0 111.111 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 144' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 159.37 89.78 Favored 'Cis proline' 0 C--N 1.342 0.185 0 C-N-CA 122.686 -1.798 . . . . 0.0 112.316 -0.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 33.2 t 179.28 -77.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.825 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 29.3 mm -105.23 -17.55 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.151 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -82.57 -21.61 35.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.133 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 86.8 m -52.75 -30.32 32.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.137 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . -52.25 -49.37 50.87 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.47 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 150' ' ' MET . . . . . . . . . . . . . 20.8 mmt -61.92 -51.14 69.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.837 0.351 . . . . 0.0 110.87 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 60.8 t -55.57 -40.78 60.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.176 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -62.56 -43.31 99.19 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.467 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -62.1 -46.93 86.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.783 0.325 . . . . 0.0 111.059 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 7.6 tp -61.87 -41.58 98.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.886 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 155' ' ' LEU . . . . . 0.705 ' O ' HG23 ' B' ' 159' ' ' VAL . 0.4 OUTLIER -61.36 -55.03 36.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.926 179.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 156' ' ' LEU . . . . . 0.699 ' O ' HG23 ' B' ' 160' ' ' VAL . 15.9 mt -52.4 -46.36 66.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 3.6 tp -54.69 -46.55 74.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.869 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.09 -40.15 82.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.946 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . 0.705 HG23 ' O ' ' B' ' 155' ' ' LEU . 54.8 t -63.18 -47.74 90.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.105 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . 0.699 HG23 ' O ' ' B' ' 156' ' ' LEU . 36.2 t -64.87 -47.86 86.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.147 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.59 -35.13 65.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.154 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 1.1 tp -72.18 -39.76 68.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.956 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.23 -44.1 44.86 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.545 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 51.9 mt -69.4 -36.97 74.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.879 0.371 . . . . 0.0 111.161 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -71.37 -39.61 61.49 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.501 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 12.6 mt -72.13 -29.75 64.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.878 0.371 . . . . 0.0 110.899 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -81.27 -36.02 30.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.842 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.5 -29.54 61.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.913 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -15.37 58.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 3.8 ppt_? -54.94 -24.89 25.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.877 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.3 -19.56 47.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.902 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 172' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.85 71.95 0.82 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.868 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 27.2 mt -74.7 138.26 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.187 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 63.4 t -135.56 93.59 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.14 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 175' ' ' ARG . . . . . . . . . . . . . 14.7 ptt85 -160.11 -172.21 3.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.879 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.34 125.49 0.75 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.878 179.975 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.456 -0.258 . . . . 0.0 112.456 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 20.4 m 64.37 153.65 0.12 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.605 0.716 . . . . 0.0 110.876 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 86.58 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.681 2.254 . . . . 0.0 112.336 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -175.09 -36.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.095 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 63.96 158.11 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.885 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 62.11 164.96 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.915 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -165.04 -76.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -175.27 -169.06 0.36 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.122 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.0 t 63.95 68.3 0.87 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.607 0.718 . . . . 0.0 110.827 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 -15.61 37.28 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.723 2.282 . . . . 0.0 112.326 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.56 -16.2 61.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.911 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.498 HG21 ' HB ' ' B' ' 148' ' ' THR . 4.0 m -76.16 -34.05 59.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.145 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.6 t -69.04 -36.86 78.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.85 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.67 ' O ' HG23 ' A' ' 58' ' ' VAL . 48.5 mt -66.55 -50.33 67.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.134 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.692 ' O ' HG23 ' A' ' 59' ' ' VAL . 65.4 mt -57.79 -44.52 86.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.156 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.5 m -57.75 -48.47 79.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.847 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.642 ' HA ' HD13 ' B' ' 156' ' ' LEU . . . -62.0 -50.12 73.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.051 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 54' ' ' ILE . 62.5 t -52.99 -37.5 26.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.124 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 55' ' ' ILE . 89.8 t -70.72 -38.01 71.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.148 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.671 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -62.77 -46.03 94.51 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.443 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.715 ' O ' HG23 ' A' ' 65' ' ' VAL . 3.2 mp -70.69 -42.38 77.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.901 0.381 . . . . 0.0 111.159 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.472 HD12 HG12 ' A' ' 58' ' ' VAL . 11.9 mt -65.41 -36.11 82.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.889 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.542 HD12 HG12 ' A' ' 59' ' ' VAL . 11.3 mt -67.79 -45.19 75.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.912 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 60' ' ' GLY . 99.9 t -61.53 -37.71 78.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.101 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 61' ' ' ILE . 89.4 t -63.95 -51.84 64.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.12 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.54 ' O ' HG23 ' A' ' 70' ' ' VAL . 60.2 t -62.64 -53.45 46.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.17 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.1 mt -60.37 -33.62 72.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.897 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.08 -48.25 81.7 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.474 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.3 t -75.07 -32.93 27.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.913 0.387 . . . . 0.0 111.115 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 66' ' ' VAL . 56.5 t -70.1 -52.13 33.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.164 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -63.08 -43.37 98.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.9 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.57 -48.67 83.21 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.472 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 58.1 mt -70.87 -25.51 26.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.91 0.386 . . . . 0.0 111.15 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.1 mt -70.65 -39.75 73.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.891 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 57.0 mt -73.27 -44.87 54.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.1 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.1 mmmm -61.12 -27.64 68.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.875 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.37 -35.15 73.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.889 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -52.35 56.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.896 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -72.68 170.37 14.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.939 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -155.77 70.41 0.71 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.954 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.39 117.08 3.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.934 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.3 mp -93.02 -66.45 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.156 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 57.39 -177.32 0.06 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.891 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 7.5 tttp . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.914 179.943 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 . . . . . 0 CA--C 1.527 0.071 0 CA-C-O 120.873 0.368 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 156.27 -25.72 0.54 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.475 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 136' ' ' CYS . . . . . . . . . . . . . 1.6 m -78.12 160.48 73.42 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.633 0.73 . . . . 0.0 110.871 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -174.7 0.95 Allowed 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.694 2.263 . . . . 0.0 112.353 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 138' ' ' THR . . . . . . . . . . . . . 4.3 p -76.62 -58.84 3.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.161 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -76.12 -73.29 0.28 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.889 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 86.91 170.49 46.87 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.509 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 141' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -177.67 1.99 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.717 2.278 . . . . 0.0 112.35 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 142' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -146.81 66.27 1.17 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.929 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 0.566 HG23 ' HA ' ' B' ' 144' ' ' PRO . 47.5 mm 64.76 135.46 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.661 0.743 . . . . 0.0 111.142 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 144' ' ' PRO . . . . . 0.566 ' HA ' HG23 ' B' ' 143' ' ' ILE . 53.7 Cg_endo -69.77 160.75 87.52 Favored 'Cis proline' 0 C--N 1.341 0.164 0 C-N-CA 122.62 -1.825 . . . . 0.0 112.369 -0.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.4 -76.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.827 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 2.6 mp -84.18 -25.09 7.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.137 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -54.62 -27.57 40.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.118 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . 0.498 ' HB ' HG21 ' A' ' 52' ' ' THR . 70.0 m -52.9 -28.97 25.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.123 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . -56.69 -58.41 14.6 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.524 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 150' ' ' MET . . . . . . . . . . . . . 30.6 mmt -58.25 -45.95 86.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.801 0.334 . . . . 0.0 110.927 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 59.4 t -57.27 -40.26 72.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.12 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -65.8 -41.77 95.48 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.485 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -63.04 -38.3 90.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.851 0.358 . . . . 0.0 111.116 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 11.0 tp -65.55 -53.84 36.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.944 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 155' ' ' LEU . . . . . 0.708 ' O ' HG23 ' B' ' 159' ' ' VAL . 18.3 tp -52.74 -54.87 27.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 156' ' ' LEU . . . . . 0.708 ' O ' HG23 ' B' ' 160' ' ' VAL . 4.1 mt -53.4 -44.12 68.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.927 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 8.0 tp -54.98 -48.07 73.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.905 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.91 -39.51 87.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.933 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . 0.708 HG23 ' O ' ' B' ' 155' ' ' LEU . 50.0 t -63.52 -48.43 86.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.132 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . 0.708 HG23 ' O ' ' B' ' 156' ' ' LEU . 37.1 t -64.37 -47.45 89.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.177 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.77 -35.73 66.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.084 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.36 -38.85 65.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.37 -40.85 54.1 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.453 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 54.6 mt -73.6 -38.53 52.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.88 0.371 . . . . 0.0 111.112 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.71 -39.14 86.33 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.495 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 10.6 mt -71.66 -40.14 69.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.836 0.351 . . . . 0.0 110.926 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -68.79 -37.46 79.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.32 -28.61 61.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.872 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.25 -21.65 59.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.888 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -69.39 -19.94 63.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.867 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 35.7 mtm-85 -144.96 30.86 1.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.882 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 172' ' ' HIS . . . . . 0.496 ' CD2' HG23 ' B' ' 173' ' ' ILE . 0.3 OUTLIER -74.97 -22.49 58.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.812 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 173' ' ' ILE . . . . . 0.496 HG23 ' CD2' ' B' ' 172' ' ' HIS . 34.1 pt -74.93 -25.09 18.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.128 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 174' ' ' VAL . . . . . 0.419 HG13 HG13 ' B' ' 173' ' ' ILE . 28.3 m -98.99 160.11 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.118 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 175' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.25 71.73 2.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.873 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 9.2 mttm 52.66 89.08 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.896 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.852 -179.997 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.7 m -83.99 160.57 57.63 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.595 0.712 . . . . 0.0 110.88 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 149.15 66.48 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.678 2.252 . . . . 0.0 112.363 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.57 -75.18 0.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.073 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -169.89 -45.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.919 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 60.35 -176.67 0.11 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.934 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.0 mpp_? -73.86 177.91 5.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.902 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -169.97 140.65 2.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.101 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.5 t -57.23 147.43 57.31 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.663 0.744 . . . . 0.0 110.869 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 -15.47 37.35 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.7 2.267 . . . . 0.0 112.365 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.88 -16.23 61.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.892 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.9 m -76.28 -35.54 58.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.133 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 t -67.87 -38.98 83.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.85 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.663 ' O ' HG23 ' A' ' 58' ' ' VAL . 49.1 mt -62.53 -48.32 88.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.139 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.695 ' O ' HG23 ' A' ' 59' ' ' VAL . 72.4 mt -59.99 -43.99 93.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.128 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.3 m -56.2 -47.11 78.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.867 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.05 -50.38 68.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.089 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 54' ' ' ILE . 62.1 t -53.04 -37.32 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.119 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.695 HG23 ' O ' ' A' ' 55' ' ' ILE . 92.0 t -71.09 -37.83 68.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.129 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.669 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -62.78 -46.07 94.41 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.438 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.706 ' O ' HG23 ' A' ' 65' ' ' VAL . 3.2 mp -70.7 -42.36 77.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.822 0.344 . . . . 0.0 111.105 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.434 ' O ' HG23 ' A' ' 66' ' ' VAL . 12.1 mt -65.41 -36.01 82.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.4 mt -67.69 -45.65 74.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.969 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 60' ' ' GLY . 99.8 t -61.14 -38.05 78.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.075 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 61' ' ' ILE . 89.5 t -63.56 -52.36 58.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.137 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.552 ' O ' HG23 ' A' ' 70' ' ' VAL . 60.2 t -61.99 -53.47 47.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.072 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.34 -32.9 71.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.78 -48.39 77.32 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.49 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.477 HG12 HD12 ' A' ' 73' ' ' ILE . 94.2 t -74.45 -33.38 32.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.86 0.362 . . . . 0.0 111.085 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 66' ' ' VAL . 72.6 t -70.32 -51.33 39.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.073 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -62.49 -46.25 89.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.905 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -57.35 -48.85 77.48 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.507 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.477 HD12 HG12 ' A' ' 69' ' ' VAL . 61.0 mt -70.83 -25.14 25.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 0.0 111.118 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.422 HD12 HG12 ' A' ' 70' ' ' VAL . 13.4 mt -70.43 -34.42 72.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.94 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 77.9 mt -80.1 -33.16 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.127 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.7 mtmm -78.37 -38.21 42.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.897 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.06 -25.63 62.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.873 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 -64.99 -70.02 0.26 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.851 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -70.85 -74.54 0.14 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.932 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -160.27 -74.62 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.931 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -165.03 -170.11 1.85 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.856 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 6.5 tp -104.94 -30.19 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.153 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 60.16 174.78 0.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.908 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 3.4 tttt . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.946 179.906 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.885 0.374 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 175.07 40.18 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.505 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 136' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -158.76 160.57 29.23 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.597 0.713 . . . . 0.0 110.831 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 175.09 8.6 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.675 2.25 . . . . 0.0 112.32 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 138' ' ' THR . . . . . . . . . . . . . 35.0 p -87.81 134.6 33.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.172 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.72 112.63 3.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.863 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -160.5 171.48 36.69 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.496 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 141' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 172.36 12.8 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.63 2.22 . . . . 0.0 112.363 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 142' ' ' LYS . . . . . . . . . . . . . 27.6 mttt -66.97 96.96 0.46 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.875 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 0.53 ' HA ' ' C ' ' B' ' 144' ' ' PRO . 2.1 mt 64.47 139.52 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.636 0.731 . . . . 0.0 111.097 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 144' ' ' PRO . . . . . 0.53 ' C ' ' HA ' ' B' ' 143' ' ' ILE . 53.9 Cg_endo -69.75 159.25 89.96 Favored 'Cis proline' 0 C--O 1.231 0.174 0 C-N-CA 122.677 -1.801 . . . . 0.0 112.38 -0.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 178.73 -76.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.87 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . 0.463 ' H ' HD12 ' B' ' 146' ' ' ILE . 3.5 mp -94.81 -20.81 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.129 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.07 -25.78 66.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.109 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 85.9 m -53.81 -27.51 29.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.137 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . -55.74 -53.02 44.58 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.442 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 150' ' ' MET . . . . . . . . . . . . . 28.9 mmt -57.13 -51.8 67.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.805 0.336 . . . . 0.0 110.887 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 59.5 t -57.47 -40.42 74.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.148 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -60.04 -43.79 97.88 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.502 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -64.69 -46.65 81.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.826 0.346 . . . . 0.0 111.126 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 2.2 tt -63.87 -54.91 27.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 155' ' ' LEU . . . . . 0.706 ' O ' HG23 ' B' ' 159' ' ' VAL . 0.4 OUTLIER -51.96 -56.53 13.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.917 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 156' ' ' LEU . . . . . 0.705 ' O ' HG23 ' B' ' 160' ' ' VAL . 14.3 mt -52.18 -45.7 65.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.899 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 4.3 tt -54.87 -47.21 74.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.86 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 5.2 tp -67.78 -39.3 84.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . 0.706 HG23 ' O ' ' B' ' 155' ' ' LEU . 54.7 t -63.77 -47.92 88.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.131 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . 0.705 HG23 ' O ' ' B' ' 156' ' ' LEU . 36.6 t -64.46 -47.7 88.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.148 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.61 -36.37 66.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.121 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.37 -38.37 65.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.929 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.05 -41.0 55.66 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.468 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 58.2 mt -74.04 -39.28 50.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.901 0.381 . . . . 0.0 111.126 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -67.54 -38.46 90.57 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.484 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 12.5 mt -72.43 -42.13 65.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.886 0.374 . . . . 0.0 110.937 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -65.95 -38.03 87.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.867 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.15 -26.39 53.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.884 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.26 -26.25 66.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.927 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 5.2 mtt-85 -67.41 -26.08 66.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.875 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 52.04 29.81 6.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 172' ' ' HIS . . . . . . . . . . . . . 13.5 m80 51.32 86.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.865 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 50.1 mm -77.45 -72.35 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.095 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 12.0 p -96.73 -29.49 3.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.134 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 175' ' ' ARG . . . . . . . . . . . . . 3.9 ttp180 -174.29 -65.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.871 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.33 147.91 3.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.933 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.856 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.2 m -151.72 160.51 31.56 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.632 0.73 . . . . 0.0 110.842 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 -23.88 30.5 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.64 2.227 . . . . 0.0 112.374 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.06 -170.84 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.131 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -160.74 -65.56 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.896 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 54.95 -170.15 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.46 28.09 0.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.856 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.78 -171.27 1.03 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.092 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.1 t 62.72 72.08 0.63 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.65 0.738 . . . . 0.0 110.867 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 -15.46 37.2 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.691 2.261 . . . . 0.0 112.359 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.82 -16.15 61.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.966 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.0 m -76.35 -35.5 58.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.146 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.9 t -67.98 -39.34 83.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.851 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.694 ' O ' HG23 ' A' ' 58' ' ' VAL . 54.7 mt -62.12 -48.05 90.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.114 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.683 ' O ' HG23 ' A' ' 59' ' ' VAL . 72.1 mt -61.24 -45.11 99.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.156 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.3 m -54.23 -47.92 71.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.798 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.93 -50.8 67.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.065 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 54' ' ' ILE . 62.7 t -53.04 -37.71 27.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.155 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 55' ' ' ILE . 92.3 t -70.46 -37.87 71.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.148 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.674 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -62.83 -46.09 94.35 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.474 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.711 ' O ' HG23 ' A' ' 65' ' ' VAL . 3.2 mp -70.78 -42.29 77.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.865 0.364 . . . . 0.0 111.132 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.563 HD12 HG12 ' A' ' 58' ' ' VAL . 11.2 mt -65.41 -36.02 82.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.439 HD12 HG12 ' A' ' 59' ' ' VAL . 12.1 mt -67.71 -45.64 74.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.932 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 60' ' ' GLY . 99.6 t -61.02 -38.15 78.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.121 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 61' ' ' ILE . 92.1 t -63.52 -52.29 59.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.156 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.551 ' O ' HG23 ' A' ' 70' ' ' VAL . 60.2 t -62.12 -53.51 46.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.116 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.39 -32.43 71.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.29 -48.2 76.85 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.495 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.478 HG12 HD12 ' A' ' 73' ' ' ILE . 92.7 t -74.92 -33.22 29.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.854 0.359 . . . . 0.0 111.106 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.569 HG12 HD12 ' A' ' 74' ' ' LEU . 74.6 t -70.72 -52.77 25.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.171 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.685 ' CE2' HD11 ' A' ' 75' ' ' ILE . 6.9 t80 -61.68 -46.23 90.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.939 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -57.62 -48.9 78.18 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.456 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.478 HD12 HG12 ' A' ' 69' ' ' VAL . 67.9 mt -72.49 -26.1 23.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.87 0.367 . . . . 0.0 111.137 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.569 HD12 HG12 ' A' ' 70' ' ' VAL . 12.5 mt -70.47 -42.07 71.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.933 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.685 HD11 ' CE2' ' A' ' 71' ' ' PHE . 49.9 mt -69.91 -35.02 62.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.112 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.5 mmtt -64.87 -43.43 92.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.924 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 67.6 mtt180 -66.87 -30.89 71.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.818 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.62 -53.0 25.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -174.66 125.96 0.3 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.897 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.09 134.68 54.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.925 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.42 160.62 22.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.93 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 5.6 tp -134.95 -40.02 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.137 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 60.18 50.94 5.94 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.887 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 7.3 tptp . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.927 179.982 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.891 0.377 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 83.0 133.89 2.12 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.485 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 136' ' ' CYS . . . . . . . . . . . . . 6.6 p -161.92 72.56 2.38 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.594 0.712 . . . . 0.0 110.924 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 105.81 1.54 Allowed 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.696 2.264 . . . . 0.0 112.348 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 138' ' ' THR . . . . . . . . . . . . . 8.3 t -84.81 143.8 28.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.155 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -164.75 129.25 2.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 135.32 -166.12 24.54 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.477 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 141' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 -172.8 0.61 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.681 2.254 . . . . 0.0 112.325 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 142' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -152.98 119.0 5.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.898 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 0.561 HG23 ' HA ' ' B' ' 144' ' ' PRO . 61.5 mt 65.23 135.33 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.616 0.722 . . . . 0.0 111.14 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 144' ' ' PRO . . . . . 0.561 ' HA ' HG23 ' B' ' 143' ' ' ILE . 53.1 Cg_endo -69.82 -167.21 3.64 Favored 'Cis proline' 0 C--N 1.341 0.18 0 C-N-CA 122.656 -1.81 . . . . 0.0 112.308 -0.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 75.09 4.9 4.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.814 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 10.8 mm -133.49 -39.61 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.14 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -51.67 -29.87 19.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.127 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 89.1 m -53.62 -27.78 28.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.193 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . -55.91 -53.46 42.0 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.505 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 150' ' ' MET . . . . . . . . . . . . . 30.3 mmt -57.86 -52.01 67.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.757 0.313 . . . . 0.0 110.877 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 58.9 t -55.96 -40.37 62.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.139 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -61.33 -43.53 99.24 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.513 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -63.61 -47.15 82.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.791 0.329 . . . . 0.0 111.068 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.98 -52.59 48.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.891 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 155' ' ' LEU . . . . . 0.656 ' O ' HG23 ' B' ' 159' ' ' VAL . 0.5 OUTLIER -53.06 -54.7 31.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.896 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 156' ' ' LEU . . . . . 0.703 ' O ' HG23 ' B' ' 160' ' ' VAL . 23.0 mt -52.49 -45.8 66.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 3.2 tt -54.81 -47.37 74.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.946 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.67 -39.25 84.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.909 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . 0.656 HG23 ' O ' ' B' ' 155' ' ' LEU . 67.2 t -63.76 -48.0 88.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.167 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . 0.703 HG23 ' O ' ' B' ' 156' ' ' LEU . 37.1 t -64.44 -47.66 88.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.109 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.59 -36.41 66.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.121 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 2.9 tp -73.32 -38.39 65.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.936 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -71.98 -41.02 55.97 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.454 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 58.2 mt -74.07 -39.41 50.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.855 0.359 . . . . 0.0 111.121 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -67.37 -38.52 91.31 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.513 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 6.7 mt -72.41 -46.02 57.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.806 0.336 . . . . 0.0 110.898 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -61.44 -37.79 84.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.903 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.81 -26.08 54.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.876 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 21.0 mtt180 -79.41 -30.69 42.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.846 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.84 -30.72 70.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 52.6 mtp85 -77.48 -15.32 59.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.903 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 172' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 54.61 31.1 14.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.84 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 36.2 mm 62.05 74.9 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.18 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 12.1 p -99.05 -27.99 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.138 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 175' ' ' ARG . . . . . . . . . . . . . 13.3 ttm-85 -156.75 160.72 39.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.828 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 14.1 tttm -161.08 123.4 3.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.892 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.876 -179.998 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 4.6 p -137.42 156.57 75.0 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.677 0.751 . . . . 0.0 110.887 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 160.93 47.88 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.7 2.267 . . . . 0.0 112.375 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.28 -58.62 7.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.087 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -69.72 156.94 38.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.903 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -146.27 77.68 1.49 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.922 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.5 ptp85 -72.66 147.74 45.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.842 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -173.85 166.71 4.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.102 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.3 t -61.31 147.53 87.09 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.684 0.754 . . . . 0.0 110.879 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -15.54 37.07 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.679 2.252 . . . . 0.0 112.372 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.79 -16.15 61.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.9 m -76.32 -35.6 58.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.164 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 t -67.79 -38.47 83.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.671 ' O ' HG23 ' A' ' 58' ' ' VAL . 78.8 mt -63.06 -49.02 85.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.132 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.702 ' O ' HG23 ' A' ' 59' ' ' VAL . 63.5 mt -58.51 -43.77 87.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.16 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.2 m -56.79 -49.25 75.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.863 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.1 -49.71 74.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.114 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.761 HG12 HD12 ' A' ' 62' ' ' LEU . 61.5 t -53.05 -37.55 27.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.138 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.702 HG23 ' O ' ' A' ' 55' ' ' ILE . 90.5 t -70.81 -37.64 69.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.118 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.671 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -62.99 -46.08 94.29 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.441 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.724 ' O ' HG23 ' A' ' 65' ' ' VAL . 3.2 mp -70.79 -42.23 77.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.879 0.371 . . . . 0.0 111.14 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.761 HD12 HG12 ' A' ' 58' ' ' VAL . 6.7 mt -65.39 -36.11 82.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.914 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.4 mt -67.67 -45.66 74.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.936 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 60' ' ' GLY . 97.6 t -61.02 -38.04 78.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.149 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 61' ' ' ILE . 90.3 t -63.58 -52.18 60.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.122 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.548 ' O ' HG23 ' A' ' 70' ' ' VAL . 59.9 t -62.38 -53.49 46.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.091 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.2 mt -60.38 -32.55 71.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.923 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.23 -48.22 76.92 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.488 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.478 HG12 HD12 ' A' ' 73' ' ' ILE . 96.5 t -74.85 -33.16 29.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.845 0.355 . . . . 0.0 111.12 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 66' ' ' VAL . 72.7 t -70.71 -52.88 24.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.163 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.69 ' CD2' HD11 ' A' ' 75' ' ' ILE . 8.2 t80 -61.64 -46.01 91.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.426 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -57.48 -49.08 76.21 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.534 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.478 HD12 HG12 ' A' ' 69' ' ' VAL . 63.7 mt -71.59 -25.2 24.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.891 0.377 . . . . 0.0 111.105 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.539 HD12 HG12 ' A' ' 70' ' ' VAL . 12.5 mt -72.58 -46.52 53.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.93 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.69 HD11 ' CD2' ' A' ' 71' ' ' PHE . 11.0 mt -52.89 -31.0 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.185 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -85.06 -35.66 21.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.911 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 -53.61 -32.86 52.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.83 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.97 -65.51 0.73 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.876 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -68.52 113.54 6.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.942 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.498 ' HG3' HG23 ' A' ' 82' ' ' ILE . 2.0 pt20 -75.65 -31.01 59.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.924 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 53.58 87.66 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.916 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.498 HG23 ' HG3' ' A' ' 80' ' ' GLN . 1.3 pt -97.11 33.35 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.11 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 25.8 mtt85 -89.47 61.54 5.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.851 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.87 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.895 0.379 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 156.81 -107.57 0.33 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.472 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 136' ' ' CYS . . . . . . . . . . . . . 1.1 m -156.14 160.48 30.74 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.599 0.714 . . . . 0.0 110.856 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.67 179.32 3.73 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.693 2.262 . . . . 0.0 112.359 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 138' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.89 -179.17 7.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.194 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -164.17 107.64 0.94 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.902 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -52.4 169.74 0.61 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.509 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 141' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 78.63 1.0 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.689 2.259 . . . . 0.0 112.302 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 142' ' ' LYS . . . . . . . . . . . . . 3.7 mmtp 68.24 -77.13 0.05 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.907 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 0.607 HG23 ' HA ' ' B' ' 144' ' ' PRO . 56.7 mt -150.31 135.77 10.16 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.669 0.747 . . . . 0.0 111.09 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 144' ' ' PRO . . . . . 0.607 ' HA ' HG23 ' B' ' 143' ' ' ILE . 53.8 Cg_endo -69.76 161.83 85.39 Favored 'Cis proline' 0 C--N 1.342 0.21 0 C-N-CA 122.711 -1.787 . . . . 0.0 112.365 -0.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . 0.403 ' HB3' HD12 ' B' ' 146' ' ' ILE . 48.4 t -176.34 -75.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.891 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . 0.459 ' H ' HD12 ' B' ' 146' ' ' ILE . 3.6 mp -94.0 -20.78 6.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.153 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.84 -25.05 67.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.106 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 18.4 m -53.51 -28.37 30.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.13 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . -59.13 -57.91 17.28 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.49 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 150' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -58.17 -46.66 85.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.87 0.367 . . . . 0.0 110.917 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 59.4 t -56.92 -40.57 72.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.11 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -65.18 -41.68 96.79 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.492 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -62.08 -51.45 67.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.84 0.352 . . . . 0.0 111.138 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.58 -52.55 64.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.946 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 155' ' ' LEU . . . . . 0.701 ' O ' HG23 ' B' ' 159' ' ' VAL . 3.2 tp -54.93 -54.94 36.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.917 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 156' ' ' LEU . . . . . 0.699 ' O ' HG23 ' B' ' 160' ' ' VAL . 19.7 mt -54.16 -45.27 72.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.903 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 4.9 tt -55.12 -46.96 75.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.94 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.77 -39.64 84.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.888 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . 0.701 HG23 ' O ' ' B' ' 155' ' ' LEU . 58.0 t -63.64 -48.06 88.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.139 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . 0.699 HG23 ' O ' ' B' ' 156' ' ' LEU . 37.2 t -64.7 -47.47 88.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.123 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.88 -35.73 66.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.088 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.28 -38.74 65.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.963 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.49 -40.83 53.43 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.469 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 54.7 mt -73.66 -38.31 51.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.905 0.383 . . . . 0.0 111.104 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.95 -39.1 85.37 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.491 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 11.6 mt -71.59 -40.42 69.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.885 0.374 . . . . 0.0 110.962 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -68.33 -37.68 80.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.936 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.48 -27.23 58.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.872 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.28 -36.48 66.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.856 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.19 -32.46 71.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.845 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 18.2 mtp85 -71.57 -15.13 62.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.875 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 172' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 62.34 64.83 0.91 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.857 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 55.5 mt -146.24 110.21 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.104 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 23.2 m -141.49 150.75 19.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.165 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.69 128.46 35.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 15.9 tttt -161.61 54.6 0.26 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.881 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 2.4 ttp180 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.854 179.982 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 2.7 m -116.64 160.51 36.17 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.595 0.712 . . . . 0.0 110.893 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -16.87 37.83 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.623 2.215 . . . . 0.0 112.38 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.0 133.29 51.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.094 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -170.36 67.96 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.909 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -82.57 172.33 13.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.902 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.09 102.48 3.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.29 -176.91 0.35 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.062 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.4 t -63.6 147.5 95.49 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.636 0.731 . . . . 0.0 110.863 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 -15.59 37.1 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.708 2.272 . . . . 0.0 112.301 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.8 -16.15 61.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.916 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.659 HG21 ' HB ' ' B' ' 148' ' ' THR . 3.9 m -76.3 -35.48 58.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.13 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.9 t -67.8 -37.65 82.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.85 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.658 ' O ' HG23 ' A' ' 58' ' ' VAL . 54.8 mt -64.4 -50.03 78.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.182 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.69 ' O ' HG23 ' A' ' 59' ' ' VAL . 63.1 mt -56.56 -42.35 75.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.152 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.9 m -59.18 -50.98 71.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.842 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.5 -49.21 78.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.099 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.738 HG12 HD12 ' A' ' 62' ' ' LEU . 62.5 t -53.11 -37.55 27.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.138 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 55' ' ' ILE . 89.8 t -70.62 -37.93 71.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.135 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.682 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -62.79 -46.1 94.34 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.503 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.71 ' O ' HG23 ' A' ' 65' ' ' VAL . 3.2 mp -70.7 -42.3 77.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.87 0.367 . . . . 0.0 111.169 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.738 HD12 HG12 ' A' ' 58' ' ' VAL . 7.7 mt -65.37 -36.15 83.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.918 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.4 mt -67.69 -45.32 75.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.896 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 60' ' ' GLY . 96.7 t -61.42 -37.82 78.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.133 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 61' ' ' ILE . 90.1 t -63.85 -51.9 63.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.108 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.548 ' O ' HG23 ' A' ' 70' ' ' VAL . 60.2 t -62.6 -53.53 45.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.094 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.47 -32.7 71.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.877 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.99 -47.93 80.88 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.49 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.432 HG12 HD12 ' A' ' 73' ' ' ILE . 95.2 t -75.11 -32.87 27.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.846 0.355 . . . . 0.0 111.11 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 66' ' ' VAL . 73.7 t -70.9 -53.05 23.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.102 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.471 ' CE2' HD11 ' A' ' 75' ' ' ILE . 5.3 t80 -62.11 -44.16 97.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.868 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.56 -49.47 76.66 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.457 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.432 HD12 HG12 ' A' ' 69' ' ' VAL . 59.6 mt -70.32 -26.15 28.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.87 0.366 . . . . 0.0 111.145 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.6 mt -69.57 -39.5 77.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.95 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.471 HD11 ' CE2' ' A' ' 71' ' ' PHE . 60.8 mt -73.72 -36.85 47.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.115 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.8 mmtt -64.85 -38.47 91.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -52.45 -35.26 51.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.89 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.2 -55.19 7.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.861 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -73.66 179.79 3.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.925 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -158.74 164.85 35.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.901 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.06 167.8 0.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.887 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 26.6 mm 58.58 68.13 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.13 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -94.28 75.15 3.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 179.962 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 . . . . . 0 N--CA 1.458 -0.044 0 CA-C-O 120.948 0.404 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.01 85.55 1.73 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.455 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 136' ' ' CYS . . . . . . . . . . . . . 1.1 m -77.51 160.59 74.69 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.628 0.727 . . . . 0.0 110.845 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 174.4 9.56 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.73 2.287 . . . . 0.0 112.362 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 138' ' ' THR . . . . . . . . . . . . . 14.9 t -146.02 31.86 1.03 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.157 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -163.01 156.03 19.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.898 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -109.72 172.66 16.12 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.502 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 141' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -19.8 35.47 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.685 2.257 . . . . 0.0 112.355 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 142' ' ' LYS . . . . . . . . . . . . . 1.5 tttt 53.52 53.11 12.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.87 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 0.582 HG23 ' HA ' ' B' ' 144' ' ' PRO . 71.4 mt 64.99 135.53 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.598 0.713 . . . . 0.0 111.137 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 144' ' ' PRO . . . . . 0.582 ' HA ' HG23 ' B' ' 143' ' ' ILE . 53.8 Cg_endo -69.73 160.82 87.32 Favored 'Cis proline' 0 C--O 1.231 0.173 0 C-N-CA 122.704 -1.79 . . . . 0.0 112.359 -0.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 2.7 t -179.37 -75.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.88 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 2.4 mp -85.17 -25.44 6.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.102 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -55.09 -26.15 35.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.129 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . 0.659 ' HB ' HG21 ' A' ' 52' ' ' THR . 40.7 m -52.42 -29.54 24.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.166 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . -59.24 -59.47 10.62 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.476 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 150' ' ' MET . . . . . . . . . . . . . 29.3 mmt -57.97 -47.25 83.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.757 0.313 . . . . 0.0 110.848 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 59.3 t -57.36 -40.42 74.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.125 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -64.07 -43.61 97.03 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.432 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -61.98 -44.19 97.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.85 0.357 . . . . 0.0 111.127 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 2.6 tp -64.84 -48.62 73.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.957 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 155' ' ' LEU . . . . . 0.718 ' O ' HG23 ' B' ' 159' ' ' VAL . 0.8 OUTLIER -52.91 -55.6 22.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.888 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 156' ' ' LEU . . . . . 0.699 ' O ' HG23 ' B' ' 160' ' ' VAL . 27.4 mt -53.7 -44.34 69.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.879 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.11 -47.19 75.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.93 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.37 -39.95 85.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.954 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . 0.718 HG23 ' O ' ' B' ' 155' ' ' LEU . 45.1 t -63.51 -48.18 88.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.12 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . 0.699 HG23 ' O ' ' B' ' 156' ' ' LEU . 38.5 t -64.69 -47.48 88.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.157 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.92 -35.31 66.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.152 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.32 -39.06 65.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.941 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.47 -41.03 53.08 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.531 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 54.3 mt -73.2 -38.08 53.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.875 0.369 . . . . 0.0 111.136 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . 0.659 ' O ' HG21 ' B' ' 174' ' ' VAL . . . -69.54 -39.12 79.38 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.497 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 5.9 mt -71.4 -38.74 71.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.807 0.337 . . . . 0.0 110.879 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -69.69 -37.02 76.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.902 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -72.55 -35.33 67.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.884 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.87 -20.61 62.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.878 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -13.62 62.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.907 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -87.36 -42.51 12.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.845 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 172' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 179.98 -75.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.852 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 1.3 tt -144.85 134.65 18.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.124 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 174' ' ' VAL . . . . . 0.659 HG21 ' O ' ' B' ' 165' ' ' GLY . 76.9 t -91.81 92.23 3.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.129 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.25 -48.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.896 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.42 -42.03 92.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.928 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 179.982 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.7 m -98.6 160.58 27.63 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.58 0.705 . . . . 0.0 110.865 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 91.5 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.718 2.279 . . . . 0.0 112.317 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -166.17 -172.08 2.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.12 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.27 44.34 0.42 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.914 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -76.01 -20.59 57.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.917 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -165.12 79.98 0.34 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.904 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -174.93 -169.41 0.4 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.07 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.0 t 66.81 142.59 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.668 0.747 . . . . 0.0 110.906 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -12.15 32.32 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.715 2.277 . . . . 0.0 112.324 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.546 ' HA ' HD12 ' A' ' 54' ' ' ILE . 0.3 OUTLIER -67.49 -17.04 64.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.891 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.5 m -75.91 -37.9 58.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.154 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.2 t -66.73 -40.94 88.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.866 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.675 ' O ' HG23 ' A' ' 58' ' ' VAL . 53.0 mt -55.89 -40.97 65.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.1 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.609 ' O ' HG23 ' A' ' 59' ' ' VAL . 75.7 mt -57.94 -42.11 81.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.146 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.2 m -66.04 -41.5 90.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.877 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.13 -51.0 59.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.1 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 54' ' ' ILE . 66.0 t -53.14 -46.2 55.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.129 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 55' ' ' ILE . 84.8 t -64.96 -36.19 77.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.139 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.67 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -61.69 -46.08 94.96 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.506 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.713 ' O ' HG23 ' A' ' 65' ' ' VAL . 2.8 mp -70.68 -42.92 77.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.799 0.333 . . . . 0.0 111.091 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.557 HD13 ' O ' ' A' ' 58' ' ' VAL . 8.5 mp -65.07 -35.84 82.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.5 mt -67.8 -45.12 75.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 60' ' ' GLY . 95.4 t -62.06 -36.81 76.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.107 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 61' ' ' ILE . 89.7 t -64.56 -51.74 63.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.139 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.555 ' O ' HG23 ' A' ' 70' ' ' VAL . 60.4 t -62.65 -53.34 48.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.122 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.3 mt -60.24 -37.42 80.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.09 -50.52 66.98 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.499 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.0 t -70.95 -39.53 75.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.859 0.362 . . . . 0.0 111.126 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 66' ' ' VAL . 62.8 t -62.53 -53.15 50.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.144 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.767 ' CD2' HD11 ' A' ' 75' ' ' ILE . 1.3 t80 -61.93 -39.94 93.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.888 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -55.65 -49.56 64.91 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.46 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 64.4 mt -64.13 -46.79 92.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.862 0.363 . . . . 0.0 111.153 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -56.4 -49.5 74.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.949 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.767 HD11 ' CD2' ' A' ' 71' ' ' PHE . 21.4 mt -57.04 -31.05 35.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.157 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.1 mmmt -85.07 -22.69 28.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.916 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 9.1 mtp85 -67.74 -28.69 67.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.851 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -64.89 -25.68 67.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.87 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -64.99 -75.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.923 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -165.09 -46.18 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.929 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.96 -177.89 3.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.877 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.475 HD12 ' N ' ' A' ' 84' ' ' LYS . 2.5 pp -134.74 -37.9 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.139 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.434 ' N ' HD12 ' A' ' 82' ' ' ILE . 2.9 tmt_? 54.2 84.52 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.918 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.475 ' N ' HD12 ' A' ' 82' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.527 0.063 0 CA-C-O 120.869 0.366 . . . . 0.0 110.815 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -157.85 105.73 0.28 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.515 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 136' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -155.6 160.49 30.8 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.626 0.727 . . . . 0.0 110.885 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.76 -178.44 2.34 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.683 2.256 . . . . 0.0 112.344 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 138' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.41 109.67 10.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.147 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -156.96 159.54 38.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.912 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -66.85 177.04 19.85 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.49 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 141' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 97.65 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.728 2.285 . . . . 0.0 112.367 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 142' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.78 -1.34 42.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.86 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 0.52 ' HA ' ' C ' ' B' ' 144' ' ' PRO . 1.9 mt 64.36 139.58 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.647 0.737 . . . . 0.0 111.152 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 144' ' ' PRO . . . . . 0.52 ' C ' ' HA ' ' B' ' 143' ' ' ILE . 54.4 Cg_endo -69.74 159.08 90.21 Favored 'Cis proline' 0 C--N 1.342 0.192 0 C-N-CA 122.717 -1.784 . . . . 0.0 112.387 -0.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 178.65 -75.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.861 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 27.3 mt -93.27 -18.46 7.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.15 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.34 -21.2 66.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.117 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 16.0 m -51.26 -30.36 17.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.135 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . -54.65 -54.06 35.21 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.505 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 150' ' ' MET . . . . . . . . . . . . . 27.3 mmt -58.62 -51.04 71.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.805 0.336 . . . . 0.0 110.922 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 59.2 t -55.19 -40.41 55.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.094 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -63.26 -41.61 99.52 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.434 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -63.45 -46.58 85.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.799 0.333 . . . . 0.0 111.121 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.96 -46.75 87.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.861 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 155' ' ' LEU . . . . . 0.7 ' O ' HG23 ' B' ' 159' ' ' VAL . 4.3 tp -54.59 -53.61 52.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.898 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 156' ' ' LEU . . . . . 0.702 ' O ' HG23 ' B' ' 160' ' ' VAL . 3.3 mt -56.75 -44.79 82.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.939 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 1.1 tt -54.99 -46.98 75.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.906 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 1.1 tt -67.64 -39.82 84.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.953 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . 0.7 HG23 ' O ' ' B' ' 155' ' ' LEU . 93.2 t -63.58 -48.04 88.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.108 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . 0.702 HG23 ' O ' ' B' ' 156' ' ' LEU . 38.2 t -64.69 -47.45 88.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.128 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.85 -35.74 66.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.103 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 1.4 tp -73.37 -38.77 65.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.934 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.37 -40.82 54.17 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.47 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 54.5 mt -73.59 -38.53 52.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.872 0.367 . . . . 0.0 111.134 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -67.88 -40.64 89.25 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.476 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 7.5 mt -70.36 -42.44 71.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.887 0.375 . . . . 0.0 110.924 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -65.88 -37.49 86.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.835 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 168' ' ' MET . . . . . 0.537 ' SD ' HG23 ' B' ' 173' ' ' ILE . 0.0 OUTLIER -75.0 -26.32 59.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.911 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -82.14 -15.84 51.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.847 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -54.84 -26.74 37.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -145.02 17.21 1.58 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.854 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 172' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 51.72 44.06 29.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.876 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 173' ' ' ILE . . . . . 0.537 HG23 ' SD ' ' B' ' 168' ' ' MET . 5.4 tt -75.56 132.64 32.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.107 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 10.8 p -102.39 151.85 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.108 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 175' ' ' ARG . . . . . . . . . . . . . 7.1 ttm180 -156.88 107.04 2.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.89 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 9.1 tptt 62.74 41.25 9.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.898 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.869 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 63.11 160.59 0.12 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.624 0.726 . . . . 0.0 110.862 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -20.45 34.65 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.698 2.266 . . . . 0.0 112.319 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.6 170.69 0.24 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.076 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -169.73 116.41 0.57 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.871 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -75.97 100.46 4.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.914 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -74.82 75.34 2.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.846 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -164.78 -170.48 2.0 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.06 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.7 t 62.93 72.94 0.54 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.682 0.753 . . . . 0.0 110.847 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 -15.66 37.46 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.717 2.278 . . . . 0.0 112.356 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.793 ' HA ' HD12 ' A' ' 54' ' ' ILE . 1.7 tt -72.62 -16.2 61.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.948 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.536 HG21 ' HB ' ' B' ' 148' ' ' THR . 4.0 m -76.35 -35.59 58.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.087 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 t -67.97 -38.06 82.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.833 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.793 HD12 ' HA ' ' A' ' 51' ' ' LEU . 7.8 mt -62.32 -48.42 88.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.086 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.682 ' O ' HG23 ' A' ' 59' ' ' VAL . 61.8 mt -55.4 -49.88 69.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.152 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.8 m -54.81 -45.61 74.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.821 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.77 -51.27 60.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.115 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 54' ' ' ILE . 63.5 t -53.04 -37.74 27.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.097 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 55' ' ' ILE . 81.7 t -71.32 -37.12 64.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.124 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.682 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -62.87 -46.01 94.49 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.494 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.715 ' O ' HG23 ' A' ' 65' ' ' VAL . 3.2 mp -70.76 -42.43 77.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.84 0.352 . . . . 0.0 111.103 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.453 ' O ' HG23 ' A' ' 66' ' ' VAL . 12.1 mt -65.33 -35.91 82.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.953 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.4 mt -67.86 -45.5 74.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.941 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 60' ' ' GLY . 98.4 t -61.33 -37.68 78.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.139 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 61' ' ' ILE . 87.9 t -64.05 -51.42 69.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.121 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.551 ' O ' HG23 ' A' ' 70' ' ' VAL . 61.9 t -63.3 -53.59 43.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.155 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mt -60.44 -32.57 71.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.936 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.2 -47.97 79.62 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.475 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.471 HG12 HD12 ' A' ' 73' ' ' ILE . 95.7 t -75.08 -33.01 27.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.883 0.373 . . . . 0.0 111.125 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 66' ' ' VAL . 73.4 t -70.89 -53.04 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.145 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.596 ' CD2' HD11 ' A' ' 75' ' ' ILE . 6.1 t80 -62.03 -45.1 95.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.835 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.426 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -58.13 -49.02 79.35 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.451 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.471 HD12 HG12 ' A' ' 69' ' ' VAL . 63.9 mt -71.63 -24.88 23.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.868 0.366 . . . . 0.0 111.157 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.43 HD12 HG12 ' A' ' 70' ' ' VAL . 12.7 mt -73.31 -47.95 38.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.898 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.596 HD11 ' CD2' ' A' ' 71' ' ' PHE . 8.6 mt -51.75 -49.84 34.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.13 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.7 -36.05 79.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.903 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.72 -26.71 62.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.892 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -72.92 -40.69 65.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -66.72 -73.87 0.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -156.03 -58.92 0.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.924 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.4 tttm 54.63 78.23 0.18 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.894 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 5.4 tp -155.02 -40.8 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.184 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 22.8 ptt180 -147.65 -178.77 6.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.904 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.911 0.386 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 101.47 30.18 6.0 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.481 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 136' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 63.2 160.55 0.12 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.631 0.729 . . . . 0.0 110.9 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.74 143.18 50.12 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.702 2.268 . . . . 0.0 112.355 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 138' ' ' THR . . . . . . . . . . . . . 20.1 p -149.66 27.45 0.81 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.158 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -149.02 101.91 3.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.863 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -75.89 168.24 54.77 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.478 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 141' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 167.97 22.85 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.66 2.24 . . . . 0.0 112.385 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 142' ' ' LYS . . . . . . . . . . . . . 19.6 mttp -150.76 42.76 0.8 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.914 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 0.539 ' HA ' ' C ' ' B' ' 144' ' ' PRO . 2.1 mt -134.24 138.99 31.64 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.642 0.734 . . . . 0.0 111.127 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 144' ' ' PRO . . . . . 0.539 ' C ' ' HA ' ' B' ' 143' ' ' ILE . 54.0 Cg_endo -69.75 -169.98 5.49 Favored 'Cis proline' 0 C--N 1.342 0.211 0 C-N-CA 122.649 -1.813 . . . . 0.0 112.374 -0.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 12.9 p -56.06 -21.58 22.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.854 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 39.0 mt -88.48 -23.38 6.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.113 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -51.41 -35.28 38.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.102 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . 0.536 ' HB ' HG21 ' A' ' 52' ' ' THR . 64.0 m -52.41 -34.11 46.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.14 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . -53.12 -55.53 23.63 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.517 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 150' ' ' MET . . . . . . . . . . . . . 22.3 mmt -62.37 -45.25 93.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.811 0.339 . . . . 0.0 110.872 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 59.1 t -55.61 -40.39 59.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.122 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -68.63 -39.77 86.25 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.503 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -60.68 -48.43 81.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.806 0.336 . . . . 0.0 111.098 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 1.1 tp -60.94 -55.32 34.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.953 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 155' ' ' LEU . . . . . 0.694 ' O ' HG23 ' B' ' 159' ' ' VAL . 0.3 OUTLIER -54.31 -55.08 31.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.929 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 156' ' ' LEU . . . . . 0.699 ' O ' HG23 ' B' ' 160' ' ' VAL . 13.5 mt -51.94 -45.5 64.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.955 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 157' ' ' LEU . . . . . 0.441 ' O ' HD13 ' B' ' 157' ' ' LEU . 0.3 OUTLIER -55.06 -46.56 75.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.914 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.504 ' O ' HD23 ' B' ' 158' ' ' LEU . 3.5 tt -68.03 -39.65 83.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.903 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . 0.694 HG23 ' O ' ' B' ' 155' ' ' LEU . 47.1 t -63.85 -47.81 89.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.151 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . 0.699 HG23 ' O ' ' B' ' 156' ' ' LEU . 37.9 t -64.8 -47.41 88.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.121 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.9 -36.17 67.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.11 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.4 -38.48 65.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.919 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.09 -41.24 54.72 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.509 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 58.1 mt -73.64 -39.16 53.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.894 0.378 . . . . 0.0 111.122 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -67.74 -38.59 89.85 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.483 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 12.5 mt -72.64 -38.83 67.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.898 0.38 . . . . 0.0 110.947 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -67.88 -39.88 83.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.856 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.05 -55.12 6.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.88 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.31 -27.11 33.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.862 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.0 -44.62 74.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 53.9 mtm180 -94.76 20.8 8.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.877 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 172' ' ' HIS . . . . . . . . . . . . . 19.8 m80 51.0 61.86 3.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -144.55 126.24 9.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.123 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 174' ' ' VAL . . . . . 0.438 ' O ' HG22 ' B' ' 174' ' ' VAL . 6.5 p -153.34 23.5 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.148 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 175' ' ' ARG . . . . . . . . . . . . . 30.4 ptt85 -72.91 179.62 3.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.874 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -169.6 -68.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.885 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.888 179.99 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.2 m -152.06 160.59 31.25 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.616 0.722 . . . . 0.0 110.856 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 135.51 30.66 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.7 2.267 . . . . 0.0 112.375 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -167.01 -50.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.095 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 69.3 -75.45 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 62.41 174.29 0.14 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.854 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.0 tpt85 -165.99 151.33 8.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.866 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -172.82 159.63 4.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.089 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.3 t -68.74 147.5 97.94 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.619 0.723 . . . . 0.0 110.854 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -15.47 37.09 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.725 2.283 . . . . 0.0 112.331 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.402 ' O ' HD23 ' A' ' 51' ' ' LEU . 1.3 tt -72.84 -16.11 61.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.912 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.9 m -76.34 -35.38 58.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.102 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.1 t -68.39 -37.22 80.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.854 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.676 ' O ' HG23 ' A' ' 58' ' ' VAL . 80.6 mt -63.09 -48.38 88.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.139 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.659 ' O ' HG23 ' A' ' 59' ' ' VAL . 57.2 mt -54.97 -44.74 75.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.094 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.6 m -59.66 -48.2 82.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.869 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.76 -48.97 78.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.087 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 54' ' ' ILE . 62.5 t -53.2 -40.46 38.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.15 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 55' ' ' ILE . 66.8 t -69.55 -35.19 65.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.101 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.598 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -63.97 -46.11 92.28 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.47 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.708 ' O ' HG23 ' A' ' 65' ' ' VAL . 3.1 mp -70.87 -43.15 77.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.912 0.387 . . . . 0.0 111.143 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.566 ' O ' HG23 ' A' ' 66' ' ' VAL . 3.5 mm? -65.27 -32.96 74.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.929 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.872 HD13 HD12 ' B' ' 157' ' ' LEU . 12.6 mt -69.37 -48.65 60.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.91 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 60' ' ' GLY . 91.7 t -59.22 -38.39 74.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.136 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 61' ' ' ILE . 91.1 t -63.88 -51.35 70.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.155 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 62' ' ' LEU . 61.3 t -63.02 -53.53 45.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.139 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mt -60.5 -32.97 71.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.912 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.74 -47.69 84.07 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.534 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.5 t -75.08 -32.91 27.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.839 0.352 . . . . 0.0 111.152 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 66' ' ' VAL . 73.8 t -70.81 -53.05 23.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.107 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -62.6 -42.57 99.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -59.34 -49.59 76.91 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.498 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 55.7 mt -69.51 -24.91 27.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.813 0.339 . . . . 0.0 111.056 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 14.2 mt -71.56 -36.87 71.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 71.8 mt -83.78 -37.29 13.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.129 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -55.02 -43.8 74.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.926 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.2 mtp180 -52.23 -60.71 2.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.889 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.5 ttt-85 -84.98 55.03 3.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.886 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.73 -175.93 1.84 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.915 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 56.14 56.63 5.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.946 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.455 ' C ' HD12 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -88.26 54.84 3.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.927 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.455 HD12 ' C ' ' A' ' 81' ' ' LYS . 3.3 mp 57.56 71.4 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.135 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -89.0 -58.35 2.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.874 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 . . . . . 0 N--CA 1.458 -0.064 0 CA-C-O 120.921 0.391 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 168.95 -145.98 9.91 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.462 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 136' ' ' CYS . . . . . . . . . . . . . 4.6 p -157.93 156.59 28.49 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.648 0.737 . . . . 0.0 110.877 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 -28.17 25.45 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.708 2.272 . . . . 0.0 112.347 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 138' ' ' THR . . . . . . . . . . . . . 1.2 m 63.13 28.06 15.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.146 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -75.54 130.82 39.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.846 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 57.13 84.9 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.506 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 141' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 -40.02 5.7 Favored 'Trans proline' 0 N--CA 1.465 -0.166 0 C-N-CA 122.706 2.271 . . . . 0.0 112.322 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 142' ' ' LYS . . . . . . . . . . . . . 5.4 mtpp 62.76 90.08 0.08 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.897 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 0.548 ' HA ' ' C ' ' B' ' 144' ' ' PRO . 0.5 OUTLIER -54.06 140.23 52.6 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.642 0.734 . . . . 0.0 111.108 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 144' ' ' PRO . . . . . 0.548 ' C ' ' HA ' ' B' ' 143' ' ' ILE . 53.7 Cg_endo -69.76 158.66 90.77 Favored 'Cis proline' 0 C--N 1.342 0.19 0 C-N-CA 122.619 -1.825 . . . . 0.0 112.364 -0.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.39 -75.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.857 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 63.0 mt -96.51 -21.82 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.129 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.82 -24.75 64.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.103 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 69.4 m -51.71 -29.83 19.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.11 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . -53.95 -55.72 24.45 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.5 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 150' ' ' MET . . . . . . . . . . . . . 28.7 mmt -57.15 -49.07 77.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.802 0.334 . . . . 0.0 110.889 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 59.4 t -57.85 -40.26 75.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.143 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -63.27 -40.03 98.55 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.527 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -65.95 -41.82 90.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.816 0.341 . . . . 0.0 111.12 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 2.5 tp -64.12 -51.95 61.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.923 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 155' ' ' LEU . . . . . 0.705 ' O ' HG23 ' B' ' 159' ' ' VAL . 5.7 tp -52.31 -49.93 63.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.897 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 156' ' ' LEU . . . . . 0.705 ' O ' HG23 ' B' ' 160' ' ' VAL . 69.5 mt -57.37 -44.23 84.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.92 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 157' ' ' LEU . . . . . 0.872 HD12 HD13 ' A' ' 63' ' ' LEU . 5.1 tt -55.04 -47.52 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.899 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 2.7 tt -67.1 -39.98 86.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.909 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . 0.705 HG23 ' O ' ' B' ' 155' ' ' LEU . 91.0 t -63.42 -48.22 88.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.173 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . 0.705 HG23 ' O ' ' B' ' 156' ' ' LEU . 38.5 t -64.63 -47.37 89.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.113 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.85 -35.63 66.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.071 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 6.3 tp -73.4 -38.85 65.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.885 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.39 -40.78 54.12 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.456 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 54.6 mt -73.66 -38.49 51.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.894 0.378 . . . . 0.0 111.124 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.16 -40.1 88.15 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.54 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 11.8 mt -70.84 -41.72 71.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.837 0.351 . . . . 0.0 110.928 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -67.12 -37.36 83.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.87 -26.02 60.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.852 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.95 -26.27 47.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.88 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.15 -24.33 67.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.881 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 50.87 45.41 27.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 172' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -146.93 26.85 1.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.875 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 173' ' ' ILE . . . . . 0.41 HD12 ' CG ' ' B' ' 175' ' ' ARG . 3.5 pt -89.19 -177.82 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.112 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 6.7 m -152.11 28.15 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.109 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 175' ' ' ARG . . . . . 0.41 ' CG ' HD12 ' B' ' 173' ' ' ILE . 2.8 ptm180 -84.15 176.43 8.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.857 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -155.5 -60.28 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.859 -179.991 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 4.5 p -136.03 156.59 76.93 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.626 0.727 . . . . 0.0 110.853 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 131.89 22.18 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.635 2.223 . . . . 0.0 112.341 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.53 -29.42 67.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.133 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -172.41 -173.03 0.99 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.844 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -148.07 124.85 11.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.905 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.96 113.01 0.19 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.855 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -172.73 -170.06 0.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.094 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.3 t -55.51 147.57 38.43 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.688 0.756 . . . . 0.0 110.836 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -15.49 37.19 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.71 2.273 . . . . 0.0 112.316 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.622 ' HA ' HD12 ' A' ' 54' ' ' ILE . 0.2 OUTLIER -72.76 -16.19 61.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.923 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.0 m -76.3 -35.59 58.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.134 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.1 t -68.2 -39.38 82.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.841 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.67 ' O ' HG23 ' A' ' 58' ' ' VAL . 27.5 mt -59.84 -46.12 94.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.16 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.676 ' O ' HG23 ' A' ' 59' ' ' VAL . 60.7 mt -56.97 -48.65 81.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.138 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 51.1 m -56.06 -45.94 79.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.48 -51.09 64.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.11 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 54' ' ' ILE . 78.1 t -53.18 -38.38 30.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.193 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 55' ' ' ILE . 93.2 t -69.94 -38.03 74.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.151 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.688 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -62.48 -46.14 94.42 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.536 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.71 ' O ' HG23 ' A' ' 65' ' ' VAL . 3.2 mp -70.62 -42.68 77.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.868 0.366 . . . . 0.0 111.133 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.595 HD12 HG12 ' A' ' 58' ' ' VAL . 10.2 mt -65.14 -35.97 82.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.922 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.656 HD12 HG12 ' A' ' 59' ' ' VAL . 10.1 mt -67.72 -45.8 73.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.903 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.688 HG23 ' O ' ' A' ' 60' ' ' GLY . 92.2 t -60.93 -37.96 78.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.172 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 61' ' ' ILE . 95.4 t -63.65 -51.89 64.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.121 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.554 ' O ' HG23 ' A' ' 70' ' ' VAL . 62.0 t -62.39 -53.48 46.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.137 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mt -60.32 -33.83 72.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.89 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.84 -49.08 75.76 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.483 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.469 HG12 HD12 ' A' ' 73' ' ' ILE . 94.0 t -73.12 -32.84 40.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.887 0.375 . . . . 0.0 111.17 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 66' ' ' VAL . 70.0 t -70.37 -45.76 73.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.124 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -63.92 -48.61 75.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.838 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -57.16 -49.54 71.4 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.493 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.469 HD12 HG12 ' A' ' 69' ' ' VAL . 62.3 mt -67.1 -28.44 42.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.82 0.343 . . . . 0.0 111.11 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.5 mt -67.51 -38.24 83.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.882 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 39.0 mt -63.74 -36.54 76.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.118 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.8 mmtt -84.97 -27.08 26.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.3 mmt85 -58.16 -23.28 54.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.885 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.9 ttm180 -64.95 -25.03 67.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.873 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -65.04 139.26 58.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.877 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -64.98 -38.77 92.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.2 mttp -75.23 86.87 2.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 41.7 pt -150.83 34.64 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.134 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.6 ttp180 -157.57 150.88 23.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.881 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 . . . . . 0 N--CA 1.458 -0.074 0 CA-C-O 120.895 0.379 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 141.32 -140.36 10.24 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.48 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 136' ' ' CYS . . . . . . . . . . . . . 19.8 t -159.3 69.26 3.29 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.602 0.715 . . . . 0.0 110.819 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.85 166.52 27.42 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.662 2.241 . . . . 0.0 112.313 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 138' ' ' THR . . . . . . . . . . . . . 2.1 p -150.87 -62.83 0.19 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.128 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -147.17 -48.66 0.18 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 59.67 -165.39 10.87 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.518 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 141' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -168.96 0.3 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.668 2.245 . . . . 0.0 112.348 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 142' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -144.85 16.06 1.58 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.886 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 0.606 HG23 ' HA ' ' B' ' 144' ' ' PRO . 46.9 mt -150.85 136.57 10.65 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.582 0.706 . . . . 0.0 111.135 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 144' ' ' PRO . . . . . 0.606 ' HA ' HG23 ' B' ' 143' ' ' ILE . 54.0 Cg_endo -69.73 157.54 91.86 Favored 'Cis proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.715 -1.785 . . . . 0.0 112.368 -0.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 1.9 p 179.05 -160.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.84 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 3.2 mp -51.25 -22.13 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.115 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -56.08 -32.33 64.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.112 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 48.1 m -54.2 -25.64 23.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.134 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . -57.12 -49.48 71.7 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.482 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 150' ' ' MET . . . . . . . . . . . . . 30.2 mmt -62.46 -51.71 66.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.796 0.332 . . . . 0.0 110.863 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 57.9 t -57.82 -40.1 74.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.098 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -64.79 -41.79 97.4 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.494 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . 0.503 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . -62.34 -49.03 77.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.869 0.366 . . . . 0.0 111.121 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 154' ' ' LEU . . . . . . . . . . . . . 1.4 tt -68.45 -45.58 72.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.94 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 155' ' ' LEU . . . . . 0.623 ' O ' HG23 ' B' ' 159' ' ' VAL . 19.6 tp -60.55 -55.35 34.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.928 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 156' ' ' LEU . . . . . 0.707 ' O ' HG23 ' B' ' 160' ' ' VAL . 32.7 mt -51.95 -47.16 64.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.897 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 157' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.33 -46.36 72.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.902 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.36 -39.79 81.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . 0.623 HG23 ' O ' ' B' ' 155' ' ' LEU . 92.2 t -63.44 -47.63 90.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.109 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . 0.707 HG23 ' O ' ' B' ' 156' ' ' LEU . 34.8 t -64.01 -47.97 88.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.112 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.17 -36.98 66.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.101 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 4.6 tp -73.25 -38.13 66.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 163' ' ' GLY . . . . . . . . . . . . . . . -71.8 -40.98 57.16 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.467 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 58.1 mt -74.2 -39.77 50.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.84 0.353 . . . . 0.0 111.087 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -66.78 -38.39 93.02 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.528 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 12.4 mt -72.26 -45.47 60.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.843 0.354 . . . . 0.0 110.93 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 167' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -60.52 -37.7 82.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.94 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.91 -25.67 59.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.86 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 169' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -75.07 -23.75 58.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.92 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 2.2 mtp85 -56.43 -25.55 50.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.869 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 171' ' ' ARG . . . . . 0.401 ' O ' ' CG ' ' B' ' 172' ' ' HIS . 8.8 mmm180 -67.04 -13.8 62.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.888 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 172' ' ' HIS . . . . . 0.401 ' CG ' ' O ' ' B' ' 171' ' ' ARG . 46.6 p-80 41.6 38.36 0.89 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.814 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 173' ' ' ILE . . . . . . . . . . . . . 4.2 tt -78.16 143.0 13.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.131 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 18.5 m -83.79 55.12 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.142 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 175' ' ' ARG . . . . . . . . . . . . . 6.4 ttt85 -84.52 -28.98 26.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.87 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 58.8 90.91 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.94 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 177' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.904 179.997 . . . . . . . . 0 0 . 1 stop_ save_